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ABSTRACT 
Deoxynivalenol (DON) is a mycotoxin naturally occurring in worldwide grain 
supplies and has caused gastrointestinal disease and immunotoxicity in animals. Methods 
were optimized for analysis and screening of food samples for DON. Immunomodulatory 
effects of low levels (< 2 mg/kg) dietary DON and acute exercise stress was investigated in 
BALB/c mice as a model for potential interaction in humans. Caffeine (CAP) was found to 
be a suitable internal standard for analytical detection of DON in wheat samples using high 
performance liquid chromatography (HPLC) with ultraviolet detection. Peak area response 
ratios DON: CAP were adequately precise over multiple runs and a range of spiked samples 
(0.25 - 6.0 ppm DON). This method will allow analysis of samples using an easily 
accessible, stable, and inexpensive compound that is not likely to be found in most samples 
of interest. A bioassay was used to screen for DON in the range of common contamination in 
a variety of food samples. Human K-562 erythroleukemia cells, modeling immune stem 
cells, were incubated with wheat and corn extract residues dissolved in complete media and 
cell proliferation was assessed by the MTS [dimethylthiazol-2yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] dye reduction assay. 
Samples containing DON ranged in concentrations from 204 to 3792 ng DON/g food which 
strongly correlated with HPLC analysis. This sensitive bioassay may serve as an inexpensive 
low-tech alternative for screening food samples or products of DON detoxification studies. 
We hypothesized that acute exercise stress would exacerbate immunosuppressive effects of 
sub-acute exposure to dietary deoxynivalenol (DON). Male BALB/c mice were fed 0 or 2 mg 
DON/kg for 14 days (n=12 per dose), then half of each treatment group were exercised to 
fatigue on a treadmill. Only the non-exercised DON-fed mice showed significant splenocyte 
proliferation suppression with increased IL-4 expression in response to mitogen stimulation. 
Antibody response to T-dependent antigen (sheep red blood cells) was significantly less for 
exercised DON-fed mice with increased IL-2 expression. Serum corticosterone levels were 
significantly higher for both exercised groups. Our hypothesis was confirmed with respect to 
T-cell dependent antibody production, but not for splenocyte proliferation. Exercise stress 
protected against DON-mediated suppression of splenocyte proliferation, perhaps mediated 
by induction of elevated stress hormones counteracting cytokine expression alterations of 
vi 
DON. This interaction was investigated further with BALB/c male mice fed 0, 1 or 2 ppm 
DON for 28 days then half of each treatment group was exercised to fatigue on a treadmill. 
Exercise was inhibitory for IL-4, NK cytotoxicity, spleen: body weight ratio, blood 
lymphocytes, hemoglobin, hematocrit but caused elevated blood neutrophils. Dietary 2 ppm 
DON inhibited weight gain, red blood cell numbers and hematocrit but increased feed intake. 
DON fed at 1 ppm stimulated NK cytotoxicity, PFCs, and spontaneous IFN-y secretion. 
Blood lymphocytes were suppressed by DON feeding independent of dose. This is the first 
report of in vivo immunostimulatory effects of sub-chronic low dose DON feeding. DON fed 
at 1 ppm seemed to promote Thl responses in vivo, most likely through differential cell 
signal transduction affecting cytokine production, which may be abrogated by acute exercise 
stress. Apparent immunological hormesis of feeding 1 ppm DON deserves further 
investigation. 
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CHAPTER 1. GENERAL INTRODUCTION 
Research Questions 
The work discussed in this dissertation originated from interests in food safety. 
Previous job duties had included inspection of food supplies with a familiarization of 
toxicological and microbiological screening of foods for mass consumption. Although DON 
work had not been conducted in our lab previously, this mycotoxin had some characteristics 
that warranted further investigation. After a cursory review of current knowledge of DON, it 
became apparent that this mycotoxin occurred in a wide variety of staple grains and 
screening for its presence in these foods was sporadic or non-existent. Human illnesses had 
occurred that appeared to be caused by DON exposure in foods, usually as epidemics 
although clear linkage between the mycotoxins presence in foods and human illness have yet 
to be confirmed. Though grain supplies in the United States are screened for DON, at 
industry discretion, foreign procured food would be less likely to be tested. 
Our initial interest in DON research was development of high throughput low-
technology screening tools for field use. There are ELIS A kits for DON on the market but 
may be too sophisticated and expensive for use in under-developed countries. Prior to 
screening assay development, a reference analytical method was needed. High performance 
liquid chromatography methods were published and peer-reviewed but required two analyses 
per sample as no internal standards for this method had been developed. We felt that an 
internal standard method would simplify the analytical method as well as reduce the volume 
of hazardous wastes produced. 
Screening assay development as a primary goal of research continued but numerous 
methods were contemplated. Immunological effects of DON had been published as well as 
several bioassays. Bioassays had been developed as tools to compare absolute toxicity of 
several mycotoxins but most cells used were not derived from nor modeled DON sensitive 
tissue in vivo. K-562 cells had been tested and found sensitive to purified DON in media 
within the range of DON sensitivity of human immune cells. Cereal sample extracts had been 
screened for DON toxicity on fibroblast cell lines. We hypothesized that these assays could 
be combined and a bioassay that was relative to known in vivo DON toxicity would be useful 
to assess detoxification strategies and metabolic products of DON in the future. 
2 
A large gap of knowledge in toxicological research was in vivo responses to toxin 
interactions. Granted, human research is difficult to conduct in this area and effects of many 
confounding factors must be considered. Controlled animal experiments may provide 
evidence that could focus or deemphasize the importance of confounding factors. Evidence 
exists for immunological effects of DON on the immune system, however limited systematic 
studies have been reported and no epidemiological studies in humans. Swine are the most 
sensitive species to DON and evidence suggests similar bioavailability for most monogastric 
animals. While not lethal to pigs, DON causes vomiting and poor growth performance at low 
dietary levels. Limited immunological assays have been conducted in pigs, due to the lack of 
reagents and expense of these studies. Mouse studies have the advantage of a large range of 
reagents available, adequate samples sizes to validate findings, and historically comparable 
immunological responses to humans. 
Exercise stress in mice as a model for human stress has been established. Stress can 
cause immunomodulation in humans and animals depending on the specific stressor duration, 
intensity, and frequency of exposure. Acute exercise stress is simple to induce in mice and 
has been comparable with human responses to similar stresses. As little work has been 
conducted investigating interactions of xenobiotic exposure and other environmental 
stressors, we hypothesized that dietary DON (doses causing minimal immunosuppression in 
mice) would exacerbate immunosuppressive effects of acute exercise stress. We further 
wondered about mechanisms of immunomodulation by these two agents including 
evaluations of effector molecules such as cytokines. Research reported here indicates 
importance of conducting epidemiologic studies to determine actual human exposures to 
ubiquitous mycotoxin food contamination and potential for previously unidentified 
interactions of food contaminants with environmental stressors and implications for 
immunomodulation. 
Dissertation Organization 
This document contains a general literature review, including the most relevant 
information to the research questions proposed. Four manuscripts for publication are 
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included as separate chapters. All references cited are listed in a separate section at the end of 
the dissertation. 
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CHAPTER 2. LITERATURE REVIEW 
General Information 
Deoxynivalenol is a trichothecene mycotoxin. There are about 180 trichothecenes but 
only a handful are significant in human and animal health. The first report of the structure of 
DON and its identification as the toxic principal from grain known to produce vomiting in 
swine was by Vesonder et al. (1973). Following organic solvent extraction and purification 
by thin layer and column chromatography, a single toxic fraction was isolated and analyzed 
by mass spectroscopy to determine the molecular weight (296.16) with an empirical formula 
of C15H20O6. Based on infrared and nuclear magnetic resonance spectra a chemical structure 
was proposed which was related but unique from already identified trichothecenes T-2 toxin 
and fusarenon-X. The molecular structure of DON and other related trichothecenes is 
illustrated below (Figure 2.1). 
Trichothecene R1 R2 R3 R4 R5 
Deoxynivalenol OH H OH OH =0 
3-Acetyldeoxynivalenol OAC H OH OH =0 
15 - Acetyldeoxynivalenol OH H OAC OH =0 
Fusarenon-X OH OAC OH OH =0 
Nivalenol OH OH OH OH =0 
Figure 2.1. Trichothecene skeleton and sidechains of selected mycotoxins. 
Biosynthesis -
Fusarium species of fungi are numerous and ubiquitous in the environment and can 
be pathogenic to common staple crops such as wheat, corn and barley. These fungi can 
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produce secondary metabolites such as mycotoxins. Mycotoxin production by these 
organisms has been known for a long time but more recently the connection between fungal 
species, mycotoxin(s) produced, and environmental conditions favorable for biosynthesis of 
these molecules has been elucidated. Deoxynivalenol is produced by three Fusarium species: 
graminearum, pseudograminearum, and culmorum. Miller et al. (1991) cultured Fusarium 
graminearum, culmorum, and crookwellense collected from China, Mexico, and the 
Netherlands. Each isolate was associated with plant pathology in cereals and was grown in 
liquid media and on rice to characterize the secondary metabolites. The metabolites generally 
fell into two classes; major metabolites, including trichothecenes, that were characteristic for 
the specific strain, and minor metabolites of trichothecene-related compounds common to 
many fusaria. From gas chromatography/mass spectroscopic analysis of the metabolites, 
chemotypes were proposed based on chemical structure of mycotoxins produced. Fusarium 
graminearum and culmorum had overlapping chemotypes since they had similar profiles. 
Chemotype IA produced DON and 3-acetyldeoxynivalenol (3-ADON) and chemotype IB 
produce DON and 15-acetyldeoxynivalenol (15-ADON). Chemotype IB is the prominent 
chemotype in North America. Asian isolates tend to be chemotype IA indicating genetic 
variability in biosynthetic pathway enzymes. Other chemotypes of F. graminearum are II, 
which produces nivalenol, and HA producing nivalenol and 4-acetylnivalenol. From this 
work, a systematic approach to classifying toxigenic Fusarium species, based on the specific 
mycotoxins produced, complementing the taxonomic classification. Genetic variability as a 
major contributor to mycotoxin biosynthesis potential was more defined. 
Much effort has been focused on the genetic influence on trichothecene biosynthesis 
since this information could elucidate a target for genetically modified control. All of the 
biosynthetic pathway enzymes have not been determined but Moss and Thrane (2004) 
indicated that the production of trichothecenes was not trivial since it required a substantial 
energy commitment of at least 9 acetyl CoA, 6 NADPH, 9 ATP molecules, and cytochrome 
P450 activity. Little was known about the purpose of mycotoxin production by the fungi. 
Lutz et al. (2003) determined a specific beneficial effect of DON biosynthesis. They 
inoculated maize leaf tissue with DON-producing strains of F. culmorum, a genetically 
modified F. graminearum DON-nonproducer, and Trichoderma, an antagonistic fungus 
6 
which can competitively colonize field residues and produces chitinase and other fungal cell 
wall-degrading enzymes. Once confirmation studies were conducted for DON production in 
the proposed in vitro system, it was determined that DON repressed a specific chitinase gene 
(nagl) in the Trichoderma. They reported that this was the first evidence of specific genetic 
alteration on an antagonistic organism although many variables influenced the effect on the 
Trichoderma including the age and cultivar of the residue. Since this work was conducted on 
the bench many questions still exist about similar effects occurring in the field and possible 
futility of continued biocontrol strategy development. Even with a great deal of effort toward 
control of Fusarium infection on staple grains, trichothecene contamination occurred 
globally although sporadically depending on environmental conditions. 
Edwards (2004) reviewed the environmental conditions found to favor mycotoxin 
accumulation in food crops. Risk factors associated with increased DON accumulation were: 
the crop grown the preceding two years particularly grain maize the previous year; minimum 
tillage of the soil was more likely to be associated with DON contamination when compared 
to deeper tillage such as ploughing; application of nitrogen fertilizers; application of 
fungicides (azoxystrobin increased DON contamination in field trials); and herbicide 
(glyphosate) application. Biological and insect control has shown promise in the laboratory 
environment but little or no progress has been made in the field. Edwards further expressed 
the evidence for synergistic interactions of risk factors for DON production as reported by 
Obst et al. (2000). Risk factors for DON contamination of wheat were crop rotation after 
maize planting, minimum tillage after maize planting, susceptible wheat variety, application 
of strobilurin fungicide, and warm wet weather during flowering. Presence of one of these 
risk factors increased the risk of DON accumulation by a factor of three whereas presence of 
four risk factors increased risk 56 fold. This information was helpful for attempting to 
educate the wheat producers on practices to reduce mycotoxin risk. DON was the only 
mycotoxin reviewed and production of other mycotoxins may occur even under conditions 
that would be predicted to reduce DON since changes in environmental conditions seem to 
favor production of specific mycotoxins. Much more research will need to be conducted 
before control of mycotoxin production in the field is successful. 
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DON may be produced by Fusarium spp. as a secondary metabolite, synthesis not 
required for survival or growth, along with other closely related trichothecenes. Taxonomic 
classification of Fusarium sp. was supplemented with chemotype designation based on 
specific trichothecenes production (Miller et al. 1991). Even though all biosynthetic 
pathways have not been determined, cellular energy resources are required for trichothecene 
production (Moss and Thrane, 2004) and they may serve to promote competitive advantage 
over antagonistic fungi on crop residues (Lutz et al., 2003). Conditions that increased risk of 
a DON outbreak in a crop were associated with tillage practices, environmental conditions, 
and crop rotation (Edwards, 2004). There are still knowledge gaps in the finer points of 
trichothecene production from Fusarium that do not allow accurate predictions of crop 
contamination outbreaks. Work not reported here, has been published concerning crop 
improvements to resist fungal infection but the fungi mutate rapidly and even if resistance 
could be effectively engineered into a crop, the resistant cultivar may only be useful in a 
fairly small region. Further work on the biosynthetic pathway may lead to identification of 
upstream, highly conserved non-essential foci that will provide effective generalized crop 
resistance. 
Worldwide occurrence 
Outbreaks of contamination occur regularly in worldwide food supplies regardless of 
any control efforts for natural mycotoxin contamination. Since analytical methods have 
become more prevalent, sensitive, and specific, food surveillance for mycotoxin 
contamination has become more common. The following is a table of some of the surveys 
that have been conducted with information on method used and other contaminants found. 
Country Food/Feed type DON # positive/ Other mycotoxins Detection Method References 
mg/kg # tested detected (limit of detection) 
China Raw corn <0.5 - 2.7 7/12 FBI, FB2, FB3, GC/MS (0.5 Groves et al. 
Commeal <0.5-1.6 8/13 15ADON mg/kg) (1999) 
Cooked <0.5-1.5 4/14 
pancakes 
China Wheat 0.016-51.45 8/8 NIV, 3ADON, ZEA GC/MS Li et al. (1999) 
Barley 0.132-3.521 2/2 N1V, ZEA (trichothecenes 
Corn 0.256-21.200 2/2 NIV, ZEA, FBI, 0.01 mg/kg) 
FB2, FB3, 15ADON HPLC (fumonisins 
0.05 mg/kg) 
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Table 2.1. (continued) 
Nepal Com grain nd- 11.00 10/58 Fumonisins Immunoassay (1.0 DesJardins et al. 
Com flour nd - 3.00 1/8 Fumonisins mg/kg) (2000) 
Cornflakes nd 0/2 Quantitative 
fluorometry (1.0 
mg/kg) 
Portugal Bran cereal <0.1 - >5.001 16/24 HPLC (0.1 mg/kg) Martins and 
Wheat flakes <0.1-5.000 16/20 Martins (2001) 
Wheat & fruit <0.1-5.000 32/44 
cereal 
Germany White wheat 0.239 + 0.228 28/28 NIV, ZEA GC/MS (0.002 - Schollenberger 
flour 0.012 mg/kg) et al. (2002) 
White wheat 0.234 ±0.215 12/13 NIV, HT-2, ZEA 
flour 
Whole wheat 0.404 ± 0.427 19/19 NIV, 3ADON, 
flour 15ADON, HT-2, T-
2, ZEA 
Germany Wheat flour 0.394 mean 59/60 discussed but not GC/MS (0.007 Schollenberger 
0.956 (90* %) reported mg/kg) et al. (2003) 
Wheat bread 0.125 mean 127/141 
0.247 (90* %) 
Noodles 0.275 mean 61/67 
1.149 (90* %) 
Rice 0.058 mean 14/26 
Oats & products 0.024 mean 12/23 
Com & products 0.034 mean 25/36 
Canada Oat-based infant 0.052 mean 33/53 OTA, ergot alkaloids GC/MS (limit of Lombaert et al. 
cereals 0.090 max. quantification (2003) 
Barley-based 0.260 mean 29/50 ZEA, OTA, ergot DON 0.020 mg/kg) 
infant cereal 0.980 max. alkaloids 
Soy based infant 0.116 mean 8/8 ZEA, OTA, FB 
cereal 0.240 max. 
Multi-grain 0.116 mean 62/86 ZEA, OTA, FB, 
infant cereals 0.400 max. ergot 
Rice-based nd 0/9 ZEA, OTA, FB 
infant cereals 
Teething biscuits 0.060 mean 18/24 ZEA, OTA, FB, 
Soy formulas 0.120 max. ergot 
Creamed com nd 0/1 nd 
nd 0/6 nd 
United Durum wheat nd - 23.0 123 tested 15ADON (nd-0.8) GC (LOD not Manthey et al. 
States NIV nd reported) (2004) 
United Hard winter 0.8 mean 94/194 not reported ELISA (0.5 mg/kg) Trucksess et al. 
States wheat 7.6 max. (1995) 
Soft winter 1.4 mean 50/59 
wheat 14.6 max 
Hard spring 3.7 mean 180/201 
wheat 18.4 max. 
Soft white wheat 0.1 mean 8/28 
Mixed wheat 0.7 max. 
Barley 2.3 1/1 
3.0 mean 79/118 
Malting barley 14.0 max. 
9.0 mean 29/29 
25.8 max. 
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Table 2.1. (continued) 
Italy Cereals, whole 0.065 median 111/111 FBI, FB2 GC/ECD (0.007 Cirillo et al. 
meals, flows (0.065-0.930 mg/kg) (2003) 
range) 
Breads 0.046 median 19/24 FBI, FB2 
(0.007 - 0.270) 
Durum wheat 0.019 median 7/17 FB2 
pasta (0.009 - 0.077) 
Breakfast 0.023 median 9/14 FBI, FB2 
cereals (0.012-0.047) 
Biscuits 0.040 median 16/24 FBI, FB2 
(0.016-0.150) 
Baby & infant 0.035 median 7/12 nd 
foods (0.007 - 0.166) 
Denmark Wheat 0.144 mean 75/88 NIV, HT-2, T-2, GC-ECD (0.020 Rasmussen et al. 
0.527 max. ZEA mg/kg) (2003) 
Rye 0.043 mean 41/69 
0.257 max. NIV, HT-2, T-2, 
Durum wheat 1.155 mean 33/33 ZEA 
2.591 max. 
NIV, T-2 
United Polenta 0.587 mean 2/2 ZEA, FBI, FB2, FB3 GC/MS (0.050 FSA (2005) 
Kingdom ±0.135 sd ZEA, FBI, FB2, LOQ) 
Corn cereals 0.227 mean 15/44 FB3.NIV 
± 0.306 sd ZEA, FBI, FB2, 
Snacks 0.157 mean 19/38 FB3, OTA 
± 0.077 sd 
United Cereals 0.138 mean 42/60 3ADON, 15ADON, GC/MS (0.010 FSA (2003) 
Kingdom ± 0.355 sd FUSX, NIV, T-2, LOQ) 
HT-2, ZEA 
Cookies 0.033 mean 49/60 NIV, ZEA 
± 0.044 sd 
Bread 0.058 mean 57/60 NIV, ZEA 
± 0.062 sd 
Cakes 0.024 mean 19/40 -
± 0.015 sd 
Flour 0.061 mean 36/40 NIV 
±0.091 sd 
Polenta 0.175 mean 7/8 15ADON, NIV, ZEA 
± 0.139 sd 3ADON, 15ADON, 
Snacks 0.251 mean 36/40 NIV, ZEA 
± 0.269 sd ZEA 
Com flour - 0/8 NIV, HT-2, ZEA 
Baby food 0.047 mean 13/17 
± 0.044 sd 15ADON, NIV, ZEA 
Snacks (2nd 0.092 mean 37/44 
survey) ± 0.073 sd 
This long list is not complete but provides a snapshot of the diversity of mycotoxins 
in foods to which humans were exposed. 
Worldwide regulations 
The regulation of mycotoxins worldwide was recently reviewed by the Food and 
Agricultural Organization of the United Nations (PAO 2004). Guidelines or regulation of 
DON was reported for 37 countries. DON levels allowed in human food range from zero 
tolerance in baby food (Belarus) to 2000 pg/kg in corn (Czech Republic). The Food and 
Drug (FDA) administration of the United States has an advisory level of 1000 pg/kg in 
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finished wheat products for human consumption. Figure 2.2 illustrates the range of tolerated 
levels in food for adult consumption and the number of countries using that guideline. 
2000 
1200 
g 1100 
8 
700 
300 
Figure 2.2. Regulatory levels of DON in human foods, with number of countries using each 
regulatory level 
A complete listing of the countries and specific regulations for all mycotoxins regulated in 
foods and feeds is available (FAO, 2004). 
Economic significance of contamination 
The Council for Agricultural Science and Technology projected the annual cost of 
DON contamination in cereal grains in the United States (CAST 2003). The model included 
727 samples of wheat and corn food and feeds from 1995-1997 FDA and private survey 
samples. Food losses were based on samples with > 1 ppm and feed losses where DON levels 
were greater than the advisory level for the intended species feed. From the survey samples, 
6.9% of corn samples and 12.4% of wheat samples had DON contamination greater than 1 
ppm. Both grains had annual output of 900 million bushel each per year. Wheat feed output 
was 275 million bushel with 1.8% exceeding advisory levels. Other costs considered were 
diverting crops for alternate uses, separation of contaminated from clean crops, and losses in 
livestock due to the current toxicity assessments. It was estimated that annual human food 
crop loss was $637 million, with $18 million lost feed crops and $2 million in livestock costs. 
The model assumed that all output loads were tested but most shipments were not thus 
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underestimation of losses was likely. Data on human toxicity was lacking so that no costs 
could be assigned. The authors were conscious of unknown factors and clearly indicated that 
these results were only a preliminary attempt. Regardless, the value of crop loss from DON 
contamination was substantial and efforts to remediate DON contamination are ongoing. 
Resistance to processing 
One of the difficulties when dealing with this natural food contaminant is its 
resistance to remediation through common food processing practices. Scott et al. (1983) were 
one of the first groups to assess DON retention in wheat from milling to baking. A naturally 
contaminated hard spring wheat sample, approximately 7.1 mg/kg DON as harvested, was 
cleaned and processed through a laboratory mill with fraction sample collection. The end 
product flour from each of duplicate lots was baked into three loaves by a standard bread 
recipe at 205° C for 30 minutes. Samples were analyzed by GC-electron capture and 
confirmation with GC-MS with method recovery of DON spiked samples 86 ± 7.8% (n = 3). 
The initial concentration of the wheat by the experimental methods was 4.62 mg/kg with a 
higher concentration occurring in the dockage, cleaning screenings (16.7 mg/kg), but this 
fraction was only 0.9% of total weight processed. The bran, shorts, feed flour and final flours 
had approximately equal concentrations (3.96 to 7.42 mg/kg) and the finished bread had at 
least 4.00 mg/kg. No statistical analysis was reported to compare the DON levels between the 
milling fractions or differences between analytical methods employed. This experiment 
revealed the potential for DON to continue through the food supply chain in common 
finished products. 
DON retention in baked products was also conducted by El-Banna et al. (1983) 
investigating the effect of higher baking temperatures used to cook Egyptian bread. A 
naturally contaminated whole wheat flour (3.31 mg/kg) and spiked uncontaminated whole 
wheat flour was made into dough and fermented by a traditional recipe. Bread was baked at 
350° C for 2 minutes. Samples were analyzed by GC-ECD and confirmed by GC-MS with 
recoveries of DON spiked into flour, fermented dough, and bread of 99.4 ± 3.4, 94.6 ± 3.7, 
and 96.1 ± 4.9% respectively. The experiment was replicated three times and comparisons 
were made between the two analytical methods used. Statistical analysis was not reported but 
the method seemed to improve over time as the DON recovery from spiked samples became 
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doser to 100% with smaller standard deviations in the final replication. They found no loss 
of DON through the fermentation or baking for naturally or spiked flours. Thus higher 
baking temperature did not affect the recovered concentration of DON, nor did the 
fermentation. 
DON tt isoDON H 
OH 
HO 
CH2OH 
OH 
OH 
Figure 2.3. Chemical structures of deoxynivalenol and isodeox vnivalenol. 
Greenhalgh et al. (1984) provided some evidence for a thermal conversion of DON to 
an isomer of DON (isoDON, Figure 2.3) as an explanation for disappearance of DON during 
some food production processes. IsoDON was synthesized and characterized through 
chemical acetylation and hydrolysis followed by thin-layer chromatographic purification and 
structural identification by *H NMR. Thermal treatment of purified DON in nitrogen at 160° 
C for 1 hour resulted in 65% loss of parent DON and 95% loss at 200°, with production of 
four new peaks as determined by mass spectroscopy. IsoDON was identified as one of the 
peaks, although it appeared to be a minor product and the other three peak's identification 
was not reported. When naturally contaminated wheat flour (0.5 mg DON/kg) and spiked 
wheat flour (0.1 and 3.0 mg DON/kg) were baked into bread, isoDON appeared in greater 
concentration in the crust than the crumb (estimated concentrations were not reported). It was 
stated that isoDON was present at 3 to 13% but it was not clear if this was a percent of the 
parent DON. The isomer was not present in the unbaked flours, but occurred in some wheat-
based heat-processed breakfast cereals manufactured from naturally contaminated wheat. 
Validity of these results was questionable as no statistical analyses or replications were 
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reported. This study provided some evidence for a compound that may be produced from 
DON due to processing but it appeared to be minor and the previous two studies did not 
report a significant reduction of DON through bread baking. An issue that was not addressed 
was the difference in apparent substantial disappearance of DON during thermal processing 
of the purified compound versus the lack of similar disappearance in the foods. IsoDON 
production may not be relevant if it does not occur to a greater extent in foods where DON 
may be protected from transformation. Importance of production of this compound would be 
confirmed by toxicity assessment of the processed product. 
Following an epidemic year for DON contamination in wheat Seitz et al. (1986) 
investigated the effects of four wheat cleaning methods on DON reduction in baking flour. 
Normal cleaning involved movement of wheat through a cleaning house (60 bushels/h) with 
multiple screens and suction to aspirate the screenings. Other cleaning treatments included 
running the wheat through the cleaning process twice (double), increasing the suction (high 
aspiration), and running the wheat through a wheat washer following the normal cleaning so 
that the wheat was thoroughly wetted (water washer). Five naturally contaminated (1.85 ± 
1.85 mg/kg) and two uncontaminated lots of commercially grown hard red wheat in Kansas 
were cleaned by described methods, milled and baked into western type bread, one loaf of 
bread per lot of wheat and treatment (28 loaves). All samples were analyzed by HPLC in 
duplicate with separate samples for the crust and the crumb. There was no significant 
difference between cleaning methods for reduction of DON and none of them were 
particularly effective with 61 ±4.5% reduction compared to the uncleaned wheat. There was 
no apparent difference between the DON concentrations in the crust versus the crumb and an 
overall reduction in DON levels (-22 ± 15%) with less reduction at higher concentrations. 
Since there was no experimental replication, the significance of any of the results could not 
be evaluated. This report does not substantiate the previous report of reduction in crust 
concentration due to thermal alteration although recovery studies were not reported for the 
analytical method. This study identifies that millers may not be able to effectively alter 
current cleaning and milling processes to utilize naturally contaminated grains. 
Processing reductions in DON contaminated corn has been investigated for making 
tortillas. Abbas et al. (1988) used two stored corn samples, one of which had been identified 
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as causing feed refusal in pigs 13 years previously. Naturally contaminated samples were 
compared to uncontaminated corn and corn spiked with zearalenone and DON (1 ppm or 5 
ppm each) or DON alone at 10 ppm. The com was processed and tortillas were prepared by a 
domestic Mexican method which included an aqueous 2% Ca (OH)% boil and overnight soak. 
Unprocessed corn, finished tortillas, and soaking water were analyzed by HPLC for DON 
and 15-ADON with TLC and GC/MS confirmation. Zearalenone concentrations were 
determined by HPLC with GC/MS confirmation. The two stored corn samples contained all 
three mycotoxins with zearalenone at 0.23 ± 0.08 and 4.23 ± 0.65 ppm, DON 3.28 ± 3.64 and 
12.26 ± 3.01 ppm, and 15-ADON 1.49 ± 1.07 and 9.83 ± 1.62 ppm, respectively. Tortilla 
processing reduced zearalenone by 59.1% in the more contaminated sample and 100% 
reduction in the lesser contaminated sample but the reduction did not appear to be due to loss 
into the soaking water. DON levels in the tortillas was consistently reduced compared to the 
original corn in all samples (71.9 to 82.4%) although soaking water concentrations was not 
reported and no statistical analysis was indicated to assess significance of reduction. 15-
ADON was reported to be completely removed by the tortilla process. Alkaline conditions 
seemed to partially degrade these mycotoxins but the only limit of detection for the analytical 
methods reported was for the HPLC analysis of DON (10 ng) and 15ADON (500 ng). A 
detection method with lower limit of detection may have characterized the disappearance of 
15-ADON better. Other than one report by Greenhalgh et al. (1984) described previously, 
characterization of degradation products chemically or toxicologically have not been 
conducted. 
As the DON contamination of wheat varieties spread across Canada in the 1980's, 
concerns arose about the influence of processing on DON contamination in different food 
products made from this wheat. Nowicki et al. (1988) studied the retention of DON in wheat 
processed to spaghetti and noodles. Two varieties of wheat naturally contaminated with DON 
(12.5 and 9.6 mg/kg) were milled and processing into Chinese and Japanese noodles and 
spaghetti. The pastas were cooked and the cooking water collected and freeze-dried. Analysis 
was by GC-ECD and GC-MS for all samples. Recovery studies included spiking a control lot 
of both wheat varieties with DON at 5.0 and 0.5 mg/kg, then processing to semolina and 
spaghetti. Total recoveries were greater than 90% with cooked spaghetti retaining 50% of the 
15 
original DON spike regardless of the spiking concentration. Japanese noodles retained an 
average of 110.9 ± 6.2% of the DON in the noodle and the cooking water, with even 
distribution. Chinese noodles exhibited a loss of DON with retention averaging 57.2 ±0.8% 
in the noodles and the water. This was attributed to addition of a commercial preparation of 
carbonate and phosphate salts of potassium and sodium that represent 1% of the recipe. This 
resulted in alkaline conditions that contributed to DON degradation similar to tortilla 
processing. No pH measurements of the cooking water were reported so this was not 
confirmed. Spaghetti results were similar to the Japanese noodles with total retention of 92.5 
± 7.7% DON in the pasta and the cooking water with 48.6 ± 3.9% in the noodles alone. 
Overcooking the noodles increased the leaching of DON into the water by another 6%. This 
work did not report any experimental replication therefore statistical significant of treatments 
could not be evaluated. These non-staple food products may have reduced DON levels in the 
consumed forms but Japanese style noodles may be consumed as soups retaining all of the 
mycotoxins present in the uncooked product. Further work would be needed to characterize 
the DON degradation products under the alkaline conditions proposed for the Chinese style 
noodles. 
Another type of food product cereal-based with the potential for DON contamination 
is extruded snacks. Baking has not proven to be a method of DON decomposition therefore 
Accerbi et al. (1999) investigated extrusion of DON contaminated wheat following treatment 
with aqueous sodium bisulfite solutions (0.0, 0.5, 1.5, 2.5 or 5.0% SO? equivalent) for 1 hour. 
The original DON concentration of the soft white wheat was 7.3 mg/kg and analysis of 
experimental samples was by GC-ECD. Whole wheat was soaked in the treatment solution, 
drained and dried overnight. Two extrusion protocols, low temperature (max. 140°C) and 
high temperature (max. 170°C), were followed with milled whole meal and flours from the 
soaked samples (n = 3 per treatment). DON concentrations were significantly reduced by 
sodium bisulfite but >1.5% sodium bisulfite treatments were not more effective. The authors 
reported statistical analysis in the methods but no standard deviations were given and limited 
assessment of significance of results. The low temperature protocol was slightly more 
effective which was attributed to instability of DON-S adducts as reported by Young et al. 
(1986b) (see page 20). From a food processing perspective, the addition of sodium sulfite to 
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flour for baking resulted in unsatisfactory consumables whereas the finished extruded 
product appeared to have acceptable odor and appearance. This study utilized highly 
contaminated wheat (7.3 mg/kg) with treatments resulting in DON levels (0.6 mg/kg in 1.5% 
SO2, low temp, extrusion) that would be acceptable under current FDA advisory level for 
food for human consumption. 
Numerous other food products with the potential for mycotoxin contamination are 
processed by retorting, food processing similar to autoclaving. Wolf-Hall et al. (1999) 
studied the effect of extrusion on corn grits and dog food and the effect of autoclaving on 
cream-style corn and wet dog food with regard to DON retention. All food samples were 
spiked; com grits with crude extract from Fusarium graminearum culture to achieve 4 mg 
DON/kg, purified DON was used to spike commercial dog food powder mix (5.47 mg/kg), 
locally purchased canned cream-style com and liver-flavored canned dog food (3 mg 
DON/kg). The canned products were removed from the original containers, mixed with the 
spiking solution and refrigerated overnight prior to autoclaving at the conditions consistent 
with commercial retort pressure and temperature. Analysis was done by ELISA with limit of 
detection 0.3 mg/kg, three replications of the experiment and two analyses per experiment. 
An additional set of analysis was conducted with inclusion of a-amylase to the aqueous 
sample extraction before DON determination by ELISA. The addition of a-amylase was to 
improve the filterability of the cream-style com but surprisingly had a significant 
improvement in the recovery of DON from the processed samples. The recovery samples 
revealed 71 to 100% recovery without a-amylase but increased to 89 - 120% with the 
enzyme in the extraction. The sample results were more dramatic with 226% increase in 
DON recovery from extruded com grits and all samples showed increased recovery 125 -
141% compared to the processed samples without a-amylase. The only process that showed 
an influence on DON retention was autoclaving cream-style com, 12% less DON than the 
unprocessed control. This study determined that these common food processing techniques 
do not significantly reduce DON levels in food and the possibility of heat sensitive binding 
between food carbohydrates and DON. This binding would most likely be released when the 
food enters the mammalian gastrointestinal tract. DON analysis in heat-treated foods may 
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underestimate the contamination. Further investigation into this interaction has not been 
reported thus far. 
Since heat processing has not been shown to reduce DON levels, studies have 
investigated recipe additives to promote DON reduction. Young et al. (1986a) tested 
chemical (hydrogen peroxide ± sodium hydroxide, sodium hypochlorite, sodium bisulfite, 
ascorbic acid, ammonium hydroxide, hydrochloric acid, sulfur dioxide gas and ozone) 
treatment on soft white winter wheat naturally contaminated at 1 ppm. Following the various 
treatments, wheat was milled and the flour was baked into cookies, cakes, crackers, muffins, 
and pancakes. Samples of milling fractions and final products were analyzed by GC-ECD. 
The greatest reduction in DON level (98%) was by the addition of 750 ml 10% aqueous 
sodium bisulfite per kg grain for 16 hours. After the treated flour was baked into a final 
product, DON levels increased 3-6 fold compared to the unbaked samples with an overall 
reduction of 31 - 51%. Other treatments resulted in 60% reduction at best. The flour product 
after prolonged sodium bisulfite treatment was deemed unsuitable for commercial use. 
Another group attempted to add ingredients to reduce DON contamination. 
Boyacioglu et al. (1993) investigated oxidizers (potassium bromate and L-ascorbic acid), 
reducing agents (sodium bisulfite and L-cysteine) and ammonium phosphate at maximum 
allowable levels added to bread recipes using a whole wheat flour contaminated with 3.13 
ppm DON or a spiked flour (2 ppm ending concentration in bread). Flours and breads were 
analyzed by GC/EC with confirmation by GC/MS and method recovery reportedly 87%. 
Baking bread without additives resulted in 7% reduction of DON, while the oxidizing agents 
had limited reduction (L-ascorbic acid -14.1 to -25.9%) or increased levels (potassium 
bromate +4.8 to +10.5). Significant reductions were achieved with the other agents (-36.7 to -
45.4%) but depending on the starting concentration, may not be adequate to assure safe 
consumption levels. 
Since microorganisms are used to produce some food products, microbial degradation 
of mycotoxins has been investigated by several groups. Boswald et al. (1995) investigated 
disappearance of zearalenone and DON in food related yeast incubations. Yeast species were 
chosen based on importance in food processing or spoilage. Standard liquid cultures were 
prepared and cell concentrations normalized prior to mycotoxin exposure. Zearalenone and 
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DON were incubated with the organisms separately and analyzed by HPLC following 24 
hour exposure. Zearalenone was extensively metabolized by all the yeast species to which it 
was exposed whereas DON was unchanged by the four experimental organisms in 
concentrations 0.0,0.125,0.25, 0.5, 1.0, and 2.0 mg/L after 8 days incubation. There were no 
morphologic changes or apparent inhibition of growth of the yeast cells reported. The test 
organisms were yeasts associated with cocoa fermentation, wine production, and beer 
spoilage. The investigators used a good concentration range but may have tried a higher 
range to determine if the organisms' behavior would have changed. Differences observed 
between the two mycotoxins tested was most likely associated with the chemistry of the 
compounds since zearalenone is a steroid and the yeast have biochemical mechanisms for 
related compounds whereas they do not have mechanisms to degrade DON or it was unable 
to cross the cell wall due to its hydrophilicity. From this study and lack of degradation by 
bread fermentation yeasts discussed previously, yeasts are not promising detoxification 
organisms. 
Current food processing techniques did not significantly contribute to the remediation 
of DON in human or animal foods. Grain milling did reduce contamination by partitioning 
DON into the fractions, highest levels in the bran, but reduction effectiveness depended upon 
the penetration of the fungi into the flesh of the kennel (Seitz et al., 1986). Baking (Scott et 
al., 1983), extrusion (Accerbi et al., 1999; Wolf-Hall et al., 1999), or boiling (Nowicki et al., 
1988) reduced the original toxin level up to 50%. Alkaline processes had the greatest 
reductive effects (Abbas et al., 1988). Addition of approved food additives produced a 
product that appeared to have reduced toxin levels but further processing by heat or digestive 
enzymes reversed this effect (Boyacioglu et al., 1993; Young et al., 1986b, Wolf-Hall et al., 
1999). Some additives produced a product that was unacceptable for continued processing or 
consumption (Young et al., 1986b). Thus far, food processing technology is not available to 
contribute to mycotoxin reduction in the food supply chain. 
Detoxification Strategies 
Limited methods for utilizing DON contaminated grains for animal feeds have been 
developed let alone tested for effectiveness. Strategies have included studies with pH and 
temperature, feed additives, abrasive feed grain treatment, and microbial transformations. 
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Wolf and Bullerman (1998) performed a controlled study on effects of pH, time and 
temperature on the disappearance of DON from a buffer solution. Purified DON, 2 pg/ml, 
was added to citrate-phosphate-borate solution buffered to pH 4.0, 7.0 or 10.0. Three 
temperatures (100, 120, and 170° C) and treatment times (15, 30 and 60 minutes) were 
investigated with repetition in triplicate. Samples were analyzed in duplicate by a 
commercial ELISA kit (limit of detection 0.3 jig DON/ g). All treatments at 170° C had 
significant disappearance of DON compared to positive controls. Samples with pH 10.0 had 
significant reduction at all temperatures, disappearance occurring quicker at higher 
temperature. There are some concerns about this study because the ELISA kit was designed 
for water extraction of grain at neutral pH and it was not stated if pH adjustment was made 
prior to sample analysis. Further, treatment times were part of the study design but the 
samples were heated in oil for these times then held in refrigeration for 24 hours prior to 
analysis thus continued DON degradation could have occurred that was attributed to the 
specific treatments. Each treatment was reported to have had at least six analyses but limited 
statistics were given. Alkaline treatments have been shown to reduce DON levels in grain 
and this study attempted to characterize the most effective combination of pH, temperature 
and treatment time but due to some experimental oversight, limited additional information 
was identified. 
Young (1986a) studied food additives as a strategy for decontamination with an 
extensive investigation of transformation products following treatment of culture derived 
DON and 3-ADON reacted with sodium bisulfite. DON disappearance was followed over 
time as well as the reappearance following hydrolysis with various pH solutions, samples 
analyzed by HPLC/UV directly. Spectral analysis by *H and 13C NMR revealed the addition 
of sulfonate side chain to C-10 (figure 2.4) and three alkaline degradation products common 
to DON-related compounds that occur after extensive reaction times. Although no statistical 
analysis was reported for this study, the line of reasoning followed seemed sound and 
provided strong evidence to explain the previous work in baked products. 
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Figure 2.4 Proposed chemical structures for deoxynivalenol sulfonate (DON-S) 
Investigation of the detoxification potential of sodium bisulfite treatment was 
continued by treating experimentally DON contaminated com with subsequent pig feeding 
(Young et al., 1987). Acute toxicity tests used nutritionally complete grower diet as four 
treatments: uncontaminated negative control, negative control treated with sodium bisulfite 
(0.3% of diet), DON-contaminated corn in diet (7.21 mg/kg), and DON-contaminated corn 
treated with sodium bisulfite, 0.79 mg DON/kg diet after treatment. An additional acute 
toxicity test gavaged pigs with purified DON and purified DON-S adduct at effective dose 
shown to cause emesis in 66% of pigs tested (EDee, 0.096 mg/kg body weight) and 98% of 
pigs tested (EDgg, 0.160 mg/kg body weight) (Prelusky, 1986 unpublished results). Four of 
six pigs gavaged with the ED^ of DON vomited within 3 hours whereas the six pigs treated 
with the molar equivalent of the DON-S did not show any signs of toxicity. The higher dose 
caused severe emesis within 20 minutes in all five pigs given the DON but no toxicity signs 
in three pigs given DON-S. The dietary inclusion of the sodium bisulfite treated DON-
contaminated com resulted in similar performance over 7 day feeding as the negative control 
diet with or without the sodium bisulfite treatment (n = five pigs per group). Those fed the 
untreated DON-contaminated diet had significantly reduced feed consumption (870 ± 150 
g/pig per day) compared to the other three diets (1500 ±120 g/pig per day) over the seven 
day feeding period and significant weight loss (-420 ± 160 g/pig per day) in the first three 
days of the study where the other three groups had steady weight gain (500 ±100 g/pig per 
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day). This study had an appropriate number of animals per treatment to show the toxic 
endpoints. Since vomiting in pigs was the original toxic effect assigned to DON exposure, 
this was a specific and sensitive endpoint to use to evaluate the detoxification potential of 
this grain treatment. It was stated that sodium bisulfite can be fed safely to pigs at double the 
study level but the practicality of treating contaminated grain in this manner was not 
discussed. Any further development of this method has not been reported to my knowledge. 
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Figure 2.5 Chemical Structure of de-epoxide deoxynivalenol (DOM-1) 
Work has been conducted to attempt to detoxify DON by microbial transformation. 
From early toxicity studies, it was determined that a de-epoxide of DON was produced by 
cattle (Cote et al., 1986a) and these animals exhibited related reduced toxicity of dietary 
DON. Cote et al. (1986b) purified and characterized the de-epoxide (DOM-1, figure 2.5) 
from an incubation of semi-purified DON (300 mg) with rumen fluid supplemented culture 
media (700 ml) which was 75 - 90% efficient but laborious in purification steps. The 
experiment was more efficient when DON-contaminated ground corn (15 g of 1300 ppm) 
was added directly to fermentation media (225 ml). After three days fermentation, no DON 
was detected by GC/ECD and DOM-1 was purified readily. The purpose of this study was 
mass production of the de-epoxide metabolite and it led to further studies to investigate the 
efficiency of microbial decontamination strategies. 
Initial studies tried to find suitable sources of microbes capable of transforming DON. 
He et al. (1992) investigated anaerobic incubation with chicken and swine large intestine 
contents and aerobic incubations with soil, from a field where F. graminearum inoculation in 
corn had been conducted, on the transformation of purified DON or field-inoculated 
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contaminated corn (450 ppm DON). Efficiency of conversion under various time and 
temperature variables was determined by HPLC/UV detection of remaining DON. The 
chicken intestinal contents had the greatest transformation resulting in 1.8 (± 0.9) % DON 
remaining after 96 hours incubation. Swine intestinal inoculations and soil were not effective 
transformers with 99.0 (± 3.9 se) and 91.6 (± 20.2 se) % remaining after 96 hours. 
Identification of specific bacterial isolates able to transform DON, 20 isolates from chicken 
gut contents and 5 from soil, was unsuccessful. Although replication of each treatment 
appeared adequate, significance of findings was poorly defined. They performed the 
incubations with whole and ground contaminated corn but did not report the condition of the 
sample following the fermentation, i.e. utility of the end product. Dietary history, age or 
number of animals from which intestinal contents were collected was not indicated which 
could affect the microbial profile. 
The utility of treating highly contaminated com with chicken intestinal microbes was 
demonstrated by He et al. (1993). Grower pigs were fed the following diets for 5 days: 
standard corn-soybean grower formula, DON-contaminated (4.8 mg/kg) diet made from 
ground highly contaminated (450 ppm) moldy com (1.7% of clean com), DON-contaminated 
com treated by incubating with chicken intestinal contents and liquid media (2.1 mg DON/kg 
diet), diet with clean corn treated with chicken intestinal contents, and DON-contaminated 
com added to the diet resulting in the same DON level as the biologically treated com diet 
(2.2 mg DON/kg diet). Diets were analyzed for macronutrients and found to be equivalent 
and adequate. Animals were housed individually and fed ad libitum, 3 males and 3 females 
per treatment diet. Daily feed intake weight gain was significantly lower for the 4.8 ppm 
DON diet compared to the other four diets. Significantly lower daily gain also occurred in the 
biologically treated DON-contaminated (2.1 ppm) and the DON contaminated diet (2.2 ppm) 
compared to the negative control pigs. There were no statistical differences between sexes. 
Feed intake and weight gain was not different between groups when they were followed for 
an additional 5 days after experimental diet withdrawal. Treatment of feed with chicken 
microbes could partially decontaminate (50%) corn although the starting concentration was 
high. They stated lack of toxicity for DOM-1, concentration assumed to be the difference 
between the original 4.8 mg/kg and the ending 2.1 mg/kg DON concentration in the diet, 
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since observed reduced weight gain was similar for both 2 ppm diets. Biologically treated 
diet was not autoclaved prior to diet addition but did not seem to exhibit evidence of toxicity 
at the level fed. Appropriate control diets and replication were included to address the 
objectives. Reduced toxicity as result of the treatment occurred but large scale feasibility was 
not addressed. Concerns about large amounts of liquid media and incubation at 37°C would 
limit the utility of this technique. 
Work to isolate DON transforming microbes continued with Shima et al. (1997) who 
isolated a soil bacterium which produced a novel DON metabolite. Soil samples were 
suspended in distilled water and the supernatants were added to enrichment media and 
incubated for 25 days. The culture was quantitatively added to fresh media supplemented 
with DON (200 pg/ml) and incubated for an additional 2 to 8 days. Disappearance of DON 
was monitored by asceptic sampling and HPLC analysis. Soil bacterium from cultures shown 
to cause DON disappearance were enriched and isolated prior to attempting taxonomic 
classification with 16S ribosomal DNA analysis. One strain was found (E3-39) and it 
transformed DON alone in media. The metabolite was identified as 3-keto-4-deoxynivalenol 
(3-keto-DON, figure 2.6) TLC purification and 'H and 13C NMR characterization. In vitro 
toxicity studies with murine splenocytes revealed significantly reduced toxicity of 3-keto-
DON in the tritiated thymidine incorporation assay at 1.0 pg/ml media (about 75% of 
control), where the parallel DON incubations exhibited about 20% of control at 250 ng 
DON/ml. They reported triplicate replication but did not provide statistical evidence of this. 
The side chain on C-3 may be an integral component of toxicity of 8-ketotrichothecenes 
H H 
Figure 2.6 Chemical structure of 3-keto-deoxynivalenol (3-ketoDON) 
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where previously the epoxide had been thought to be the main contributor to toxicity. The 
authors did not indicate the possible application of mass detoxification with this microbe. 
A continuous fermentation system was investigated for anaerobic rumen microbial 
DON degradation and aerobic batch soil microbe incubation (Binder et al., 1998). Rumen 
fluid from cattle (no specifics on diet or age) was included in a standard media supplemented 
with 40 ppm DON, for an acclimation period of two weeks, then increased to 180 ppm. The 
disappearance rate of DON increased from 1.37 mg/g dry matter per day to 2 mg DON/g dry 
weight with the increase of the concentration. DON and metabolites were monitored by 
HPLC with purification with TLC and characterization with mass spectroscopy. The main 
metabolite identified was the de-epoxide and its toxicity was assessed by growth inhibition of 
Saccharomyces cerevisiae bioassay. Organism sensitivity to DON was 50% inhibition of 
growth at 31 ppm whereas DOM-1 had 10% inhibition of growth at 316 ppm in media. The 
aerobic soil incubation supplemented with 120 ppm DON had slow transformation with 50% 
reduction in 48 hours and complete disappearance in 96 hours. Five metabolites appearing by 
both HPLC and TLC were selectively stained for epoxides, all metabolites retaining this 
structural characteristic. This would be consistent with Shima et al. (1997) identifying 3-
keto-DON as a soil bacterium DON metabolite. Continuous fermentation systems were a 
possible detoxification technique but utilization of a liquid substrate would require additional 
DON disposal steps. Industrial application of this type of process does not seem efficient or 
economically feasible to obtain a functional end product. 
A more recent attempt to find a practical microbial detoxification method was 
proposed by Volkl et al. (2004). They screened 906 mixed and pure cultures from soil and 
cereal ears, 236 pure cultures from insects, 72 isolates from a water pond, and 70 
Pseudomonas spp. from an institutional collection. The only culture found to have any DON 
transforming ability was a mixed culture from spontaneous infected minimum medium with 
glucose and protein (MMGP). This culture was specified at D107 and maintained its ability 
to transform DON for at least 6 months. The main DON metabolite was produced over 5 
days and resulted in complete disappearance of DON assessed by TLC. The metabolite was 
identified as 3-keto-DON by mass spectroscopy, JH and l3C NMR. A specific isolate could 
not be identified from the mixed culture and the transformation required the presence of 
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cells. This work was conducted on a microscale and would need considerable effort to scale-
up. The authors proposed isolation and investigation of the microbial enzyme(s) responsible 
since finding a detoxification species was difficult. From the number of species screened in 
this study, without a specific organism identified, it was suspected that this was a different 
organism from E3-39. Additionally, the substrate profile was slightly different, D107 being 
able to transform DON, fusarenon-X, 3ADON, and 15ADON but E3-39 could not transform 
fusarenon-X. It was further proposed that due to the rarity of the DON transforming ability of 
these organisms, these substrates are utilized by chance not as primary substrates. The 
likelihood of this line of research producing a feasible method for remediation of DON 
contaminated food or feed seems remote. 
There have been a few products introduced to the animal feed industry claiming to 
remediate mycotoxin contamination by adsorption and/or degradation. Doll et al. (2004) 
developed an in vitro model to evaluate the efficacy of these products already available and 
other possible candidates. The model was a buffer system that mimicked the pH, 
temperature, and transit time of the pig gastrointestinal tract. Substances evaluated included 
six commercially available adsorbers (some with unspecified enzymatic activity), one 
proposed commercial product and three laboratory substances. Detoxification was assessed 
as removal of DON from the buffer supernatant as analyzed by HPLC. The starting 
concentration represented a meal containing 10 mg DON/kg diet with 25% dry matter. The 
only substance that significantly reduced DON concentration in the buffer was activated 
carbon (67 ± 6% reduction compared to spiked, untreated control). The authors did replicate 
this experiment but did not provide recovery study data. The comparability between the in 
vitro model and manufacturers' instructions of use was not discussed. There may be other 
factors involved thus the ultimate test would be in vivo assessments. 
Avantaggiato et al. (2004) attempted to assess the potential of activated carbon as an 
intestinal adsorbent of DON and NIV. They used an in vitro model that simulated the 
gastrointestinal tract of the pig and analyzed the mycotoxin distribution through the 
compartments representing stomach, duodenum, jejunum, and ileum. A feed sample was 
prepared that contained 2.8 ± 0.3 mg DON/kg and 3.8 ± 0.4 mg NIY/kg diet. Activated 
carbon was added at 0, 0.5%, 1.0%, and 2.0% of diet. Each six hour experiment was 
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duplicated and dialysate was collected from each compartment with mycotoxin analysis by 
GC/ECD. Although the carbon inclusion significantly reduced the simulated adsorption of 
DON and NIV compared to the negative control, the range was only 29 - 45% for DON and 
23 - 41% for NIV. The most efficient reduction was with the 0.5% inclusion level which is 
the recommended dose and was not likely to interfere with nutritional components of the 
ration. Since only one dietary DON level was studied, a dose response would be helpful. The 
concentration used was adequate to cause signs of toxicity in pigs although the adsorption 
observed in this model may not be adequate to substantially reduce toxicity. 
Another approach to reducing the DON contamination of animal feeds was partial 
processing to remove the toxin. House et al. (2003) investigated the effect of pearling 
(abrasion to remove hull) on remediation of DON contaminated barley for pig feed. The 
laboratory scale process was conducted in triplicate on three barley lots of variable DON 
contamination (4.8 ± 0.5, 9.8 ± 1.3, and 21.1 ± 2.1 mg/kg). The only variable tested was the 
time of pearling, 0 to 120 seconds in 15 s increments. DON was analyzed in the pearled 
barley by commercial enzyme immunoassay. The most efficient treatment was 15 s pearling 
which reduced the DON content by 66 ± 0.7% across samples with a concurrent barley mass 
reduction of 15 ± 0.2%. Grain nutrient analysis after treatment revealed an increase in 
digestive energy and reduced non-digestible fiber. The authors provided adequate statistical 
analysis and experimental replication to support their findings. This work was conducted on a 
small laboratory scale but should be considered for scale-up for further development. For the 
most contaminated sample a longer pearling time was required, with increased loss of grain 
mass, which could be evaluated by a cost-benefit analysis. 
Detoxification of DON contaminated food or feed sources have not had much success 
to date although some processes showed promise. Alkaline treatments caused DON 
degradation (Wolf and Bullerman, 1998) and treatments with sodium bisulfite produced 
reversible DON-S adducts under alkaline conditions (Young, 1986a) but seemed to reduce 
toxicity in vivo (Young et al., 1987). Microbial transformations produced two metabolites 
depending on the microbe. Chicken (He et al., 1992) and cattle microbes (Cote et al., 1986b, 
Binder et al., 1998) have transformed DON into a de-epoxide (DOM-1) had reduced toxicity 
in a yeast bioassay (Binder et al., 1998) and in a swine feeding trial (He et al., 1993). A 3-
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keto-DON metabolite was isolated from two different sources; a soil isolate (Shima et al., 
1997) and a mixed spontaneous culture (Volkl et al., 2004). This metabolite had reduced 
toxicity compared to DON in a mouse splenocyte bioassay (Shima et al., 1997). Feed 
additives intended for animal feeds have been introduced commercially but were not proven 
to be effective by Doll et al. (2004). Removing DON from feed barley by an abrasive 
pearling process had significant toxin reduction but will need scale-up to determine 
commercial feasibility (House et al., 2003). 
Much effort has been expended looking for methods to remediate DON 
contamination in food and feed with little success. Continued vigilance is necessary to screen 
potentially contaminated grains and properly disposal of lots with DON levels higher than 
allowed for specific purposes. Concerns occur as to the frequency of screening and the 
potential for contaminated foods on the market. 
Methods of Detection 
Since initial identification of DON in grain samples, efforts continued to find the 
most sensitive, accurate and reliable analytical methods for foods and biological samples. 
Bioassays have also been employed to screen for biological activity of DON, process a large 
number of samples, and assess relative toxicity of detoxification strategies and DON 
metabolites. The methods to be reviewed here are the most current with an emphasis on high 
performance liquid chromatography (HPLC) and additional details on sample preparation, 
biological sample analysis, bioassays and innovative techniques. 
Analytical methods 
Two official Association of Analytic Chemists (AOAC) methods exist for DON 
quantification, thin layer chromatography (TLC) and gas chromatography (GC) (Scott, 
1995). Trichothecenes and other mycotoxins were analyzed by a variety of analytic methods 
as reported in table 2.2 below. 
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Table 2.2. Analyl tical Methods or Deoxynivaleno Detection 
Method Sample Detection limits Special Considerations References 
Thin-layer 
Chromatography (TLC) 
grain 300 ng/g -hazardous waste production 
-time consuming 
Scott (1995) 
Gas chromatography 
(GC) 
grain -requires derealization Scott (1995) 
High performance liquid 
chromatography-
UV detection 
(220 nm) 
(HPLC-UV) 
wheat flour, bran, 
corn, rice 
20 ng/g; determined by 
lowest spiking samples 
-clean up of extracts required 
-commercial immunoaffinity and 
charcoal-alumina columns 
available 
-derivatization not required 
-collaborative study reveals wide 
range repeatability, recovery and 
reproducibility between labs 
-multiple trichothecenes detected 
Trucksess et al. 
(1996) 
Trucksess et al. 
(1998) 
Mateo et al. (2002) 
High performance liquid 
chromatography - mass 
spectroscopy 
(HPLC-MS) 
Corn grain, urine 25 ng/ml DON and 
DOM-1 in urine 
-multiple mycotoxins and 
metabolites quantified 
-sample extraction and clean-up 
similar to HPLC-UV 
-dexamethasone internal 
standard 
Razzazi-Fazeli et al. 
(2003) 
HPLC-UV urine, blood, bile, 
feces 
10 ng/ml (blood, urine); 
20 ng/ml (bile, feces) 
-preparative HPLC 
recommended for fecal samples 
-immunoaffinity column clean­
up limits sample loading 
-de-epoxide metabolite detected 
Janes and Schuster 
(2001) 
Valenta et al. (2003) 
Enzyme-linked 
immunosorbent assay 
(ELISA) 
wheat, corn 0.5 mg/kg 
dilution required for > 5 
mg DON/kg 
chicken egg yolk 
antibodies LOQ 0.16 
mg/kg 
-conjugation to hapten required 
-cross-reactivity with 3ADON, 
15ADON — reduced with 
chicken egg yolk antibodies 
-aqueous extraction limits 
recovery 
-rapid screening of large number 
of samples but samples should be 
batched 
-poor correlation to TLC 
Sinha et al. (1995) 
Trucksess et al. 
(1995) 
Wolf-Hall and 
Bullerman (1996) 
Schneider et al. 
(2000) 
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Table 2.2. (continued) 
Ruorometry wheat, bran, corn, 
barley, malted 
barley 
range of quantification 
0.5 - 50 mg/kg without 
dilution 
-fluorescent derivatization must 
be specific for DON to minimize 
cross-reactivity 
-sample prep same as HPLC-UV 
-good correlation with HPLC-
UV 
Malone et al. (1998) 
Fluorescence 
polarization 
immunoassay 
wheat, corn not indicated -requires linking of fluorescent 
tracer and specific antibody 
-specialized instrumentation 
-cross reactive with 3ADON 
-matrix effects with corn samples 
-time critical preparation steps 
-aqueous extraction reduces 
recovery from corn 
Maragos and Plattner 
(2002) 
Electronic nose (volatile 
compound mapper) 
barley -no sample preparation required 
-prolonged instrument clearing 
between samples 
-good GC-MS correlation for 
ochratoxin but not DON 
Olsson et al. (2002) 
Molecularly imprinted 
polymers (MIP) 
purified DON, 
ZEA 
-reusable stationary phase 
-cross-reactive with nivalenol 
-alternative to immunoaffinity 
methods 
-does not require hapten 
-not commercially available 
Weiss et al. (2003) 
HPLC methods, although peer-reviewed (Trucksess et al., 1998), have not yet been 
accepted as official AO AC methods. Although the variability among HPLC methods was 
high, there are no reports of internal standard inclusion. Other innovative methods are being 
developed and show promise of increased specificity and sensitivity. Development of MIP 
(Weiss et al., 2003) was interesting in that once the polymer was formed the matrix could be 
reused repeatedly by solvent washing, compared to immunoaffinity columns (which cannot 
be reused). 
Comparison of levels of mycotoxins found in foods assist organizations such as the 
World Health Organization (WHO) conduct risk assessments concerning human exposures. 
Josephs et al. (2001) conducted an interlaboratory study to evaluate the methods used for 
mycotoxin detection worldwide. Blank, naturally contaminated (479 ± 48 and 975 ± 98 ng 
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DON/g) and spiked (467 ± 47 ng DON/g) wheat samples were sent to 18 laboratories in 12 
countries for analysis by the methods employed in the respective lab. The labs were 
instructed to conduct two analyses on each sample at least one week apart (duplicates within 
day) and they were to use in-house control solutions. Methods employed by the test labs were 
HPLC-UV (6), GC with electron capture detection (5), ELISA (4), GC- mass spectroscopy 
(2) and HPLC - fluorescence detection (1). Extraction and clean-up methods also varied with 
acetonitrile/water most common (15 labs) and commercial Myco-Sep clean-up columns (9). 
The overall mean for the spiked wheat sample was 488 ±187 ng/g and was not statistically 
different from the target DON concentration. Two outlier values (significantly higher than 
expected means) occurred in both wheat and corn naturally contaminated samples that were 
removed from the data sets. Although GC and HPLC methods tended to be within expected 
range, ELISA consistently overestimated contamination levels which may be associated with 
reported cross-reactivity with 3-ADON. As a measurement of accuracy of analysis, 
coefficients of variability (CV) was calculated and found to range between 32 and 41% for 
between-laboratory reported DON concentration in naturally contaminated samples. The 
authors indicated one explanation for poor accuracy was lack of distribution of a common 
control solution. Although an official AO AC GC method has been validated, variability in 
sample analysis may still occur due to differences in sample preparation, technicians 
handling samples, different matrixes effects. As was discussed earlier, regulations or 
guidelines for DON contamination in foods are varied worldwide, with some types of 
samples at zero tolerance (FAO, 2004). The analytical method chosen for these samples must 
not only have the specificity and accuracy but comparability to other methods so that 
mycotoxin levels are universally acceptable. 
Bioassays 
Although analytical methods provided information on the absolute concentration of 
mycotoxin(s) within the sample, bioassays were developed to compare the dose-responsive 
biological activities of the compound(s). Bioassays for trichothecenes utilized eukaryotic 
cells or cell lines as these were sensitive, although widely variable concerning specific cell 
used and biological characteristic assayed. Below is a table of bioassays developed for DON 
screening and specific important aspects of these methods. 
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Table 2.3. Bioassay Methods for DON Screening 
Bioassay Cell 
Type(s) 
Assay Type Sample & Limit of 
Detection 
Special Considerations References 
K-5621 cell line MTT2 purified DON in 
media 
0.4 ng/ml 
-range of linearity 0.1 to 25 ng/ml 
-MTT assay requires careful dissolution 
of formazan product with high conc. 
organic solvent 
-cells nonadherent and easy to maintain in 
culture 
Reubel et al. (1987) 
BALB/c mouse 
splenic lymphocytes 
stimulated with 
PHA mitogen 
Inhibition of 
proliferation 
by 
[3H] thymidine 
incorporation 
purified DON; 
contaminated corn 
extracts 
-solvent extracts dried, redissolved 
DMSO 
-IC503 (purified DON) 115 ±23 ng/ml 
-matrix inhibition not explained by toxins 
present in extract 
-up to 4 mg/kg did not affect cell growth 
curves 
Porcher et al. (1987) 
K-562 
MIN-GL14 
Human peripheral 
blood lymphocytes 
MTT purified 
mycotoxins 
-CD»5 
300 ng/ml (K-562) 
400 ng/ml (MIN-GL1) 
430 ng/ml (lymphocytes) 
-15-ADON equally toxic to K-562 and 
lymphocytes 
- 3-ADON 5 times less toxic than DON 
Visconti et al. (1991) 
BHK-21 cell line6 MTT 
MTS7 
purified DON 
-CD50 
DON 112 ng/ml (MTT) 
141 ng/ml (MTS) 
MTT result can only be measured once 
-culture can continue to metabolize MTS 
after addition 
Rotter et al. (1993) 
3T3 cell line 
(Swiss mouse 
fibroblasts) 
BrdU8 
MTT 
LDH9 
purified 
mycotoxins 
-BrdU most sensitive assay (IC50 = 263 ± 
18 ng DON/ ml media 
-cytotoxicity not determined for MTT or 
LDH due to insensitivity of cells 
-adherent cells requiring extra culture 
preparations 
-cells only incubated with mycotoxins for 
24 hours compared to most other assay 48 
hours 
Widestrand et al. (1999) 
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Table 2.3. (continued) 
3T3 cell line BrdU wheat, wheat bran, 
oats, barley 
extracts 
-significant matrix effects from oats 
-cells more sensitive to purified toxin than 
wheat spiked with DON 
-IC50 (spiked wheat) 1.216 ± 0.094 mg/kg 
flour 
-highest conc. extract tested was 400 mg 
cereal equivalent/ml media 
-cereal samples prepared as for HPLC 
analysis except solvent evaporated and 
residue redissolved in media 
Widestrand et al. (2003) 
K-562 Trypan blue 
dye exclusion 
MTT 
BrdU 
purified DON -cell viability not affected (Trypan blue) 
- IC50 
651.2 ± 8.9 ng/ml (MTT) 
473.2 ± 148.0 (BrdU) 
Minervini et al. (2004) 
3T3 BrdU DON, de-epoxide 
DON (DOM-1) 
15-ADON, 3-
ADON 
-production of DOM-1 from incubation of 
DON with pig feces and purification by 
preparative HPLC column (GC-ECD 
confirmation) 
- IC50 (DON) 444 ± 101 
-15-ADON equally toxic as DON 
-3-ADON 9 X less toxic than DON 
-DOM-1 52 times less toxic 
Eriksen et al. (2004) 
(Lozzio et al., 1981). 
ZMTT assay- Colorimetric dye cleavage dependent on mitochondrial activity to reduce yellow substrate [(4,5 - dimethylthiazol — 2 — yl) — 
2,5 - diphenyltetrazolium bromide] into blue formazan product. 
3ICso - median inhibitory concentration for proliferation 
"MIN-GL1 - Human Epstein-Barr virus transformed lymphoid B-cell line 
5CDso - median cytotoxic dose 
6BHK-21 - Baby hamster kidney cell line 
MTS - Colorimetric dye cleavage similar to MTT except yellow substrate [5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazol-2-yl)-3-
(4-sulfophenyl) tetrazolium] is metabolized to a water soluble formazan. 
sBrdU - Assay for cell proliferation based on detection by immunoassay of DNA incorporation of 5-bromo-2' -deoxyuridine. 
9LDH - Lactate dehydrogenase released into the media as an evaluation of plasma membrane damage. 
Bioassays can be utilized to compare toxicities of compounds rapidly and without use 
of experimental animals. Bioassays should be relatively easy to conduct and screen many 
samples simultaneously. Another characteristic that can be incorporated into bioassays is 
relevance to the toxin's biological effects. Most bioassays listed in the table above use cell 
types that have not shown evidence of toxicity in vivo, such as fibroblast (Eriksen et al., 
2004; Widestrand et al., 2003) or kidney cell lines (Rotter et al., 1993). K-562 cells were 
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found to have linear dose-responsive inhibitory responses in several bioassays (Minervini et 
al., 2004; Reubel et al., 1987; Visconti et al., 1991). K-562 cells originated from a patient 
with chronic myelogenous leukemia (Lozzio and Lozzio, 1979). These cells have a high rate 
of proliferation (46 - 50 X in 7 day culture) and stay in suspension (Lozzio and Lozzio, 
1979). K-562 cells have differentiated into progenitors of granulocytes (immature 
neutrophils), monocytes, and erythrocytes (red blood cells) (Lozzio et al. 1981). These cells 
may serve as models for bone marrow progenitor cells to which DON was toxic (Lautraite et 
al., 1997). When human peripheral lymphocyte cytotoxicity was compared to K-562 cell 
cytotoxicity following DON exposure in media, the cell line was slightly more sensitive than 
the primary cells, 300 ng DON/ml and 430 ng DON/ ml respectively (Visconti et al., 1991). 
Bioassays of this type may directly relate the effects observed on the bench to potential in 
vivo effects. Although the true test would be in vivo studies, reduction of laboratory animals 
and expense of doing these trials can be an important benefit to this work. 
Bioavailability and Metabolism 
Since the initial studies of toxicity of DON, determination of the fate of this 
xenobiotic in different species has been limited and variable. Some information has been 
gleaned from studies with alternate objectives. The initial studies were in rats and ruminants 
with some information available for mice and pigs more recently. There are only a few 
studies with human data but thus far no definitive evidence for metabolic fate. 
DON 
CH2OH 
OH 
DOM-1 
OH CH.OH 
Figure 2.7 Chemical structure of deoxynivalenol (DON) and de-epoxide deoxynivalenol 
(DOM-1) 
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The first study to identify a metabolite of DON was from Yoshizama et al. (1983). A 
bioavailability study was conducted in Wistar male rats, gavaging them with 6 mg DON/kg 
bw in a single dose. Urine and feces were collected every 12 hours for 96 hours when 
animals were terminated with collection of plasma and liver. Analysis of DON in samples 
was by GC/ECD. They reported elimination of DON from the rats within the first 72 hours 
and peak elimination of DON at 12 hours in both urine and feces. The metabolite (designated 
DOM-1, figure 2.7) had peak elimination at 36 hours in urine and 48 hours in feces. DON 
was detected in the liver and the plasma 12 hours after dosing at 63 and 43 ppb respectively 
and DOM-1 was detected at 24 ppb in the plasma and 16 ppb in the liver. DOM-1 was 
characterized through GC/MS, negative staining for epoxides on TLC, and a third method 
that appeared to be related to NMR but was not defined. The evidence presented seemed 
adequate to report discovery of the DON metabolite but methods were not described fully, 
number of animals used or proportion of DON eliminated as DOM-1 was not indicated. 
Studies would be required to elucidate importance of this molecule in the metabolism of 
DON. 
Lake et al. (1987) reported metabolism of radiolabeled DON in four adult male PVG 
rats. Animals were given a single oral dose of 10 mg DON/kg bw and placed in metabolic 
cages for collection of urine, feces, and expired air for 96 hours. The dose had been 
determined from preliminary studies evaluating toxicity in these animals. Analysis of urine, 
feces and tissues after euthanasia was by acidic and neutral condition HPLC and GC/MS for 
metabolites. It was found that most of the radioactivity was excreted in the feces (63.6 ± 
0.5%) with less in the urine (25.4 ± 1.7%) and only 0.11 ± 0.07% in expired air. The urinary 
excretion occurred primarily in the first 24 hours after dosing (14.6 ± 2.8% of total dose) but 
the highest recovery from the feces occurred in the period 24 - 48 hours after dosing (31.0 ± 
3.5% of dose). Tissue retention of DON after 96 hours was minimal with the greatest 
retention in the liver and gastrointestinal tract (0.005% total dose). HPLC analysis of urine 
revealed five major peaks, 50% radioactivity in two peaks with retention times less than four 
minutes. Comparing radiochromatograms of neutral and acidic HPLC conditions indicated 
two non-polar urinary metabolites and a mixture of polar metabolites, most likely DON-
conjugates. The fecal metabolite profile appeared similar but with different proportions; polar 
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conjugates (75%), parent DON (10%) and a non-polar metabolite (15%). Repetitive HPLC 
purification followed by GC/MS analysis of the non-polar metabolite gave a spectra 
matching previously identified de-epoxy DON (DOM-1) (Yoshizawa et al., 1983). There 
appeared to be low interindividual variability of excretion in this study but inadequate 
information was reported to evaluate metabolite variability as the species of polar conjugates 
were not proposed. 
A contradiction to these findings was reported by Cote et al. (1987) when they 
studied the glucuronidation of DON and DOM-1 in vivo and in vitro in rats and pigs. 
Mycotoxins were incubated with hepatic microsomes from Sprague-Dawley rats and pigs 
(induced by phénobarbital and 3-methyl-chcholanthrene) to assess mixed function oxidation, 
NADPH oxidation and microsomal glucuronidation. Residual parent compounds were 
analyzed by reverse phase HPLC or TLC separation followed by scintillation counting. Three 
Sprague-Dawley male rats and one female pig were given a single oral dose of DON (2 
mg/kg bw for both species) followed by urine and fecal collection for 72 hours for rats and 
52 hours for the pig. Excretions were analyzed directly or preincubated with ^-glucuronidase, 
DON or DOM-1 detected by GC/ECD. No metabolism of DON or DOM-1 occurred in any 
of the microsomal incubations as 98% recovery of the parent compounds was reported for the 
test systems. No conjugation of DON or DOM-1 occurred in the in vivo studies. The pig did 
not excrete any DOM-1 but an undisclosed amount was detected from the orally dosed rats. 
This study reported appropriate assay controls indicating the microsomes were functioning 
but an incubation time of 30 minutes may not have been adequate. Since the in vivo study 
and the rats used for hepatic microsome induction were the same strain but different from the 
strain in the previous study, strain variability for metabolism of DON should be considered. 
Worrell et al. (1989) investigated the role of gut microorganisms in metabolism of 
DON in rats. Adult male Sprague-Dawley rats were given a single oral dose of 10 mg [14C] -
DON/kg bw followed by collection of urine and feces for 72 hours. Additional animals were 
dosed similarly following microbial depletion with antibiotics (bacitracin sulphate, neomycin 
sulphate and tetracycline hydrochloride). In vitro incubations were conducted using strictly 
anaerobically collected rat cecal contents with [14C]-DON (35 pg/ml). Sample analysis was 
HPLC separation and determination of radioactivity in collected fractions measured by 
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scintillation counter. Urine collected from normal rats had four main radiolabeled peaks, one 
was parent DON, another was DOM-1, and two were unidentified. The antibiotic treated rats 
had one of the unidentified peaks and the parent DON but no DOM-1. Fecal radio-elution 
was similarly affected with 13.3 ± 1.9% radioactivity co-eluting with DOM-1 in the first 24 
hours but antibiotic treated rats had only 0.9 ± 0.6%. Incubation of DON with cecal contents, 
4 pooled rats, resulted in a steady conversion to DOM-1 with 90% of radioactivity co-eluting 
with DOM-1 in 24 hours. Individual rat cecal incubations revealed substantial variability of 
DOM-1 production with 74 ± 24% (29% to 89% range) over 7-hour incubations. The authors 
reported lack of de-epoxidation if strict aerobic conditions were not maintained during the 
cecal content collection or incubations. This study was well controlled and provided evidence 
that gastrointestinal organisms were responsible for de-epoxidation of DON in the rat. 
Interindividual variability was evident from the in vitro incubations after 7 hours but not the 
in vivo which may indicate ability of the gut microbes to maximally biotransform DON 
during gut transit time. 
Absorption and tissue distribution of DON in mice has been investigated in only one 
published report as part of a larger study. Azcona-Olivera et al. (1995) gavaged mice with 
[3H]DON at 5 and 25 mg/kg bw with tissues collected at 0.5, 1, 2, 4, 8, and 24 hours after 
dosing, 3 mice per group. Plasma and tissues were solubilized and mixed with scintillation 
cocktail for measurement of residual radioactivity. Peak plasma [3H]DON occurred within 30 
minutes for both doses and plasma clearance after 24 hours was approximately 94% and 88% 
of dose in mice given 5 and 25 mg/kg respectively. Toxin elimination appeared to follow 
two compartment kinetics with rapid initial disappearance (t'A = 0.36 hr 5 mg/kg, t'A = 0.56 
hr 25 mg/kg) and slower terminal clearance (Wi = 7.62 hr and 88.9 hr). The 25 mg/kg dose 
resulted in a secondary DON peak at 4 and 8 hours after dosing suggesting enterohepatic 
recirculation. No attempt was made to define the metabolite profile. Since terminal clearance 
was prolonged at the higher dose, toxicity studies at this dose level should consider the 
longer term effects of single or repeated exposures. 
The fate of DON has been investigated in cattle and sheep. Ruminant species were 
more tolerant to higher dietary contamination with DON which may be explained by 
differences in metabolism from non-ruminants. Three dairy cows were fed 66 ± 11 mg 
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DON/kg diet (Cote et al., 1986a) with variability in diet concentration due to daily milk 
production based feeding. Cattle were fed the contaminated ration twice daily during milking 
for 5 days. Urine, feces, and milk were collected 5 days prior, during, and three days after 
feeding the DON contaminated diet. Samples were analyzed by GC/MS for DON and DOM-
I. Urine from one cow was preincubated with ^-glucuronidase to assess presence of 
glucuronide metabolites. There were no significant differences between animals for feed 
consumption or milk production over the feeding period and no adverse effects were 
reported. Unconjugated DON was not detected in milk but unconjugated DOM-1 was 
detected 12 hours after DON feeding began, was not detected 24 hours after last feeding with 
peak concentration of 26 ng DOM-l/ml milk. Unconjugated DON and DOM-1 was detected 
in urine and feces within 12 hours of start of feeding and continued for up to 3 days after the 
5 day trial, with peak excretion occurring after three days on the contaminated ration. 
Incubation of one cows' urine with ^-glucuronidase resulted in 1.6 to 3 fold increase in DON 
detected and 7 to 16 fold increase in DOM-1 detected. This trial reported consistent 
excretion, although low concentration, of a DON metabolite into a major human food but it 
would have been important to know the concentration of conjugated metabolites being 
excreted with additional studies on the survival of metabolites through milk processing and 
digestion following human consumption. There was high variability in excretion data due to 
milk production based DON feeding because milk production was between 19.2 ±2.1 and 
II.7 ± 1.0 kg per day but there appeared to be an accumulation of DON and metabolites 
since peak excretion occurred 3 -4 days after start of feeding with maximum 18.0 jig/ml 
unconjugated DOM-1 in urine from one cow. Differences in route of excretion between cows 
were not discussed but cow #2 had the highest peak urinary excretion while being the median 
milk producer. Cow #2 was also the lowest fecal excreter with peak DOM-1 excretion 2200 
ng/g compared 13,000 ng/g excreted from the highest milk producer. This study provides 
evidence for the tolerance of cattle to high DON contamination due to their capacity to 
biotransform DON although the variability between animals could not be explained by the 
difference in intake alone. The difficulty of a feeding study of this type was not indicated 
although several data points were omitted most likely due to urine collection problems. 
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The study of the metabolism of DON in ruminants was more aggressively undertaken 
by Prelusky et al. (1985) using sheep as a model. Initial work focused on plasma 
pharmacokinetics using adult castrated male sheep. DON was administered intravenously 
(i.v.) to sheep at 0.5 mg/kg bw (3 animals) and directly into the rumen through a surgically 
placed fistula at 5.0 mg/kg bw (4 animals). Blood and rumen fluids were collected for 30 
hours following ruminai administration, blood was collected for 10 hours post-dosing for i.v. 
administration. DON and DOM-1 was detected by GC/ECD with extent of conjugation 
determined by incubation of samples with ^-glucuronidase to determine difference in DON 
and DOM-1 concentration from unhydrolyzed samples. For i.v. dosing, two-compartment 
elimination was observed with initial distribution occurring quickly (tVia = 12-23 minutes) 
and the terminal elimination phase occurring over a longer period (t'/zP = 67 min mean, 57-78 
min range). Peak conjugated DON concentration occurred at 77 min (60-90 min range) and 
accounted for 15 to 23% of total DON detected in plasma. DOM-1 was detected in plasma, 
1.4 to 1.7% of administered dose. Following ruminai dosing, DON was detected in the 
plasma within 30 minutes and peaked at 583 ng/ml (470-760 ng/ml range) between 4.0 to 5.3 
hours post-dosing. DOM-1 was detected in plasma following the rumen dose but only 
accounted for 1.8 - 2.8% of DON dose given. Glucuronide conjugated DON accounted for 
an apparent 63-86% of dose. Bioavailability of DON, defined as the ratio of AUG oral dose 
over the AUG of i.v. dose, was calculated as 7.5% (5.9 - 9.9%). To determine the fate of 
DON in the rumen, rumen fluid was monitored for DON concentration and a cobalt marker 
(rate of disappearance indicated outflow from the rumen). DON's rate of disappearance from 
the rumen was 2-3 times faster than the cobalt marker suggesting substantial microbial 
metabolism. Hepatic biotransformation of DON to DOM-1 was also suspected since a low 
concentration of this metabolite occurred in the plasma from i.v. dosed sheep. Low 
bioavailability and substantial biotransformation of DON in the rumen helped to explain the 
tolerance of ruminants to higher doses of DON from contaminated feed sources. 
Prelusky et al. (1986) followed-up with investigation of DON elimination using adult 
castrated male sheep which had gall bladder and urinary bladder surgical catheterization prior 
to oral and i.v. dosing with 5.0 mg/kg and 0.5 mg/kg respectively. Bile and urine was 
periodically collected for 14 hours in two animals following i.v. dosing and for 36 hours 
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from two sheep dosed orally. GC/ECD was used to analyze samples following incubation ± 
^-glucuronidase to determine conjugation of DON and DOM-1. Both routes of 
administration resulted in excretion of free DON and conjugated DON and DOM-1. No free 
DOM-1 was detected by either route. Intravenous dosing resulted in 63.2 ± 2.7% total 
excretion in urine; 24.1 ± 0.7% as parent DON, 21.3 ± 1.8% conjugated DON, and 17.3 ± 
0.1% conjugated DOM-1. Biliary excretion was 3.5 ± 0.1% of dose administered. Oral 
dosing resulted in much lower percent recovery of all DON metabolites; 2.1 ± 0.4% 
unchanged DON, 3.6 ± 0.3% conjugated DON, 1.2 ± 0.5% conjugated DOM-1, and 0.06 ± 
0.02% free DOM-1. Fecal excretion was determined from the orally dosed animals only; 40.0 
± 8.5% as DON and 24.5 ± 6.4% as DOM-1. Total recovery of administered dose was 70 and 
63% for oral and i.v. dosing. Urine and bile was incubated with sulfatase (enzyme to 
deconjugate sulfonide conjugates) with no change in DON or DOM-1 detected. This 
elaborate study only used two animals per route of administration but helped to confirm the 
data of Cote et al. (1986a) and support previous findings of Prelusky et al. (1985) but 
additional gaps of knowledge were revealed. Neither route had complete recovery of dose 
nor an attempt to postulate the fate of the missing 30%. It was also interesting the high 
proportion of conjugated DOM-1 excreted from i.v. dosed animals even though the authors 
did not think enterohepatic circulation contributed much in distribution and metabolism. De-
epoxidation had not been identified from any source other than gastrointestinal 
microorganism although it was suggested in the previous study. They also did not indicate 
the recovery time following surgical placement of the bladder cannulae but it was indicated 
that proper placement was confirmed on necropsy. The stress of the surgery and the diet of 
these animals could have influenced the microorganisms of the rumen resulting in population 
changes that could influence DON biotransformation. 
An in vitro study incubating DON (1.25 mg) with rumen microbes in anaerobic 
culture media (37.5 ml total volume) revealed biotransformation of DON to DOM-1 over 48 
hours (Swanson et al., 1987). Samples were removed from the incubations every 12 hours 
followed by analysis by GC/MS. Only one DON metabolite was detected which matched the 
spectra of DOM-1. This study provided confirmation of rumen microbial biotransformation 
of DON to DOM-1 but strict anaerobic conditions may not have been followed resulting in 
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reduced microbial concentration reported over 48 hours. Worrell et al. (1987) reported the 
importance of strict anaerobic conditions to achieve complete de-epoxidation from rat cecal 
contents. The importance of incubation conditions may also explain the difference between 
in vitro results reported here and the high concentrations of DOM-1 excreted from DON fed 
cattle (Cote et al., 1986a). This study only used one cow's rumen fluid and cows on different 
rations may have different microbial profiles. 
Coppock et al. (1985) investigated the metabolism of DON in female crossbred pigs 
with i.v. dosing two animals (0.5 mg/kg bw) following implantation of bilateral central 
venous lines and urinary catheters. Two controls were included in the study and one of the 
treated pigs was given i.v. saline infusions to study the effect increased urinary output on 
DON excretion. Blood for DON level determination was collected from catheters 10 times in 
the first hour, 1.5, 2 hours and hourly for 24 hours after i.v. infusion of DON dissolved in 
ethanol. Serum clinical chemistries were analyzed from a separate blood sample taken 
hourly. Urine for DON analysis and urine chemistries were collected every 15-30 minutes. 
Both pigs exhibited acute toxicity following dosing, vomiting commencing within 7 minutes, 
diarrhea in 1.5 hours, semiconsciousness in 5 - 6 hours with recovery 11 and 13 hours after 
initial dosing. The animals finally ate 19 hours after dosing and appeared normal at 
termination 24 hours after dosing. Pharmacokinetics of both pigs fit a one compartment 
model indicating linear elimination and limited prolonged release from 'storage' sites such as 
muscle or adipose tissue. Urinary elimination of DON from the saline infused pig was 57.2% 
of the dose and 28.1% from the other pig and the plasma half-life was 2.08 and 3.65 hours 
respectively. The only tissue with residual DON was the kidney with 24 ng/g. As an early 
study in the pharmacokinetics of DON, no fecal or bile data was collected although the 
authors suggested hepatic clearance or metabolism to account for the large percentage of 
DON not recovered. No residual tissue DON was found but pigs are fed ad libitum therefore 
levels could accumulate. This study provided some preliminary data but there was a 10 kg 
difference between the weights of the treated pigs and each pig was treated differently. The 
dose appeared to be excessive since the animals all but went into shock which most likely 
affected the elimination in the pig not given i.v. saline. 
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Friend et al. (1986) conducted a metabolic study as part of chronic feeding trial for 
market pigs. A diet was formulated from contaminated wheat (5.26 mg/kg diet) and 
compared to a wheat based standard grower diet. Seven littermate pairs of pigs were assigned 
to control or test diet and following a week acclimation to diet and experimental conditions, 
feces and urine was collected for 5 days. Aliquot samples were taken from 24 hour urine 
collection and mixed pooled individual feces. Analysis for DON and DOM-1 was by 
GC/ECD after all samples were incubated with ^-glucuronidase. The total amount of DON 
consumed in a 24 hour period was 3.50 mg, range 2.49 to 4.57 mg. DON was excreted in the 
urine 63% of ingested, 7% in feces, 6% in urine and feces as DOM-1, and 23% unaccounted. 
The authors reported an apparent 67% absorption of DON due to high urinary excretion of 
DON and DOM-1. All samples were hydrolyzed prior to analysis so proportion of DON and 
DOM-1 excreted as glucuronide conjugate was not determined. High variability of DON 
intake occurred due to acceptability of the toxin contaminated diet. Animal inclusion in this 
study was not random because dietary acceptance was determined prior to inclusion of the 
pair, animals must have eaten at least 0.6 kg of DON contaminated diet per day. This may 
have caused bias in metabolism results since the animals able to tolerate this level may have 
hepatic detoxification strategies as yet not defined. 
To further define the metabolism of DON by the pig, Prelusky et al. (1988) conducted 
a key study following the fate of [14C] DON by oral and i.v. dosing. Yorkshire castrated male 
pigs 10-14 weeks of age were anesthetized for gall bladder, urinary bladder, jugular vein, and 
stomach cannulation. Animals were allowed to recover for 3-4 days. Orally dosed animals 
were given 0.6 mg [14C] DON/kg bw through the stomach cannula and animals assigned to iv 
dosing were given 0.30 mg [14C] DON/kg bw directly into the vugular vein. Blood samples 
from both groups was collected periodically for 24 hours, fecal samples were collected from 
the metabolic cages hourly and urine and bile were collected continually and sampled for 24 
hours. Measurement of radioactivity in samples was by liquid scintillation counting 
following oxygen combustion. DON and metabolites were separated and detected by 
GC/MS. Signs of toxicosis (retching, emesis, pallor) occurred in pigs dosed by both routes 
but was transient and did not result in subject removal. Plasma elimination followed either 
biphasic or triphasic models. Two pigs exhibited a rapid distribution phase (t'/za = 6.57 ± 
42 
2.24 min.) and longer terminal phase (t'/zP = 3.59 ± 0.12 hrs). Three pigs had distribution 
split into a rapid phase (tVia = 5.84 ± 1.03 min) and prolonged phase (t'/zP = 1.61 ± 0.21 hrs) 
followed by prolonged elimination phase (t'/zy = 8.52 ± 1.48 hrs). Following oral 
administration, plasma levels peaked in 15 - 30 minutes and remain unchanged for about 9 
hours before slowly declining, half-life of elimination was calculated as t'/zP = 7.14 ± 2.13 
hours. Bioavailability based on comparing AUG of oral dose versus iv dose was calculated as 
54.9 ± 8.4%. Urinary and biliary excretion following iv dosing was 93.6 ± 9.0% and 3.5 ± 
1.1% of the administered dose respectfully. Intragastric administration resulted in fecal 
excretion of 20.3 ± 5.8%, urinary excretion of 68.2 ± 14.2% and bile containing 2.2 ± 1.1% 
of administered dose. Only minor metabolism was reported as >95% of DON was excreted 
as parent compound. Plasma protein binding of DON was investigated in vitro with spiked 
(2- 100 fig DON/ml) blood samples where they found only 9.15 ± 3.9% DON was protein 
bound and this level of binding was independent of spiking level or incubation time. They 
also determined DON partitioned equally between plasma and red blood cells in vitro 
regardless of DON concentration. The authors found prolonged elimination of radioactive 
DON from both iv and intragastric dosed animals, radioactivity being detected in plasma and 
urine at the end of the sampling time (24 hours) even though the levels were near limit of 
quantification. The apparent volume of distribution (Va = 1.13 ± 0.37 1/kg) was greater than 
the total body water (Vc = 0.17 ± 0.03 1/kg) which could not be explained by plasma protein 
binding indicating distribution through out tissues. This high quality study had adequate 
numbers of animals and sampling times to provide well defined toxicokinetic parameters for 
metabolism of DON in pigs. Increased sensitivity of pigs to DON appears most likely is due 
to increased bioavailability and lack of metabolism of the toxin compared to ruminants or 
rodents. 
More recently, Danicke et al. (2004) fed DON contaminated (4.2 mg/kg) diet to 
eleven castrated male pigs for seven days to determine the segmental absorption of DON 
through the digestive tract and occurrence of DOM-1. The diet formulated was nutritionally 
complete and was restricted fed (1.1 kg plus twice as much water) twice daily to insure 
complete ingestion in 10 minutes. The pigs were randomly slaughtered at designated times 
after the morning meal on the seventh day of the trial, one pig per time (1, 2, 3, 4, 5, 6, 8, 15, 
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18, and 24 hours) and one pig was slaughtered unfed, designating a zero hour control. 
Digesta was collected from each of the following segments: stomach, small intestine (three 
equal sections), cecum, colon, and rectum. Digesta and blood was analyzed by HPLC/UV 
following immunoaffinity column clean-up. DON was absorbed from the stomach and first 
segment of the small intestine with peak plasma concentration occurring about 6 hours after 
feeding. DOM-1 did appear in higher concentrations in distal segments and accounted for up 
to 80% of the recovered DON from the rectum, although only 10% of DON given was 
recovered from the large intestine. This study was hard to interpret and lacked power as only 
one animal was slaughtered per time point. A further complication of data interpretation 
included diet acclimation thus toxicokinetic data based on one dose may contain carryover 
from previous feedings. The plasma data was interesting in that peak DON plasma level was 
much later than reported for previous studies and only reached about 14 ng/ml with return to 
zero by 15 hours post-feeding. Prior studies had given the DON directly into the stomach or 
had not determined plasma levels. Diet components may effect absorption of DON from 
contaminated food or feed in monogastric animals (including humans). 
Since pigs are an important food source, Prelusky and Trenholm (1992) investigated 
potential residual DON in edible tissues from pigs following chronic feeding. Samples of 
kidney, liver, and backfat were taken from three studies of animals being fed 6.0 to 7.6 mg 
DON/kg diet from naturally contaminated sources and as purified amendment. Samples were 
analyzed in duplicates by HPLC. Surprisingly, not all tissue samples were positive for DON 
with 87% of total 187 samples had <10 ng/g tissue. Average tissue residuals was 6.7 ± 9.6 
ng/g for backfat, 5.0 ± 9.2 ng/g for kidney, and 3.0 ± 3.5 ng/g for liver and these were not 
significantly different from each other. These animals had been fed chronically and had been 
killed within three hours of their last feeding. This study provided evidence that pigs do not 
significantly retain DON within these tissues although analysis of muscle tissue may have 
been helpful since it is the bulk of body weight and is the tissue to be consumed by humans. 
Very little is known about metabolism of DON in humans. One piece of evidence for 
urinary excretion levels was reported by Meky et al. (2003). In the search for a biomarker of 
DON exposure in humans, urine was collected from 15 subjects in two areas of China. 
Analysis of urine followed incubation with or without (^-glucuronidase then HPLC/UV DON 
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detection and HPLC/MS confirmation. All 15 human urine samples had DON levels greater 
than the detection limit of 4 ng/ml. Samples from the high risk area had 37 ng DON/ml (14 -
94 ng/ml range) and the low risk had 12 ng DON/ml (4-18 ng/ml range) and these were 
significantly different from each other. High risk subjects were from an area of China where 
wheat and corn are staple foods whereas the low risk subjects primarily consumed rice based 
diets. Following enzymatic hydrolysis, DON levels increased by 1.2 to 2.8 fold. The authors 
were able to confirm the identity of DON in the urine with standard elution with both 
HPLC/UV and HPLC/MS. The level of glucuronidation in humans appeared to be variable 
but the small number of samples did not allow speculation. Since all of the subjects had 
detectable DON levels in their urine, it would be interesting to increase the power as well as 
make sure negative controls are included in the analysis. 
Eriksen and Fetters son (2003) conducted an in vitro incubation study with human 
feces to assess the potential of de-epoxidation. Ten individuals (five of each sex) donated 
fresh fecal samples which were aliquoted to four tubes (1 ml feces per tube) of McDougal 
buffer solution. One tube remained the negative control while two tubes were treated with 10 
pg 3-ADON or nivalenol (NIV) each, and positive control of 5 pg of each added to tube after 
incubation. Anaerobic conditions were maintained and incubation occurred for 48 hours at 
37°C. Analysis of samples for DON, 3-ADON, NIV and metabolites was by GC/ECD with 
comparisons made between samples for the same individual. No de-epoxide metabolites were 
found for either trichothecene and 3-ADON was efficiently deacetylated to DON (78 ± 30%). 
The absence of de-epoxidation surprised the authors due to this ability observed in ruminants, 
rats, and pigs. They reported 90-96% recovery of toxins from the spiked sample after 
incubation. 3-ADON was studied since this mycotoxin was produced commonly by the 
Fusarium strains in the Netherlands but it would have been beneficial to include incubation 
with DON since there may have been a delay of conversion of 3-ADON to DON that did not 
allow time for de-epoxidation. There was also the issue of strict anaerobic conditions that 
was important for the study by Worrell et al. (1989) who used a sophisticated anaerobic 
chamber to maintain the oxygen depleted environment and observed significant reduction in 
de-epoxidation with deviation from this method. The subjects were not controlled for diet 
prior to sample donation and it was reported they were consuming a normal Swedish diet. 
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Since this was the first report of this type for humans, more controlled studies will be needed 
with different types of diets to make any conclusions about the capacity of humans to de-
epoxide these compounds. 
The most complete bioavailability information was available for pigs and sheep. 
Through some early sophisticated although low power studies in sheep (Prelusky et al., 1985 
and 1986) and cattle (Cote et al. 1986) it was evident that their tolerance to highly DON 
contaminated feeds was due to rumen microbial de-epoxidation of DON into DOM-1. 
Ruminants also produced a large proportion of conjugated DON metabolites that are excreted 
via urine, feces and minorly in milk. Swine do not exhibit the capacity to biotransform with 
<5% excreted as the glucuronide conjugate (Prelusky et al., 1988) and high systemic 
bioavailability and de-epoxidation capacity (Danicke et al., 2004) but it occurs in the large 
intestine after very little DON remains in the digestive tract. Rodents seem to be between 
these two metabolism patterns with glucuronidation and de-epoxidation capacity confirmed 
in the rat (Lake et al. 1987, Worrell et al., 1989, Yoshizama et al., 1983) but not yet 
determined in the mouse. Human data was sorely lacking but it was known that some 
individuals produce DON-glucuronide conjugates excreted in urine (Meky et al., 2003) while 
human fecal microorganism may not de-epoxidate DON (Eriksen and Pettersson, 2003). 
Much more work is needed on DON bioavailability. 
Toxicity 
Mode of Action 
Understanding and predicting in vivo toxicity depends on elucidation of the molecular 
mechanism of toxicity of xenobiotics. Early work made generalized conclusions about the 
trichothecenes. The ability of Fusarium trichothecenes to inhibit protein synthesis in 
eukaryotic cells was compared by Ueno et al. (1969). Using a rabbit reticulocyte [14C]-
leucine incorporation assay, they found dose-response relationships for the trichothecenes 
with an order of potency of diacetoxyscirpenol (DAS) > fusarenon-X > NIV (IC50 of 0.05, 
0.25, and 2.5 pg/ ml respectively). Mechanisms of protein synthesis inhibition by these 
structurally related compounds were more specifically elucidated by Cundliffe et al. (1974). 
By monitoring uptake of [^C]-leucine in H-HeLa cells and both [^H]-uridine and [14C]-
leucine in yeast spheroblasts from Saccharomyces cerevisiae, they found 12,13-
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epoxytrichothecenes inhibit protein synthesis but do not primarily inhibit mRNA synthesis. 
Through cell lysis and sucrose gradient centrifugation, the effect on the polyribosome was 
compared for trichothecenes alone and in combination with antibiotics with known 
polyribosome interaction profiles. It was found that T-2 toxin and NIV caused inhibition of 
initiation of protein synthesis while trichodermin caused inhibition of elongation or 
termination since the former trichothecenes caused rapid breakdown of the polyribosome 
while the trichodermin polyribosome profile was not different from untreated controls. They 
proposed that the molecules covalently bound to the ribosomes, more specifically peptidyl 
transferase, by opening the epoxide ring and that alterations in the side chain of C-15 
determine the specific mode of action. One fault of this study was that all trichothecenes and 
antibiotics were used at the same concentration (25 ng/ml) which is now known to be a 
highly toxic concentration to cells sensitive for NIV and T-2 toxin. The cells were only 
exposed for 20 minutes but repetition of this experiment to determine the threshold of effect 
would be helpful to better define the proposed mechanism. 
A partial answer to this question came from Ueno and Matsumoto (1974) when they 
determined polyribosome breakup to occur within one minute after exposure to 0.01 ng/ml 
T-2 toxin of rabbit reticulocytes in vitro. All the trichothecenes investigated in this study 
were protein synthesis initiation inhibitors but they found that fusarenon-X, which has an 
acetyl sidechain at C-4 whereas DON has an -OH at C-4, binds to and inhibits SH- enzymes 
such as alcohol dehydrogenase, lactate dehydrogenase, and creatinine phosphokinase. The 
enzymes were inactivated when fusarenon-X was incubated with the enzyme prior to 
substrate addition (up to 3 mg/ml) but not after. Enzyme inhibition was studied further by 
Ueno and Matsumoto (1975) when they investigated 3H-fusarenon-X binding to alcohol 
dehydrogenase from yeast, lactate dehydrogenase and creatine phosphokinase from rabbit 
muscle. The labeled mycotoxin inhibited alcohol dehydrogenase activity only if incubated 
prior to substrate addition, 0.6 mM for 15 minutes resulted in 20% inhibition; activity could 
not be restored with a thiol group protectant, dithiothreitol. It was demonstrated through 
assessment of radioactivity in gel filtration fractions that the labeled mycotoxin bound to the 
SH-enzymes proportional to the number of active SH- sites on the enzyme, four in alcohol 
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dehydrogenase. Further investigation into the biological significance of this finding has not 
been reported nor has DON been studied for this effect. 
Greater understanding of the molecular mechanism of DON toxicity alluded to by 
previous work was provided by Wei et al. (1974). This work focused on the mechanism of 
ribosomal binding in trichodermin inhibition of protein synthesis in human HeLa cells and 
rabbit reticulocytes. By labeling trichodermin they identified that it bound to reticulocyte 
ribosomes at a maximum binding ratio of 0.44 molecules per ribosome. Binding occurred 
under conditions of active protein synthesis in isotonic, hypotonic, and hypertonic solutions 
and at 37°C and 0°C. Competition studies, with other compounds known to function by 
interference with protein synthesis similarly, inhibited binding of labeled trichodermin 
indicating a single binding site for these molecules. The authors indicated that since binding 
to the ribosome was not 1:1, binding may depend on the ribosomal cycle i.e. the length of the 
protein being translated or the location of the peptidyl-tRNA. Allosteric and/or 
conformational factors were considered important for explaining a poor affinity of the 60S 
isolated ribosomal subunit but strong affinity in the polyribosome as well as the differences 
in mode of action of closely related trichothecene molecules. Up to this point, DON had not 
been included in any of these studies, since it had just been isolated. To this day limited work 
has studied DON in similar experiments and the main mechanism of toxicity, protein 
synthesis inhibition, has been assumed to be virtually the same for all trichothecenes. 
DON specific effects on the polyribosome were reported by Ehrlich and Daigle 
(1987). They investigated the structurally related natural and synthesized analogs of 8-keto-
12,13-epoxytrichothecenes effect on protein synthesis inhibition in Vero (African Green 
monkey kidney) and MEL (murine erytholeukemia) cells. Dose response of protein synthesis 
was assessed by tritiated leucine incorporation after 30 minute incubations with the 
compounds. Concentrations resulting in 50% inhibition of protein synthesis (ID50) was the 
lowest for DON in Vero cells (0.9 ng/ml) compared to the synthesized analogs but the MEL 
cells were slightly more sensitive to 3,7-DiDON (-OH at C-4 and C-15 but not C-7) (0.8 
|ig/ml) compared to DON (-OH at C-3, C-15 and C-7) (1.6 ng/ml). Other structurally related 
analogs had at least 10 fold greater ID50 concentrations. The authors also studied the 
structure-activity relationship on polyribosome profiles of MEL cells after 10 minutes 
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exposure to the compounds. T-2 toxin was included since it was known to cause 
polyribosome breakdown. DON at 10 pg/ ml (67 ± 9%) and 3,7-DiDON at 50 pg/ ml (64 ± 
9%) conserved the polyribosome as indicated by similarity to the untreated control (66 ± 7%) 
for percent radioactivity from tritiated uridine remaining with the ribosomal fraction 
following fractional centrifugation. T-2 toxin (5 pg/ ml) and the other analogs (>100 jag/ ml) 
caused polyribosome breakdown resulting in 24 ± 12% retention of radioactivity in the 
ribosome. From the data presented it was concluded that DON and 3,7-DiDON were protein 
elongation inhibitors where the other analogs were initiation inhibitors. Structural features 
that seemed to differentiate these two mechanisms were the substituents at C-3 and C-4. If 
both sites were occupied by hydroxyls or other bulkier side groups, the compounds inhibited 
initiation but if either site had hydrogens, elongation inhibition occurred. This only held true 
for the 8-keto trichothecenes because substituents on the A-ring also contributed to toxicity 
and potency. From the space-filling models of the molecule, there was evidence of 
interaction between the constituent at C-4 and the 12,13-epoxide. A hydroxyl or acetyl can 
effectively shield the epoxide but hydrogens would expose the epoxide which was thought to 
be a key structural component for toxicity. From the information thus far, it can be concluded 
that trichothecenes cause intracellular protein synthesis inhibition in eukaryotic cells but the 
structural diversity can dramatically change the specific mechanism of this effect. 
The suggestion of other mechanisms of action was made by Thompson and 
Wannemacher (1986) when they compared in vitro and in vivo toxicity for more than a dozen 
12,13 -epoxytrichothecenes. Protein synthesis inhibition (tritiated thymidine incorporation 
assay) studies were conducted in the Vero cell line and mitogen-stimulated primary rat 
splenocytes with exposure to various dilutions of mycotoxins. The IC50 for protein synthesis 
inhibition for DON was 444 ± 39 ng/ml and 252 ± 24 ng/ml for Vero cell and rat splenocytes 
respectively. 3-ADON exposure had much less effect; IC50 of 9198 ± 1516 ng/ml and 1503 
± 275 ng/ml in Vero cells and rat splenocytes respectively. Lethality trials were conducted on 
mice injecting 10 mice per concentration per mycotoxin by either intraperitoneal or 
subcutaneous routes. DON and 3-ADON lethality was not affected by the injection route nor 
did they have significantly different LD50 (dose causing 50% of animals to die within 72 
hours of exposure), 45 mg DON/kg bw (30 - 55 mg/kg 95% confidence limit) and 59 mg 
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3A-DON/kg bw (51 - 85 mg/kg 95% confidence limit). The authors discussed possible 
mechanisms to explain large differences observed for in vitro protein synthesis inhibition that 
was not observed in vivo. The obvious reason for the difference between DON and 3-ADON 
would be in vivo metabolism (deacetylation) that may not occur in the culture systems. A 
comparison that did not make sense with the current knowledge was a comparison of NIV to 
DON. NIV had a six-fold greater LD50 by subcutanteous injection but DON had six-fold 
lower IC50 for protein synthesis inhibition in Vero cells. The structural difference between 
these compounds is that NIV has a -OH at C-4 whereas DON has a -H. The authors 
suggested that more potent metabolites were produced in vivo or secondary effects occurred 
to explain greater in vivo potency of DON but they also proposed investigation into 
mechanisms of action other than protein synthesis inhibition. 
More recently, investigation to elucidate these mechanisms have focused on 
differential responses of mRNA and translation products following DON exposure of mice. 
In a recent review by Pestka et al. (2004) the complexity of the molecular effects without 
strong evidence for specific mechanisms was described. Cell signaling pathways have been 
shown to be activated by DON, as low as 1 mg/ kg bw, through gene induction and activation 
of several mitogen-activated protein kinases (MAPKs) but the trigger or mechanism of 
induction has not been elucidated. Shifrin and Anderson (1999) proposed ribosome binding 
requirement for DON s inhibition of protein synthesis and activation of cell signaling 
pathways termed 'ribotoxic stress response' but active protein synthesis was not required for 
some trichothecenes to activate the stress response, indicating another although not 
independent mechanism of action. These authors compared related trichothecene structures 
with their ability to activate c-Jun N-terminal (JNK)/p38 kinases in the human Jurkat (T 
lymphoid) cell line, but no correlation was found. DON was found to be a strong inducer of 
apoptosis, 13 fold activation of caspase-3 at 2.96 pg/ml for 3 hrs, and a strong inducer of p38 
and JNK kinases, 12 fold induction at 2.96 pg/ml for 3 hrs. Only one dose was tested and cell 
viability was not assessed which may complicate the interpretation of this study since all 
mycotoxins were tested at 10 jaM and large differences in potency occur across these 
mycotoxins. The importance of this study was the suggestion that mechanisms other than 
protein synthesis inhibition of cellular toxicity are possible and that structurally related 
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trichothecenes may not function by the same mechanism, which had previously seemed to be 
the dogma. 
Many studies have attempted to elucidate the site of initial influence of DON on cell 
signaling pathways. The most recent evidence links apoptosis due to DON exposure at doses 
> 100 ng/ ml in media to activation of hematopoetic cell kinase(Hck) and double-stranded 
RNA-(dsRNA)-activated protein kinase (PKR) with cascade activation of p38, p53, caspase-
3 resulting in apoptosis (Pestka et al., 2004). Although these authors summarized data that 
indicated low dose trichothecene upregulation of cytokine, chemokine and inflammatory 
genes while high trichothecene doses seemed to produce leukocyte apoptosis and immune 
suppression, there appear to be large gaps in knowledge of the pathways of action of DON. 
Trichothecene mechanism of action was initially identified as protein synthesis 
inhibition by Ueno et al. (1969) but more specifically ribosomal binding to the peptidyl 
transferase center (Cundliffe et al., 1974) inhibiting active protein synthesis (Wei et al., 
1974). Fusarenon-X, a close structural relative to DON, was found to bind to critical -SH 
groups inactivating three different enzymes (Ueno and Matsumoto, 1975). DON was 
specifically classified as a protein elongation inhibitor (Ehrlich and Daigle, 1987). The 
possibility of DON mechanisms of action other than inhibition of protein synthesis was 
proposed by Thompson and Wannemacher (1986) due to inconsistencies between in vivo and 
in vitro DON exposure. Molecular mechanisms involving alteration of cell signaling 
pathways and gene expression were shown in response to DON exposure (Shifrin and 
Anderson, 1999; reviewed by Pestka et al., 2004) although the specific site of action has not 
been determined. The complexity of the system seems underestimated. Ribosomal binding 
and transcriptional arrest seem too simplified. Although this was a common mechanism for 
some of the trichothecenes, investigation into relative binding affinity for specific inherent 
proteins has not been conducted. 
In vivo Toxicity other than Immunological 
The key papers reviewed here will emphasize toxic effects contributing knowledge to 
the original work reported within this dissertation and relevance to human health. The first 
studies of DON toxicity were conducted in swine because incidences of toxicosis in this 
species were reported from the field. The most common signs of toxicity were emesis and 
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feed refusal. To better characterize the dose-response of pigs, Forsyth et al. (1977) conducted 
trials dosing pigs intraperitoneal^ (i.p.) to determine the emetic threshold and in the diet to 
determine the threshold of feed refusal and effect on weight gain. Pigs (45.5 kg, n = 4) fed 
7.2 ppm purified DON sprayed on a standard diet, ate 59.1% of the amount the control pigs 
ate over 4 days. A dose-response was observed for pigs (20 kg, n = 4) fed diets with 0, 3.6, 
7.2, or 40 ppm purified DON with significant reduction of total weight gain and feed intake 
at all doses. Pigs fed 3.36 ppm had reduced weight gain 68.7% of controls and daily feed 
intake 80.2% of controls, both parameters significantly different from controls (p < 0.01). 
Doses as low as 0.1 mg/kg bw given i.p. to pigs (9.4 kg) caused repeated vomiting within 46 
minutes with higher doses causing a more rapid effect. Gavage of DON in water (0.2 mg/ml) 
did not cause emesis at 0.075 mg/kg bw in pigs (9.3 kg, n = 3) but caused one of six to vomit 
at 0.1 mg/kg and 3/3 at 0.4 mg/kg bw, although it took about an hour until first vomition, i.p. 
dosing took about half the time. Besides the evidence for emesis and feed refusal from this 
study, it was also apparent that other emetic factors may be present in naturally contaminated 
grains. This was due to the observation of complete feed refusal of a feed mixed with 
naturally contaminated corn analyzed as 12 ppm whereas pigs fed a diet with 16 ppm 
purified DON ate 31.4% of controls. Although an additional pig was fed a diet with 3.2 ppm 
DON and 1 ppm zearalenone (ZEA) with no additional feed refusal effects observed due to 
the ZEA, the diet was only fed to one pig for one day. The contaminated corn was analyzed 
by GC and TLC with no T-2 toxin, fusarenone, or 3-ADON detected. The authors did not list 
any other trichothecenes specifically. The feeding trial was conducted over a short period and 
it was evident from the data that it took a couple days for the full effect of DON feeding to 
occur. Doses between 3.2 ppm and 0 DON were not fed so a NOAEL was not determined. 
Since emesis, feed refusal, and poor weight gain were observed toxic endpoints of 
dietary DON exposure, trials were conducted to determine if effects on weight were directly 
related to reduced feed intake. Pigs (8.4 kg, n = 10) were fed a diet containing 10.5 ppm 
DON and 1.1 ppm ZEA from experimentally contaminated corn (Lun et al., 1985) that was 
analyzed by GC and did not contain T-2, HT-2, diacetoxyscirpenol, nivalenol, or fusarenon-
X. A third treatment group was fed the same weight of uncontaminated diet as a paired 
DON-fed pig. Total feeding time was 21 days with feed intake, body weight, and blood 
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parameters being monitored weekly. Overall the DON fed group ate 45% less feed and only 
gained 50% of the weight of the full-fed controls although similar to pair-fed controls. DON 
fed pigs did appear to adapt to the diet as it was stated that initial feed refusal was not as 
great after the first week. There were significant treatment differences in hematocrit (Hct) 
(DON-fed pigs reduced, p < 0.05), hemoglobin (Hb) (reduced in DON-fed pigs in weeks 2 
and 3, p < 0.05), and red blood cell (RBC) counts (pair-fed pigs reduced in weeks 1 and 2 but 
not 3, p < 0.03). DON-fed pigs tended to have reduced serum calcium (p < 0.06) and serum 
phosphorus (p< 0.05) compared to full-fed controls but pair-fed controls tended to have 
higher serum Ca and lower serum P than DON-fed animals which was suggested as a 
possible DON effect on mineral absorption or metabolism. Other blood parameters measured 
but not affected by treatment included: serum total protein, albumin, urea, cholesterol, 
creatinine, conjugated bilirubin, albumin to globulin ratio, glutamic-oxaloacetic 
transaminase, glutamic-pyruvic transaminase, alkaline phosphatase, and creatinine 
phosphatase. The authors concluded that effects other than mineral differences appeared to 
be feed refusal related as similar effects were observed in DON-fed and pair-fed controls but 
no mechanisms were proposed. It was stated that no emesis was observed in the DON-fed 
pigs which contradicts the previously cited work of Forsyth et al. (1977) since 0.5 mg/kg bw 
would have been the dose based on data presented. Both studies had similar weight pigs and 
used crossbreds but Lun et al. (1985) used castrated males while sex was not stated in the 
former study. This apparent difference in toxicity between these studies most likely was 
assosciated with the dosing strategy as this study fed DON-contaminated diet while the 
previous study gavaged the dose thus gastrointestinal DON levels should have been higher. 
More recently, work on reduced feed intake versus DON toxicity has been examined. 
Rotter et al. (1995) investigated dietary DON exposure to Yorkshire castrated male pigs 
(12.0 kg) over 42 days with inclusion of pair-fed controls. DON was incorporated into the 
diet at 4.0 ppm from a naturally contaminated corn that had been found to be free of other 
trichothecenes and zearalenone. Feed intake was monitored daily in the DON-fed group and 
that amount was fed to a pair-fed control pig. Pig weights were monitored weekly (more 
frequently in initial two weeks) and blood parameters monitored weekly. DON-fed pigs ate 
20% less feed. Reduced weight gain observed was due to reduced feed intake since the pair-
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fed control pigs did not differ in body weight gain from the DON-fed pigs. Absolute and 
relative organ weights of thymus, spleen, thyroid, kidneys, liver, and adrenal glands were not 
significantly different between treatment groups. The brain to body weight ratio was 
increased in the DON-fed and pair-fed groups due to an 11% reduction in body weight 
without changes in brain weight (control =1.17, DON-fed = 1.34, pair-fed = 1.42, SE = 
0.05). The stomach mucosa was assessed for gross changes to the dietary treatments with the 
DON-fed group having more corrugation in the fundic region but no histopathology was 
conducted to determine the possible mechanism of alteration. There was a transient 
significant reduction of Hb in DON-fed and pair-fed animals after 3 weeks but the DON-fed 
group matched controls by the end of 6 weeks. Serum proteins also had transient effects with 
lower albumin levels in DON-fed and pair-fed during week 1 and 2 and lower total serum 
protein in weeks 2 and 3 in the DON-fed group compared to both control groups but no 
differences in protein levels occurred at the end of the study. The authors suggested a real 
reduction of protein synthesis in the liver during a rapid growth phase and the animals 
adapted, no mechanism given, to the DON-containing diet during the second half of the trial. 
Reduced weight gain due to reduced feed intake in food-producing animals can have major 
economic consequences due to increased time to slaughter weight. DON may have effects 
other than feed refusal such as in vivo protein synthesis inhibition. 
Investigations using rodents to further characterize the toxicity of DON have 
identified some similarities and differences compared to effects observed in swine. Acute 
toxicity in B6C3F1 female weanling mice with DON and 15-ADON were conducted by 
Forsell et al. (1987). Both mycotoxins were purified from culture and administered by 
gavage or i.p. injection first in LD50 range finding doses of 10,100, and 1000 mg/kg bw then 
the refinement by administering four smaller increment doses. Animals were dosed once and 
killed after 14 days, if they survived that long. Of those that did receive a lethal dose, animals 
died within 48 hours regardless of route of exposure or mycotoxin. These toxins had LD50 
values of 78 mg/kg bw by gavage and 49 mg/kg bw i.p. for DON and 34 mg/kg bw by 
gavage and 113 mg/kg i.p. for 15-ADON (no statistics given). Differences between routes of 
exposure were suggested to be due to differences of absorption and metabolism with a 
possible influence from intestinal microorganisms although limited evidence substantiates 
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this possibility. Organs from animals in this study were examined histologically with 
minimum doses estimated to cause tissue effects. Intestine, spleen, thymus, bone marrow, 
and heart were equally sensitive requiring 100 mg/kg bw orally and 60 mg/kg bw i.p. to 
cause lesions from DON exposure. Tissues were more sensitive to 15-ADON as 40 mg/kg 
bw orally caused lesions in the intestine; spleen, thymus and bone marrow required 60 mg/kg 
bw orally, and the kidney was affected at 100 mg/kg bw. All tissues were equally sensitive at 
160 mg/kg i.p. for 15-ADON. The kidney was relatively resistant to DON effects as lesions 
were only detected at 1000 mg/kg i.p. Liver, brain, lung, and pancreas were not affected by 
either mycotoxin. Lesions in all tissues were characterized as necrotic particularly in immune 
organs. Acute toxicity in B6C3F1 mice was found to depend on mycotoxin and route of 
exposure. Animal use was reduced in this study following a reproducible protocol but values 
may be different for other strains. More significant may be the finding of similar range of 
toxicity for 15-ADON compared to DON and possibly more toxic with oral exposures. Since 
15-ADON can be produced simultaneous with DON from the same fungal strain, it is 
important to consider 15-ADON exposure when assessing toxicity of foods or analysis of 
human food for hazard assessments. 
Toxicity of DON may involve production of reactive oxygen species (ROS) as acute 
toxic effects in rats was prevented by dietary antioxidants (Rizzo et al., 1994). Male Wistar 
rats were fed semi-purified diets either deficient in antioxidants, or containing supplemental 
selenium (Se) for 2 weeks. Additionally animals on the supplemented Se diet were given one 
time oral supplements of more Se with or without vitamins C and E, 16 hours prior to a 
single oral dose of DON (28 mg/kg bw) or T-2 toxin (3.6 mg/kg bw). Each toxin dietary and 
supplemental antioxidant treatment combination had an appropriate control group. Rats were 
decapitated 24 hours after the toxin dose. All of the rats fed either of the basal diets had 
diarrhea (10/10) with fewer exhibiting hemorrhage around the nose, ruffled fur, or lethargy. 
Se boosting almost completely suppressed toxic symptoms (only symptom was diarrhea 
1/10), and no symptoms were seen when the rats were acutely supplemented with Se and 
vitamins. Acute toxicity was similarly observed with acute dosing with T-2 toxin although 
antioxidant treatment did not effectively reduce toxic symptoms and may be associated with 
giving a dose close to the LD50 of 4 mg/kg bw. Lipid peroxidation in the liver [measured by 
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thiobarbituric acid-reactive substances (TEARS)] was increased with both toxin treatments in 
rats fed either basal diets (p < 0.05) compared to the diet control groups. Supplemental Se 
prior to DON dosing resulted in normalization but the additional antioxidant vitamins 
significantly reduced TEARS compared to diet controls (p < 0.05), which was also observed 
in supplemented controls not dosed with DON. All groups dosed with either of the toxins, 
regardless of diet, had decreased liver glutathione levels but supplementation with Se and 
vitamins remediated some of this effect. Liver antioxidant enzymes, catalase (hydrogen 
peroxide reduction) and superoxide dismutase (SOD, superoxide radical protection), were 
generally consumed under the influence of DON or T-2 toxicity but activity was protected 
with supplementation of antioxidants. Evidence was presented that supports ROS production 
from acute exposure to DON or T-2 toxin in rats and the protective effect of supplemental 
antioxidants Se and vitamins C and E. Appropriate diet controls were included and adequate 
animal numbers although mortality following T-2 exposure did produce imbalance. Free 
radical production by trichothecenes has not been adequately investigated and may be linked 
to signal transduction pathways being investigated. 
Sub-acute and chronic feeding studies more closely follow the likely human 
exposures to dietary DON thus several rodent studies investigating the effects of more 
prolonged exposures will be reviewed. Morrissey et al. (1985) fed male Sprague-Dawley rats 
(190 - 210 g) 20 ppm dietary DON (purified from culture) for 90 days, including pair-fed 
controls (n = 10). Although limited effects were observed, the DON-fed group consumed 
significantly more feed (27.3 ± 1.9 g) compared to control (24.6 ± 2.0 g) and the pair-fed 
controls (24.9 ±1.2 g), it seemed odd to observe this difference in pair-fed controls. There 
was no significant differences in body weight gain but the RBC count was reduced in the 
DON-fed group (6.4 ± 0.6 106/mm3) compared to control (7.1 ± 0.8 X 106/mm3) and pair-fed 
rats (7.7 ± 1.2 X 106/mm3). Organ weights, histopathology, or liver proteins were not 
affected by treatments. No possible explanation was proposed for the increased feed 
consumption or the reduced RBC counts of the DON-fed rats. Even though appropriate 
methods and statistics were reported in this study, the food intake data seems suspect since 
the pair-fed controls should have had similar intake. 
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A more extensive study was conducted by Arnold et al. (1986) to compare chronic 
dietary DON exposure in mice and rats. Weanling male Swiss-Webster mice and Sprague-
Dawley rats were fed one of the following diets: commercial rodent chow (118 ppb DON), 
formulated diet containing 80% uncontaminated wheat (53 ppb DON) or formulated diet 
containing 83% contaminated wheat (6250 ppb DON). Ten mice per group were killed at 7, 
13, 18, 24, 95, 110, 124 days on diet with the remaining mice killed on day 137. Ten rats per 
group were killed on days 7, 21, 35, 85 and 91 days on diet. Significantly lower rate of gain 
occurred in both rats and mice fed the DON contaminated diet (p = 0.001 mice and rats) and 
this effect could not be completely explained by decreased feed consumption. Transient 
effects were observed in mice as initially decreased erythropoesis in the bone marrow and 
spleen then either no treatment effect (spleen) or slight enhancement sustained from day 13 
until the end of the study (bone marrow) for DON-fed (6250 ppb) animals compared to the 
other two diets. They also found significant differences between the uncontaminated wheat 
diet and the DON contaminated wheat diets: Hct reduced in mice (p = 0.003) and rats (p = 
0.014), decreased Hb in mice (p = 0.006), WBC increased in mice (p = 0.028), decreased 
RBC count (p = 0.026) in rats, and mean corpuscular hemoglobin content (MCHC) increased 
in rats (p = 0.031). Only two parameters were significantly different between the commercial 
lab chow and the uncontaminated wheat diet groups; platelet count (p = 0.005) and MCHC (p 
= 0.013) were both increased in rats fed commercial rodent chow. Although it was not 
specifically stated, it was assumed these differences were observed through out the feeding 
period. It appeared from this study that RBC homeostasis is affected by 6.25 ppm in both rats 
and mice and these rats were more sensitive to the effects of dietary DON compared to the 
previously described study. Even though the same strain of rat was used, the dietary source 
of DON was different and no statement was made regarding other mycotoxins analyzed in 
the contaminated wheat. 
A dose-response 8-week dietary DON study was conducted in weanling female 
B6C3F1 mice (Forsell et al., 1986). DON purified from culture was added to semi-purified 
AIN-76A diet with final concentrations of 0,0.5, 2.0, 5.0, 10.0, and 25 ppm. Two diets with 
purified ZEA were included, one at 10.0 ppm ZEA and the other 10.0 ZEA plus 5.0 ppm 
DON (n = 8 per group). Mice were fed for 56 days with twice weekly feed intake and body 
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weight measurements. Diets of 2.0 ppm DON or more had significantly reduced body weight 
gain (p < 0.01) after 24 days on test and through the remainder of the trial. Only the group 
fed 25 ppm DON had significantly reduced feed intake (p < 0.01). Organ weights were 
significantly reduced by greater than 5 ppm DON but more specifically kidney affected at >5 
ppm (p < 0.05), liver >10 ppm (p < 0.01), and spleen at 25 ppm (p < 0.01). ZEA at 10 ppm 
alone in the diet did not have any significant effect on organ weights but the combination of 
10 ppm ZEA and 5 ppm DON resulted in reduced liver weight (p < 0.05) and reduced kidney 
weight (p < 0.01). Blood parameters required at least 10 ppm DON to cause significant 
effects; reduced WBC (p < 0.01) and monocyte counts (p < 0.05) but 25 ppm was needed to 
reduce lymphocyte (p < 0.01) while increasing neutrophil (p < 0.05) counts. The only blood 
parameter affected by ZEA in the diet was significantly increased RBC numbers (p < 0.01). 
It was interesting, although not mentioned by the authors that the spleen, thymus, and liver 
weights as well as WBC count appeared to be increased by 0.5 ppm DON. The conclusions 
by the authors suggest mice fed 25 ppm in this study may have been experiencing an 
antigenic insult since the neutrophil count was elevated with concurrent reduced total WBCs 
although limited evidence could substantiate this conclusion. This study provided evidence 
for the sensitivity of B6C3F1 female mice with a threshold of 2 ppm dietary DON. The 
concurrent occurrence of ZEA in naturally occurring feeds would be unlikely to contribute 
much to DON toxicity unless highly contaminated. 
Robbana-Bamat et al. (1987) also observed low-dose sensitivity to DON in mice. 
Weanling male BALB/c mice were fed a commercial diet with purified DON from culture 
incorporated at concentrations 0, 2.5, 5.0, 10.0, 20.0, 50.0, and 100.0 ppm. The experiment 
was replicated three times, n = 4, for one week feedings. A pair-fed control group was 
included that received the basal diet in the same amount as the 2.5 ppm group. Significant 
reduction in feed intake was observed in diets with >2.5 ppm DON (p < 0.005) but 
significant weight reduction was not observed until >10 ppm was fed (p < 0.005). All the 
animals in the 100 ppm group died within 4 days, equaling 50 to 65 mg/kg bw total intake, 
which is less than the LD50, and the authors thought this may indicate increased sensitivity of 
this mouse strain and/or an accumulation of systemic DON since no information was known 
about bioavailability. Thymic weight was significantly reduced by 10 ppm (p < 0.01), and 
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histologically revealed marked atrophy of both the cortex and medulla. This study revealed 
short-term feeding low-dose DON effects in BALB/c mice which agree with previous mouse 
studies. 
The mechanism of feed intake reduction has not been identified but was suspected to 
involve a DON effect on neurochemical signals, particularly serotonin which functions in 
regulation of emesis. Fioramonti et al. (1993) used male NMRI mice to assess gastric 
emptying following oral dosing of 10 - 1000 pg/kg bw purified DON, vehicle not given, 
followed by a radioactive milk-based meal. Gastrointestinal muscle activity was assessed by 
surgically implanting electromyography electrodes in adult male Wis tar rats, allowing 5 days 
healing then dosing them with 10, 50 or 100 pg DON/kg bw 10 minutes prior to a milk-based 
meal. A significant dose-response effect was observed on gastric emptying starting at 50 
pg/kg bw (p < 0.01) but intestinal propulsion was only significantly reduced by the 1000 
pg/kg bw (p < 0.01). The effect was mediated through 5-HT] specifically as inhibition of 
gastric emptying at 50 pg/kg bw was significantly reduced by 5-HTs receptor antagonist 
ondansetron [10 pg/kg subcutaneous (s.c.) injection] and equal to controls (no DON) treated 
with the antagonist alone. Selective antagonists for other serotonin receptors were not 
effective in reducing the gastric emptying effect of DON. The effect of DON was produced 
locally in the stomach and not centrally because i.v. injections of DON (5 pg/kg) did not 
inhibit gastric emptying and dosing with ondansetron (i.v.) did not reverse the orally 
administered DON effect. This study did not attempt to further define the mechanism such as 
source of increased serotonin, other than enterochromaffin cells, or specific effect on 5-HTg 
receptors. This mechanism would appear to be a non-species specific effect as pigs exhibit 
feed refusal and vomiting at low DON levels and humans with suspected DON exposures 
express feelings of fullness and vomiting (Bhat et al., 1989). Further characterization of this 
effect has not been published. 
The publication that appears to be most frequently cited with regards to chronic 
exposures in mice and risk assessment was Iverson et al. (1995). B6C3F1 male and female 
mice were fed commercial certified diets containing 0, 1,5, or 10 ppm DON with 50 mice 
per sex per dose level and fed for 2 years as a carcinogenicity study. DON was acquired from 
extraction and purification from field inoculated corn and from hydrolysis of 3-ADON 
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produced in liquid fungal culture. Average body weight of both sexes was reduced by 5 and 
10 ppm dietary DON but only the males had reduced daily feed consumption at 5 and 10 
ppm (p < 0.001) compared to controls. Of organ weight parameters, only the males exhibited 
significant reductions: liver at 5 ppm (p < 0.05); liver, spleen, and testes at 10 ppm (p < 
0.05). Male mice also exhibited significant alterations of blood parameters: elevated RBC 
count, Hb, Hct, reticulocytes, and monocytes (n = 7, p < 0.05) at 1 ppm; reduced platelets 
and increased reticulocytes (n = 9, p < 0.05) at 5 ppm; increased eosinophils at 10 ppm (n = 
10, p < 0.05). The females did not have any alterations of blood parameters nor did either sex 
have any alteration of bone marrow differentials. Females fed 10 ppm had significant 
increase in serum IgA (n = 10, p < 0.05) but no immunologic alterations were observed in 
males. Male mice exhibited significant negative correlations of several neoplastic lesions and 
DON dose but after Bonferroni adjustment for multiple comparisons the only significant 
effect was reduced incidence of hyperplastic nodules with increasing dose (n = 48 - 50, p < 
0.05). Controlling for confounding factors was very strict in this study and the results reveal 
adequate samples to validate data. The authors report that although DON did not appear to 
have any inherent carcinogenic potential the reduction of neoplastic lesions was related to 
reduced body weight (20%). Little biological relevance was given to alterations in blood 
parameters and organ weights other than confirmed male sensitivity. 
Dogs and cats may be exposed to DON or other mycotoxins as commercial diets have 
large proportions of corn or other cereal grains. The dietary toxicity was investigated 
utilizing a naturally contaminated wheat (37.2 mg DON/kg) mixed into nutritionally 
complete diets with 0, 1, 2, 4, 6, 8, or 10 mg/kg DON for dogs and cats (Hughes et al., 1999). 
Diets were extruded following DON incorporation and DON analysis following extrusion 
confirmed stability of toxin during processing. Doses of 8 ppm caused vomiting in 4/7 dogs 
exposed and 10 ppm caused vomiting in 9/13 dogs. Feed intake was reduced by 6 ppm or 
greater and several animals were removed from the study due to anorexia. Cats seemed to be 
slightly more tolerant as no vomiting was observed for doses less than 8 ppm although the 10 
ppm pens had feed intake 46.7 ±10.1% of the control group. The authors concluded that 
dogs may be as sensitive as pigs while cats may be more tolerant which may be due to 
differences in eating patterns, dogs being rapid consumers and cats being nibblers. It was also 
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suggested that rapid absorption and metabolism occurred following DON ingestion by dogs 
because emesis occurred quickly following meals and recovery was also rapid. Few animals 
were used in this study and the experimental unit was pens with variability of diet acceptance 
observed within pens. No other reports of toxicity in these species have been published but 
metabolic studies would define suitability of these species for other toxicity testing such as a 
non-rodent species for immunotoxicity testing. 
There are no direct toxicity studies of the effect of DON on humans obviously but an 
epidemiological study was reported by Bhat et al. (1989). An incident in the Kashmir Valley 
of India occurred in the summer of 1987 in which several thousand people were affected by 
gastrointestinal disorder, initially not causing alarm but peaking interest when people of 
various socioeconomic statuses became affected indicating etiology other than sanitation 
related. House to house surveys were conducted in villages as well as surveys of 
consecutively clustered houses in randomly selected municipal wards. Of 150 families 
surveyed, 39 reported at least one member of the household affected by distinct 
gastrointestinal disease that previous summer. All 97 people affected reported feelings of 
fullness and mild to moderate abdominal pain 15 minutes to one hour after consuming their 
breakfast or evening snack that consisted of locally produced or homemade wheat bread. 
Other symptoms reported included throat irritation (63%), diarrhea (39%), vomiting (7%), 
blood in the stools (5%), and facial rash (2%). Increased incidence of upper respiratory tract 
infections was reported in children who had consumed the wheat bread for more than a week. 
Interviews also revealed lack of improvement with medical treatment and illnesses subsided 
when consumption of the wheat bread stopped. The investigation revealed that the spring of 
1987 weather had been unseasonably rainy and most wheat marketed was mold-damaged 
with resulting flours of poor quality. Samples of flours and wheat in the local markets at the 
time of the investigation were collected, analyzed by TLC and found to contain DON (0.346 
- 8.38 ppm, 11/17 positive), NIV (0.03 - 0.1 ppm, 2/19 positive), T-2 toxin (0.55 - 4 ppm, 
4/19 positive), 3-ADON (0.6 - 2.4 ppm, 4/19 positive) but were negative for aflatoxins and 
ergot alkaloids. To evaluate the toxicity of the wheat, contaminated samples were extracted 
and incorporated into bread and fed to weanling canine pups at 200 pg/kg. All seven dogs fed 
the bread vomited within 3 hours whereas none of the four control pups showed any toxicity 
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signs. The authors estimated that mild toxicity was caused by the consumption of 30 to 150 g 
bread containing 0.34 mg/kg DON. While this was the only report of a dedicated 
investigation into an apparent DON related human toxicity event, the samples of wheat were 
collected at least two months after the outbreak, more contaminated product was most likely 
consumed. The estimated minimum toxic dose seemed low and the reasoning behind the 
calculation is not clearly stated. Interestingly, symptoms reported are consistent with animal 
toxicity studies and an increase in childhood upper respiratory infections after a week of 
consumption, although historically reported, many indicate immunosuppression doses of 
DON contributing to clinical illness. 
DON was found in the urine of men affected by chronic idiopathic spastic paraparesis 
(CHISPA) with and without concurrent infection with human T-cell lymphotropic virus type-
1 (HTLV-1) which occurs in hot humid climates (Leon-S et al., 1996). The finding was 
accidental in the initial patient but was further investigated in 12 patients with CHISPA + 
(positive for HTLV-1) and 3 patients CHISPA -, Urine (25 ml) was collected from these 
patients as well as from 4 apparently healthy and two patients with other neurologic disorders 
as controls. HPLC with fluorescence detection was used to analyze the urine for aflatoxins 
(Bl, B2, Gl, and G2), ochratoxin A, NIV, DON, and fumonisin Bl. All the control samples 
were negative for all mycotoxins but DON was detected in 13 patients (0.3 to 12.4 pg/ 100 
ml urine), 8 patients positive for fumonisin Bl (9.35 to 222.6 jug/ 100 ml), and 7 patients 
positive for NIV (0.22 to 1.3 pg/ 100 ml). Although no food samples were collected nor any 
statement about food consumption history, the authors made a comparison to an area of 
Japan that was endemic for CHISPA+ and consistently detected contamination of local foods 
with DON and NIV. Since metabolism of DON in humans was likely to be similar to other 
monogastric animals (pigs and dogs), the people who had mycotoxins in their urine would 
have consumed the contaminated foods within hours of urine collection and although it 
seems interesting that the control subjects did not have any detectable mycotoxins in their 
urine, it could have been by chance. Also the CHISPA subjects had been affected for at least 
6.3 years so even though the finding is interesting, cause and effect can not be speculated. 
Differences in species sensitivity to in vivo DON exposure are evident from numerous 
experimental trials. Swine appear to be the most sensitive with acute toxicity (emesis) 
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occurring at 0.1 mg/kg bw by i.p. injection or gavage (Forsyth et al., 1977). Reduced weight 
gain and feed intake occurs in pigs fed 4 ppm DON but not all altered physiologic parameters 
can be explained by energy restriction (Rotter et al., 1995). Dogs seem to be similarly 
sensitive with vomiting occurring at 6 ppm dietary DON or higher (Hughes et al., 1999) 
although cats tolerate a slightly higher dose (8 - 10 ppm), eating behaviors may explain this. 
Mice appear to be more sensitive than rats with a particular sensitivity of males (Iverson et 
al., 1995). Acute toxicity in rats may involve reactive oxygen species as toxic signs and 
alterations of free radical scavengers were prevented by supplementation with Se and 
Vitamins C and E (Rizzo et al., 1994). Mice have shown reduction of feed intake at doses of 
2.5 ppm dietary DON (Robbana-Bamat et al., 1987) which may be related to the mechanism 
of reduced gastric emptying induced by doses as low as 50 pg/kg bw (Fioramonti et al., 
1993). This mechanism may also be functioning in humans as the most common complaint 
was feeling full following a suspected DON toxicity investigation (Bhat et al., 1989). 
Anecdotal evidence for immunotoxicity in humans was reported in the former study with 
increased incidence of upper respiratory tract infections in sub-acutely exposed children and 
the finding of three mycotoxins in the urine of men with CHISPA with or without concurrent 
HTLV-1 infections (Leon-S et al., 1996). In vivo data indicated sensitivity to DON toxicity 
was dependent on species, strain, sex, route of administration and length of exposure. Studies 
should be interpreted with these variables in mind. 
In vitro Toxicity other than Immunological 
Evaluation of toxicity of DON exposure to primary cells or cell lines, outside of 
immune related cells has been limited although have helped to characterize mechanisms of in 
vivo toxicity. Studies reviewed here discuss effects on hepatocytes and colonic cell lines. 
Bradlaw et al. (1985) investigated the effect of purified DON on unscheduled DNA synthesis 
(UDS) as a measure of genotoxicity in primary rat hepatocytes. Primary hepatocyte cultures 
were prepared from adult male Sprague-Dawley rats by collogenase perfusion of fresh livers 
and the viability of acquired hepatocytes was assessed by Trypan Blue exclusion (82 - 86%). 
Cells were cultured in Williams Medium E with 10 pCi of [Me-3H]thymidine per ml media 
and DON 0.1 to 1000 pg/ml media, 2-acetylaminofluorene (2-AAF) 22.3 and 223 ng/ml 
media as positive control, or DMSO vehicle controls for 19 hours. UDS was measured by 
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counting the number of cells in replicative DNA synthesis per 1000 cells with replication 
assignment based on greater than 100 grains, incorporation of [Me-3H]thymidine detected by 
autoradiographic development, per nucleus. Background counts were consistent with media 
controls and cells were deemed metabolically active due to significantly increased UDS in 2-
AAF exposed cells (p < 0.01), cellular activation required for chemically induced DNA 
damage. DON did not cause any alteration in UDS at 13 doses in range given above. Three 
replicates of each dose were tested and adequate controls were included to validate the data. 
No statement of prior diet, acclimation period, or number of rats used (pooled?) was stated. 
Additional genotoxicity studies were conducted with primary rat hepatocyte exposure 
to DON and the Ames test with Salmonella typhimurium strains TA98 and TA100 with and 
without S9, hepatic microsomal preparation for test chemical activation (Knasmuller et al., 
1997). Hepatocytes, isolated from female Fischer 344 rats which had been on lab chow and 
acclimated for at least 2 weeks, were obtained by collagenase perfusion and incubated in 
minimal essential media with the toxins added to the media dissolved in DMSO for 3 hours, 
3 plates per concentration. Media was exchanged for fresh and cells were stimulated with 
epidermal growth factor (40 ng/ml) for 48 hours, cells fixed and stained to determine the 
mitotic index and micronuclei per 1000 cells. Chromosomal aberrations were also 
determined from one of the replicate plates. The Ames test was conducted as plate 
incorporation assays mixing 0.1 ml stationary phase bacteria cells, 0.1 ml of various 
concentration test compounds, ± 0.5 ml S9 (Aroclor 1254 induced rat) in 2.0 ml top agar on 
selective media plates. After 48 hours incubation colonies were counted, increased colonies 
compared to media controls indicates mutation induction by the test substance. DON (0.7 -
500 (ig/plate, 3:1 dilutions, 7 levels), FBI and moniliformin (MON), at any concentration 
tested, did not induce mutation in the Ames test. DON caused reduced mitotic index (p < 
0.05) at 10 ng/ml and cytotoxicity at 1000 pg/ml in expose hepatocyte cultures. Hepatocyte 
micronuclei were more frequently observed only at 10 ng DON/ml media (p < 0.05), 
although also elevated at 1 and 100 ng/ml, and increased chromosomal aberrations were 
observed in these cells at 1.0 (p < 0.05) and 10.0 pg (p < 0.005) DON/ ml media. Generally 
the other two mycotoxins, same dose range as DON, caused a similar pattern of reduced 
mitotic index at higher doses, increased frequency of micronuclei at lower doses and 
64 
chromosomal aberrations at higher doses. FB1 and MON are not related to DON and exhibit 
difference mechanisms of action although FB 1 has been found in DON contaminated com 
samples. DON was not genotoxic in the Ames test, but evidence for DNA damage was 
observed in rat hepatocytes, which has not been observed in vivo. The authors suggested a 
possible connection with free radical production and protective effect of antioxidants 
reported by Rizzo et al. (1994) although no evidence of carcinogenesis occurred after two 
years of dietary exposure to mice (Iverson et al., 1995). Adequate controls and appropriate 
statistical analysis was included in this study. Due to the lack of evidence for a 
complementary in vivo toxic effect of DON exposure, further research to characterize this 
effect has not been conducted and does not seem warranted. 
Dietary DON exposure has caused gross and histopathologic changes in gastric 
epithelium. In vitro effects of DON exposure to human colonic adenocarcinoma cell lines 
(Caco-2 and T84) was assessed by measurements to evaluate cell growth (scanning electron 
microscopy), differentiation (brush border membrane associated hydrolases alkaline 
phosphatase and sucrase-isomaltase), and tight junction integrity (lucifer yellow dye 
exclusion and transepithelial electrical measurements, TEER) (Kasuga et al., 1998). The cells 
were exposed to DON in the media (0, 50, 100 or 200 ng/ml) upon seeding and at the same 
concentration with subsequent media addition. Cellular confluence of Caco-2 cells was 
reached after 12 days of incubation at any DON concentration but widening of cellular 
junctions and elongation of microvilli was observed at 100 ng/ml and became more 
pronounced at 200 ng/ml although most microvilli were absent or shortened. The loss of tight 
junction integrity was quantified by increased lucifer yellow dye permeability (p < 0.05) 
across the cell lawn at 100 ng/ml for Caco-2 cells and at 200 ng/ml for T84 cells. As an 
indicator of increased ion permeability across the cell monolayer, TEER was significantly 
decreased (p < 0.05) at 50,100 and 200 ng/ml for Caco-2 and at 100 and 200 ng/ml for T84 
cells. Differentiation of Caco-2 cells was also affected as alkaline phosphatase activity was 
reduced (p < 0.05) by 100 and 200 ng DON/ ml media from the 6th to the 15th day of culture 
but sucrase-isomaltase activity was decreased (p < 0.01) by 50 and 100 ng DON/ ml at 10, 15 
and 20 days of culture. The authors chose DON doses below preliminarily determined acute 
cytotoxicity dose so that cells would reach confluence. The authors suggested that the results 
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of this study may provide evidence for lesions observed following in vivo DON exposure 
since enterocyte differentiation was required as a barrier to infectious agents. Enterocytes 
have high turnover thus DON effects on proliferation and differentiation may be important. It 
would also be important to investigate the effects of DON exposure in a mature monolayer 
and measure the same parameters. 
Two types of cells which may be exposed to high DON levels upon ingestion were 
investigated for dose-responses, primary rat hepatocytes and immortalized colonic cell lines. 
DON did not cause increased unscheduled DNA synthesis (Bradlaw et al., 1985) but was 
determined to cause chromosomal aberrations at higher doses (Knasmiiller et al., 1997) in rat 
hepatocytes. Proliferation and differentiation of Caco-2 and T84 cell lines was altered 
resulting in loss of tight junctions, 50 - 200 ng DON/ml media, and monolayer integrity 
(Kasuga et al., 1998). As liver toxicity has not been observed in vivo, results with primary 
hepatocytes confirmed the lack of DON toxicity in this organ. Gastrointestinal epithelium 
toxicity has been observed in vivo in animals and anecdotally in humans (Bhat et al., 1989) 
therefore it was important to investigate the impact of DON on these cell types. These cells 
were sensitive to doses that could be achieved with oral ingestion of DON contaminated 
foods. Loss of tight junctions and poor brush border development could contribute to 
diarrhea, necrosis of gastric epithelium either due to barrier loss and acidic gastric content 
exposure to deeper tissues, increased absorption of toxic substances from the lumen, lack of 
absorption of nutrients, or opportunity for microbial invasion. 
Immunotoxicity 
Xenobiotic effects on the immune system have been recognized for a long time. 
Importance as a distinct target organ with specific protocols for testing a chemical for 
immunotoxicity has only occurred within the last twenty years. Standardization of the 
descriptive toxicological studies to evaluate effect on the immune system was attempted 
through a committee effort for the National Toxicology Program (Luster et al., 1988). The 
goal was to develop and validate a flexible yet sensitive and specific protocol for 
identification of immunotoxic compounds. The committee proposed a tiered approach based 
on a series of screening assays following appropriate exposure routes and times in rodents 
and the option of further immunologic evaluation if warranted by results of the first round of 
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assays. Tier I evaluates both innate, natural killer cell cytotoxicity and lymphocyte 
proliferation, and acquired immunity, IgM antibody plaque-forming cells to sheep red blood 
cells, as well as general body conditions and immunohistopathology. Tier II assays would be 
dictated by the type of immune alteration expressed in the first tier to further characterize the 
mechanism of compound immunomodulation. Tier II assays could include spleen cell 
phenotyping and enumeration, IgG antibody response to SRBC, delayed hypersensitivity 
response, function of peritoneal macrophages, and two or three host resistance challenge 
models. The authors indicated that of the compounds tested under this scheme, none had 
shown alterations in Tier II assays without some alteration of Tier I. The protocol design for 
Tier I assays were intended to be incorporated into a standard carcinogenesis protocol with 
dosing based on intended or suspected human exposures. Mice were chosen as the species of 
choice due to more historical control data, availability of immunological data, large 
background of genetic data, and validated models of susceptibility for host resistance 
evaluation. Since the goal of this committee was to develop standardized guidelines, the 
immune assays were evaluated by several factors prior to inclusion: intra- and interlaboratory 
reproducibility, accuracy based on optimal historical data, assay sensitivity determined by 
dose-response curves, and predictability based on correlations with other immune function 
tests. These criteria allowed a grading system for comparing immunotoxicants as well as data 
validity for human risk assessment. Initial validation studies were conducted for five 
compounds in three labs and it was observed that reproducibility and accuracy improved as 
the laboratories developed expertise and that variability decreased since a standardized 
protocol was followed. Considering the reserve capacity of the immune system and the 
pleotrophy of resistance to invading challenges, the validation studies were able to determine 
that some Tier I assays were better able to predict and correlate with appropriate host 
challenge studies. For example, an impaired induction of plaque-forming cells to sRBC and 
suppressed lymphocyte proliferation correlated well with impaired increased mortality in 
Plasmodium or influenza challenges. The validation studies were further able to establish 
control values for normal animals that will add to the historical database. As the initial 
guidelines for a standardized protocol, all of the measures were incorporated for validation. 
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Positive controls were included and variability observed improved with repetition. The tiered 
approach saves resources by being comprehensive initially and more focused when required. 
NTP guidelines were followed for several years to develop a database of 51 
chemicals. This database was used to evaluate the sensitivity and predictability of the assays 
(Luster et al., 1992) for immunotoxicity. To define a chemical as immunotoxic a liberal 
definition of immunotoxicity was derived. The chemical either produced a significant (p< 
0.05) dose-response effect, excluding body weight alteration, in one or more immune 
function assays or significantly altered two or more tests at the highest dose tested. The 
authors recognized bias in the analysis produced by attempting to determine immunotoxicity 
from conducting immune function assays but were not able to correct for this. Further 
validity to the analysis was achieved by independent review by five outside experts. More 
conservative statistical approach was used to analyze for correlation between altered immune 
function tests and non-immune endpoints such as carcinogenesis. Sensitivity, specificity, and 
concordance (correctly predicting immunotoxicity from immune function tests) were 
determined from two-by-two contingency tables using results of the immune function assay 
on one axis and the chemical's immunotoxicity classification on the other axis. Thus the 
authors were able to statistically define the relationship of one immune function assay to 
immunotoxicity of the chemical in question. It was determined from this analysis that the T-
cell dependent sRBC PFC assay (78%) or the splenic lymphocyte population phenotyping 
(83%) had the highest concordance to predict an immunotoxic outcome. None of the other 
individual assays alone were good predictors of immunotoxicity and generally the decrease 
in concordance was due to lack of sensitivity. Concordance could be improved (> 90%) if 
two assays were conducted, particularly if one of them was the PFC or lymphocyte 
phenotyping and a few combinations of three assays could achieve 100%. Concordance was 
also evaluated between immunotoxicity and carcinogenicity. The database of chemicals was 
reduced due to lack of data for some compounds but it was found that of the immunotoxic 
compounds 100% were carcinogenic (19/19) and of those in the database not immunotoxic 
only 63% were carcinogenic (5/8). The authors recognized the limited number of compounds 
included in this analysis, due to data completeness, and recommended a larger database to 
make further conclusions. Conversely genotoxicity and immunotoxicity had poor 
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concordance (48 to 69%) and no relationship could be defined. An explanation for the power 
of the PFC assay and lymphocyte phenotyping was minimization of reversibility due to 
proximity of assay to the in vivo function. In other words, the cells have had less influence 
from media and time for the effects of the test chemical to wear off. Additionally, multiple 
processes are involved in the functional aspects of these cells (antigen processing and 
presentation, synthesis and release of cytokines, cell proliferation, differentiation and 
secretion) so alterations in function are more closely related to in vivo effects. One problem 
with lymphocyte phenotypic enumeration discussed by the authors was interindividual 
variability in the human population that does not exist to the same extent in inbred mice. 
"Normal" human databases will most likely need to be developed as sources for data 
comparison. This comprehensive study provided substantial validity to an immune function 
testing protocol. They had a database of 51 different chemicals to compare in the specificity, 
sensitivity, and concordance of the assay results and immunotoxicity of the compound. Even 
though the authors admit that a liberal statistical definition of immunotoxicity was applied, a 
few assays reliably predict immunotoxicity. This does not mean that fewer assays should be 
conducted in the first tier of a chemical's immunotoxicity evaluation but that if positive 
results are found for PFCs or alterations of lymphocyte phenotypes, the chemical is more 
likely to be immunotoxic. 
Predicting chemical immunotoxicity through immune assays only tells part of the 
story. Resulting alteration in susceptibility to tumors or infectious agents in the face of the 
complexity of the immune system is much more difficult to predict. The database developed 
through the NTP guideline development and validation was used to try to define the 
relationship between immune function assays and host resistance assays (Luster et al., 1993). 
Using the established database and two additional dose-response trials with the prototypic 
immunotoxicant cyclophosphamide, statistical analysis was conducted to determine the 
specificity, sensitivity and concordance between immune tests and host resistance assays in 
mice. They found overall 100% specificity but only 50% sensitivity resulting in low 
concordance. Positive immune assays would only accurately predict reduced host immunity 
50% of the time notably due to the liberal definition of immunotoxicity. When correlations 
between immune function tests and host resistance assays did occur, it was due to related 
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immune mechanisms. For example, suppressed PFCs were correlated with increased 
susceptibility to Listeria, Staphylococci, or Plasmodium because specific antibody 
production is needed for resistance to these organisms. NK cytotoxicity was not as reliable, 
being correlated to altered resistance to Listeria and PYB6 tumor formation but not B16F10 
melanomas. An important finding in this study was that host resistance suppression only 
occurred if there had also been immune function test alterations. The host resistance assays 
need to be selected with some prior knowledge of mechanism of immune function alteration 
to get the best information for characterization of the effects of the chemical being tested. 
Further, the results of the host resistance assay would depend on the virulence and dose of 
the challenge tumor or organism. The challenge may be able to overwhelm any individual in 
the population even with apparently adequate immunity or conversely a small change in 
immune function may have a large impact on host resistance depending on the challenge. 
Using additional cyclophosphamide exposure assays with a large range of doses (25 to 200 
mg/kg bw in 25 mg increments), the authors were able to develop models of the relationships 
between the immune test and host resistance assays. In most cases the relationships fit linear 
or linear-quadratic regression models. Thus a certain percent change from control in an 
immune assay would result in a similar percent change in host resistance although variability 
was reflected in wide confidence limits for some assays. For example a 10% decrease in 
resistance to S. pneumoniae would be reflected as 11.6% (4.8 - 40.7%, 95% confidence 
interval) suppression of PFCs. Additionally, the models developed for cyclophosphamide 
generally did not fit any of the other 18 compounds with enough data for comparison. It 
could be concluded that each compound affects the immune system differently with a 
different relationship between the effects on a measured immune test and the in vivo host 
resistance. This study brought together a substantial amount of data on a wide variety of 
compounds and provided validity for the guidelines proposed for immunotoxicity testing of 
compounds. Even though a liberal definition of 'immunotoxic' was applied to chemicals 
resulting in altered immune function tests, linear relationships occurred between immune 
function tests and host resistance assays. In a large population where there would be 
variability in immunotoxicant exposure and infectious agent exposure, the importance of 
dose-response relationships becomes vital to understanding the risk of a population. 
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Most investigations of immunotoxicity currently include cytokine assessments. 
Cytokines are glycoproteins produced by cells in the immune system upon activation that 
provide signals to other cells. There is some cell specificity of cytokine production but 
activity tends to be redundant and pleomorphic. For example, interleukin-4 (IL-4) is 
produced by activated T-helper cells and acts to inhibit cellular immunity and promote 
antibody production by B-cells but IL-10 also has a similar function. Due to the complexity 
of the cytokine system, measuring an alteration in only one or two of these proteins may 
provide evidence for a mechanism of immunotoxicity but does not define a chemical as 
immunotoxic. House (1999) reviewed the significance and complexities of cytokine 
assessment. Cytokines are measured by ELISA or specific cytokine-sensitive cell lines. 
Generally cytokines are not released without cell activation and most assays use mitogen 
stimulated immune cells as the cytokine source although some can be measured directly in 
serum. Serum levels may not be accurate because the half-lives of some cytokines are very 
short (minutes), sensitivity of the assays requires superphysiological concentrations, and 
'normal' levels have not been established. Immune cell activation to measure cytokines 
following in vivo chemical exposure has the complication of potential reversal of toxic 
mechanism due to length of incubation. In vitro exposure to the test chemical may provide a 
more controlled environment for alteration in cytokine production but without the interaction 
of the whole immune system and whole body effects, relevance of changes in cytokine 
production may be more difficult to interpret. The mouse cytokine system was the most 
understood and has the largest number of assays available but there are species specific 
cytokine functions that need to be considered if extrapolating cytokine data to another 
species. For example, IL-5 has different functions in the rodent and humans. An additional 
approach to assessing cytokines is molecular biology techniques that measure specific 
mRNA which was being reported more frequently in the literature. These techniques may be 
very sensitive and specific for increased expression of mRNA for a cytokine but functional 
molecules are not measured thus the biological significance may not be correlated to the 
measured alteration. 
While the preceding series of reports outline a valid, comprehensive approach to 
immunotoxicity testing in experimental animals, the ultimate goal is to accurately extrapolate 
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this information to risk assessment of human exposures to immunotoxic compounds. The 
ideal situation would be to conduct these studies in exposed humans but the drawbacks of 
this are obvious. Tryphonas (2001) outlined the practicalities of performing immunotoxicity 
evaluations in humans. This review related that even though the experimental animal 
database is extensive for immunotoxicity of chemicals, human data is limited and 
incomplete. Of data that has been obtained in human studies, it was usually following 
occupational or accidental exposures that were difficult to characterize and often appropriate 
unexposed controls were not obtained. The author lists several published screening protocols 
for assessing immunotoxicity in humans but related that no epidemiological study has used 
any of these in its entirety. Immune system assays described by the author that can be 
conducted in humans were similar to ones recommended by Luster et al. (1988) with minor 
modifications. WBC in humans has more value than in animals since it exhibits little 
individual variability over time although can be significantly influenced by factors such as 
age, sex, race, stress, pregnancy, nutritional status, smoking, or coexistent infections. 
'Normal' values used for comparison should be age and sex matched minimally. Similarly 
for peripheral blood cell phenotyping, age was a particularly important control factor since 
total lymphocyte counts change in age groups, especially as lymphocyte populations are 
maturing in childhood. Quantification of basal serum immunoglobulin classes had limited 
value as predictor of susceptibility of infection but antibody production to specific antibody 
had predictive value similar to rodent studies. Tryphonas (2001) recommended two antigens 
that could be safely administered to people, bacteriophage phiX174 and keyhole limpet 
hemocyanin (KLH), since they have not been observed to cause any adverse effects with 
repeated injections and were not likely to have been encounter by the immune system 
previously. Assays to assess cellular immunity include mitogenic response of peripheral 
blood lymphocytes and measurement of inherent and stimulated cytokine release from these 
cells, delayed hypersensitivity responses to a battery of skin injected test antigens, and 
cytotoxicity of NK cells from peripheral blood. All of these assays have large databases of 
rodent data and have been validated repeatedly but interpretation of results would be 
complicated by large interindividual variability. The author cautioned that any changes 
observed in immune function must be correlated with blood/adipose tissue levels of the 
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toxicant in question. This review provided information on clinically relevant immune assays 
that can be conducted in humans when investigating an immunotoxicant and some insight 
into the considerations important to study design. The most restrictive aspect of conducting a 
study would be the number of subjects required to achieve adequate power for valid 
interpretation of acquired data and appropriate controls in order to detect effects of exposure. 
Immunotoxicity evaluation of any compound should involve a battery of assays 
assessing the major functions of the immune system as well as cells available to mediate 
these functions. Luster et al. (1988) found strong concordance between alteration in 
production of PFC in response to sRBC and spleen cell phenotyping and accurate prediction 
of chemical specific immunotoxicity. Inhibited Tier I functions warrant further investigation 
by Tier II assessments which include host resistance assays. Alterations in host resistance 
assays were not found without immune function alteration (Luster et al., 1993) and tend to 
have a linear regression relationship. Cytokine measurements from serum or ex vivo can 
suggest mechanisms of immunotoxicity but House (1999) cautioned that many cytokines are 
labile and functionally overlap. Work involving cytokine mRNA expression has limited 
utility if xenobiotic toxicity occurs at transcription or post-transcriptional. Studies to 
investigate immunotoxicity in humans was described as more complicated (Tryphonas, 2001) 
due to confounding factors, limited exposure regimes available, careful selection of 
appropriate 'normal' controls, and interindividual variability. Study of xenobiotic effects on 
the immune system was a relatively new specialized avenue of investigation but has become 
more prevalent as the incidence of childhood asthmas and concerns for hypersensitivity 
reactions to new protein antigens introduced by genetically engineered foods. Difficulties 
arise from investigation of a xenobiotic's potential for immunotoxic effects in the controlled 
environment of the laboratory and extrapolation of that data to human risk assessment. Not 
only is the chemical of interest not the only chemical to which people are exposed but 
humans expose themselves to so many other immunomodulating factors (smoking, nutrition, 
exercise, stress) that finding anecdotal evidence for immunotoxicity in a human population 
warrants further investigation. Interactive factors that may expose a high-risk population, 
particularly if control measures can be instituted, should be determined by a comprehensive 
systemic approach as outlined by the previous reports. 
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Immunomodulation by DON in vivo 
In vivo immunotoxicity studies have been conducted almost exclusively in mice with 
complementary studies in numerous cell types in vitro to further characterize effects of DON. 
An early study evaluated the humoral dose-response of weanling male Swiss-Webster mice 
to once a day gavage with DON for 5 weeks at doses of 0.75, 2.5 and 7.5 mg/ kg bw with the 
inclusion of solvent and untreated controls (12 per group at initiation of study) (Tryphonas et 
al., 1984). All of the animals died that were given the highest dose and 4 animals died in the 
2.5 mg/kg group, all due to the treatment. Antibody titers to sRBCs (given i.p. 5 days prior to 
termination) were significantly reduced in both remaining dose groups compared to vehicle 
controls (p < 0.004), PFCs were reduced but statistical significance was not met. Thymic 
weight reduction was dose-responsive (p < 0.001) but spleen weight was only reduced by 
0.75 mg/kg bw (p < 0.02). Serum protein profiles by electrophoresis was altered significantly 
by the lower dose with an increase in albumin (p < 0.01) and reduction in a-2 globulin (p < 
0.001) resulting in a significant elevation of albumin/globulin ratio (p < 0.01) compared to 
the vehicle controls. This study was reported to be preliminary data but there was apparent 
vehicle effects, most likely the result of handling stress to gavage, that reduced (not 
statistically significant) spleen and thymus weights as well as PFC and antibody titers. 
Although DON treated groups were compared to the vehicle control animals, this chronic 
stress effect may have influenced the true immunotoxic effect of DON. 
In follow-up experiments (Tryphonas et al., 1986), weanling male Swiss-Webster 
mice were fed 0, 0.25, 0.5, or 1.0 mg DON/kg bw which was equivalent to 0, 1, 2, or 4 ppm 
DON in the diet. After 5 weeks exposure (starting at 3 weeks of age) the only significant 
effects were reduced serum a-2 globulin in all DON fed groups (p < 0.035, n = 10) and 
increased albumin in the 1.0 mg/kg group (p < 0.048). To investigate the reversibility of 
dietary DON effects, the protocol from the first experiment was repeated (n = 6) but at the 
end of the 5 week feeding, all groups were fed the control diet for 40 days before 
termination. Serum protein effects were not reversible with elevated albumin in all DON 
dose groups (p < 0.041) and reduced a-1 globulin in the 1.0 mg/kg bw group. Serum 
antibody titers, PFCs, spleen or thymus weights were not significantly different. A Listeria 
challenge study was conducted on a third set of mice fed the same DON diet above (n = 10) 
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injecting i.v. 8.4 X 104 colony forming bacteria (LD20-30) diluted in saline and mortality was 
recorded over 18 days. It was not stated if the experimental diets were continued. Even 
though a similar number of animals died per group (3 from each control, 0.25, and 0.5 mg/kg 
bw groups; 2 from 1.0 mg/kg bw group) DON caused a dose-response inverse relationship to 
time of death (7.3, 6.3, 5.5, 5.3 days for control, 0.25,0.5, and 1.0 mg/kg respectively). One 
final study was conducted using the same protocol but after 5 weeks feeding the test diets (n 
= 6), splenocyte proliferation assays were conducted using the mitogens Con-A, PHA-P, and 
LPS. Cells were incubated with and without mitogen for 48 hours prior to addition of tritiated 
thymidine and incubation for an additional 16 hours. Although no significant differences 
were observed for any media controls or mitogen stimulated splenocyte cultures, the data 
suggested a stimulatory effect of DON with or without Con-A and PHA-P. The authors also 
reported significantly reduced feed consumption for mice fed 1.0 mg/kg bw compared to 
controls (p < 0.001) although body weight gains fluctuated for all groups since all four 
experiments were pooled for this comparison. The authors estimated the no-effect level of 
DON exposure resulting in immunomodulation to be between 0.25 and 0.5 mg/kg bw per 
day. This seems reasonable as sub-chronic dietary studies observed reduced weight gain and 
feed intake at 2 ppm dietary DON (Forsell et al., 1986). 
As previously indicated, multiple mycotoxins may occur in one food source, 
particularly DON and ZEA. Pestka et al. (1987) investigated the immunological effects of 
dietary DON and ZEA separately and in combination in B6C3F1 weanling female mice. 
Purified DON and ZEA from culture were incorporated into AIN-76A semi-purified diet 
resulting in diets containing: 0.5 ppm DON, 5 ppm DON, 25 ppm DON, 10 ppm ZEA, or 5 
ppm DON +10 ppm ZEA. Additional pair fed control groups were included that were given 
the same amount of feed consumed by the 5 ppm and 25 ppm DON groups. Animals were 
fed for either 2 weeks or 8 weeks then immune function assays were conducted: splenic 
clearance of Listeria monocytogenes injected i.v. (diet treatments 0.5 DON, 5.0 DON, 10.0 
ZEA, 0.5 DON + 10.0 ZEA and 5.0 DON + 10.0 ZEA), PFC response to sRBC priming (diet 
treatments 5.0 DON, 25.0 DON, 10.0 ZEA, 5.0 DON + 10.0 ZEA), and delayed 
hypersensitivity to KLH injected in footpad, same diet treatments as PFC. Dietary exposure 
to mycotoxins for two weeks resulted in significantly delayed splenic clearance of Listeria (1 
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X 104 CPU) in the DON (5.0) + ZEA (10.0) group 1 day after injection (p < 0.05, n = 5) 
compared to ad libitum controls which continued 4 days post challenge, and DON (0.5) + 
ZEA (10) group had significantly delayed clearance compared to DON (0.5) (p < 0.05, n = 5) 
at 4 days post challenge. The groups fed DON (25 ppm), DON (25 ppm) + ZEA (10 ppm), 
and ZEA (10 ppm) had significantly delayed clearance (5 X 104 CPU) compared to ad 
libitum controls (p < 0.01, n = 9) but not restricted controls 4 days post challenge. There were 
no differences detected after 8 week dietary treatment for either challenge dose or time post 
challenge. Humoral immunity was also effected by dietary treatments resulting in 
significantly reduced sRBC PFC/ spleen in DON (25 ppm) (n = 10) compared to ad libitum 
controls (n = 24) (p < 0.01) while the pair-fed controls consuming equal diet to the DON (25 
ppm) group were the only group having reduced total spleen cell counts compared to ad 
libitum controls (p < 0.01) after 2 weeks feeding. There appeared to be a mean increase in 
PFC/ per 106 spleen cells in the DON (5.0 ppm) group but the SEM was 50% of the mean. 
After 8 weeks exposure reduced total spleen cells occurred in pair fed controls (25 ppm) and 
DON (25 ppm) groups (p < 0.01) but DON (5.0) + ZEA (10.0) had significantly higher cell 
numbers (p < 0.05) compared to ad libitum controls. Sheep RBC PFC per 106 spleen cells 
was increased by restricted feeding (p < 0.01) compared to ad libitum controls whereas PFC 
formation after DON exposure (25 ppm) was significantly reduced when compared to pair 
fed controls (p < 0.01). Delayed hypersensitivity to KLH was reduced by 3 week feeding of 
DON (25 ppm) compared to ad libitum or pair fed controls (p < 0.01) and DON (25 ppm) + 
ZEA (10 ppm) (p < 0.05). No treatment effects were observed after 8 weeks feeding. The 
authors summarized the effect of DON and ZEA on splenic Listeria clearance based on the 
two experiments but one important factor that was omitted in the discussion was the 
difference in challenge dose. Delayed clearance observed when mice were challenged with 1 
X 104 CFU was not observed at 5 times the dose with a larger sample size (5 vs. 8 animals) 
and 25 ppm DON fed mice were not challenged with the lower bacterial dose. Although all 
three immune function assays conducted were affected by dietary mycotoxin exposure, dose 
of agent challenge and length of mycotoxin exposure were important parameters elucidated 
by this study. Feed refusal as a consequence of mycotoxin exposure may contribute to 
suppressed immune function but since these authors did not report the actual feed intake, it 
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was difficult to assess the extent of feed intake reduction. Mechanism of adaptation to 
chronic mycotoxin exposure has not been investigated and could prove to be one explanation 
for lack of toxicological incidence in populations where mycotoxins are found in food 
supplies chronically. 
General immunosuppressive effect of DON in weanling male BALB/c mice exposed 
to daily i.p. injections of 5 mg DON/kg bw in DMSO-PBS (1:9 vol/vol) or dietary DON 
(purified from culture) fed at 2.5 to 100 ppm was also determined (Robbana-Barnat et al., 
1988). Ad libitum and pair fed controls, to what dose of DON was not indicated, were 
included. Injection of DON, although tolerated well, caused reduced thymus/ body weight 
ratio (p < 0.01, n = 8) compared to ad libitum controls but did not result in a significant 
reduction of anti-sRBC antibody titer. In the same experiment mice fed 50 ppm dietary DON 
(5 mg/kg bw equivalent) thymus to bw ratio was significantly reduced (p < 0.001) and 
antibody titers were reduced (11 ± 1.8 vs. 208 ± 48, p < 0.001) compared to ad libitum 
controls. Dietary restriction had no effect on these two parameters. When lower doses were 
fed, 10 ppm was the threshold of significant reduction of: anti-sRBC antibody titers at 1 (n = 
8) and 2 weeks feeding (n = 5) (p < 0.05); thymus: bw ratio (p < 0.01) after 1 week; 
[3H]thymidine incorporation in PHA stimulated spleen cells ( p < 0.001), LPS stimulated 
spleen cells (p < 0.001), and PHA stimulated thymic cells (p < 0.001) after 1 week feeding 
compared to pair-fed controls. Histological examination of mice fed lOppm DON revealed 
marked thymic atrophy to the extent of inability to distinguish between cortex and medulla. 
Although the aims of this study were the immunosuppressive responses of these animals, 
inclusion of data for dietary intake and immune responses of ad libitum controls would have 
been helpful to assess any influences of dietary restriction. Mice fed 1 ppm for 2 weeks were 
included in the sRBC data along with 2.5 and 5 ppm. These doses did cause some 
suppression of antibody titers and proliferative responses of immune cells. Although the 
authors mentioned differences in response recorded between the two routes of exposure 
initially tested, lower doses were not tested by i.p. injection and 5 mg/kg bw was half of the 
dose that killed all of the mice in their dietary study (100 ppm). These animals were also 
quite young (4-6 weeks old) and diet was not specified. This study omitted data that would 
have helped clarify the response observed but it did provide evidence of immunosuppression 
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in B ALB/c male mice may occur at doses consistent with other mouse strains. Previously this 
investigator had found B ALB/c male mice to be sensitive to dietary DON with feed intake 
reduction at 2.5 ppm (Robbana-Barnat et al., 1987). Investigation of other experimental 
parameters that can alter the immune response in these animals such as age (immaturity) or 
environmental stressors (singly vs. group housed) may provide additional insight into 
differences between studies with the same animal strain. 
As discussed in the general introduction to immunotoxicity above, host resistance 
assays are more definitive assessment of the effect of immunomodulation in vivo. Two 
studies have investigated specific responses to different immunological insults in the face of 
DON exposure. Atroshi et al. (1994) tested the hypothesis that acute or sub-acute exposure to 
DON would influence the incidence and severity of mastitis in mice infected with 
Staphylococcus hyicus or Mycobacterium avium as a model for bovine mastitis. Lactating 
(first litter) NMRI mice were gavaged with 12.5 mg/kg bw once or 6.25 mg/kg bw once a 
day for 7 days, last treatment 6 hours prior to infecting two mammary glands (R4 and L4) 
with S. hyicus (2.5 X 108 CPU) or M. avium (3 X 106 CPU). Due to differing growth 
characteristics of these organisms, S. hyicus infected mice were examined for effects 48 
hours after infection while 17 days was the period for M. avium infected animals. There 
were significantly decreased number of animals that appeared ill (p < 0.01) and severity of 
infection in the glands was reduced but inflammation was still evident when infected with S. 
hyicus. M. avium infected animals treated with a single dose of DON were not different from 
controls for signs of illness (80% ill) or severity of infection in glands. Animals that had been 
dosed with DON for a week before S. hyicus infection were not different from controls for 
illness but the severity of mammary gland infection was significantly reduced (p < 0.05) as 
well as number of CPU recovered from the infected glands. Serum IgA (ELISA analysis) 
was significantly elevated in both infection groups (p < 0.05) following a single oral dose of 
DON and after a week of treatment serum IgA, IgG, and IgM were all significantly elevated 
(p < 0.05) compared infected controls. Although the authors attempt to extrapolate this data 
to mastitis in cows, DON bioavailability differences between these two species were not 
considered and likely would invalidate mice as a model for cattle. IgA stimulation appeared 
to be independent of infecting organism but non-infected DON treated controls were not 
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included in the study to distinguish this issue. Although all classes of Ig were elevated by one 
week DON treatment, 48 hours would not be adequate time to influence a primary immune 
response to S. hyicus unless a secondary response was observed due to prior exposure to this 
organism or one with cross-reactivity. Again another control group would have provided 
clarity to the actual interaction between oral DON exposure and a mastitic organism. 
Hara-Kudo et al. (1996) investigated the immune response of male B ALB/c mice to 2 
ppm DON (in water) two weeks prior to and concurrent with oral intubation of Salmonella 
enteritidis (3 X 106 CPU). Mice were euthanized 3, 5 and 7 (n = 4 mice per treatment per 
time period) days after S. enteritidis exposure with continuous DON exposure and bacteria 
counts were conducted in the mesenteric lymph nodes (LN), liver and spleen. DON treated, 
non-infected mice did not exhibit reduced weight gain, water intake, or alteration of liver or 
spleen weight. Bacterial counts were increased in mesenteric LN 3 days after infection in 
DON-treated mice compared to infected controls but were not different at 5 or 7 days after 
infection. Spleen bacterial counts were significantly higher at 7 days post-infection for the 
DON-treated mice (p < 0.05). Even though appropriate controls were included, it appeared 
that statistical analysis was conducted with each animal as an experimental unit while 
animals were housed 4 to a cage with a common water source. Details on diet composition 
and feed intake were also not reported. This report indicated an inhibitory effect of ingested 
low dose DON on clearance of a commonly encountered enteric bacteria but it would be 
useful to repeat this study with dietary exposure and measurement of immune function such 
as bacteria specific antibody responses and blood and spleen cellularity. 
Investigations into the immunologic effects of DON have become more specific and 
mechanistic in the last decade. Two reports with relevance to our research will be reviewed 
here that measured in vivo cytokine release from orally DON exposed mice. Zhou et al. 
(1997) measured a battery of cytokine mRNA expressed in the spleen and Peyer's patches 
(PP) of male B6C3F1 mice following a single oral dose of 0, 0.1, 0.5, 1.0, 5.0, or 25.0 mg/kg 
bw (n = 3) DON dissolved in carbonate-bicarbonate buffer. Two hours after treatment tissue 
cytokine mRNA was extracted, measured by reverse transcriptase-polymerase chain reaction 
(RT-PCR) with Southern blot analysis. Serum cytokine measurements (ELIS A) were made 
from mice exposed to a single oral dose of 25 mg/kg bw and bled 3 hours later. Elevations in 
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expressed mRNA due to 5 or 25 mg/kg bw DON dose was observed for TNF-a, IL-1(3, IL-6, 
IFN-y, IL-2, IL-12 p40, IL-4, IL-10 in the spleen and to a lesser extent in Peyer's patches. 
Lower doses did not significantly alter cytokine expression. TGF- P and IL-5 were 
constitutively expressed and were not affected by treatments, no other cytokines were 
measured. TNF-a, IL-6, IFN-y were the only cytokines found in detectable levels in the 
serum of DON dosed mice while no detectable levels were found in vehicle control mice. A 
protocol detail of concern was the dissolution of DON in a carbonate-bicarbonate buffer (pH 
9.6). DON is sensitive to alkalinity (Wolf and Bullerman, 1998; Abbas et al., 1988) and 
depending on the time in this solution, some compound degradation could have occurred 
lowering the effective dose. Although all animals were handled similarly, the stress of food 
and water removal 2 hours prior to gavage, with euthanasia 2 or 3 hours later (unspecified 
route) could have caused a stress hormone spike which may have altered cytokine mRNA 
expression. Inclusion of an untreated control group would have ruled out this potentially 
confounding factor. This study is reviewed here because it is the first report of dose-response 
cytokine effects although extrapolation of this data to our research interest is limited. 
In a follow-up study, Zhou et al. (1998) investigated sub-chronic dietary DON 
exposure following a similar protocol for cytokine mRNA described above, although serum 
cytokines were not measured. Male B6C3F1 weanling mice were fed 10 or 25 ppm DON in 
AIN-76A semi-purified diet for 4 weeks then mice were euthanized by CO2 asphyxiation 
prior to spleen and Peyer's patch removal. Cytokines with increased mRNA expression (fold 
increase over vehicle control mice, p < 0.05) were; TNF-a 2 fold increased at both doses in 
spleen but only in 10 ppm group for PP, IFN-y 2.5 fold in 10 ppm spleen, 1.5 fold in 25 ppm 
spleen, IL-2 2 fold both doses for spleen and 10 ppm PP, and IL-10 3.5 fold 10 ppm spleen, 2 
fold 25 ppm spleen. Since no serum levels were measured, significance of these levels of 
mRNA expression is unknown but animals that were gavaged with 5 mg DON/kg bw, 
equivalent to 25 ppm diet, for 2 days had twice the concentration of serum TNF-a although 
the measured mRNA was not different from controls but significantly reduced from mRNA 
from mice treated one day with the same dose. Either the stress of gavage two days in a row, 
recognized by authors, or other mechanisms resulted in modulation of the acute effect. The 
same DON vehicle system was used as the previous study and it was not reported if solutions 
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were freshly made on the second day of the trial. Sub-chronic dietary DON at 10 ppm caused 
significantly increased mRNA expression but lower dose responses have not been reported 
for the same time course. Without correlation of this data with cytokine release into the 
serum and from cells with the resulting biological response to any alterations observed, value 
of the data presented cannot be assessed. 
Immunomodulation by DON in vitro 
Numerous studies have investigated the in vitro effects of DON on immune system 
cells. The most relevant reports reveal information concerning alterations in cell function by 
direct action of DON entering the cells. Extrapolating this data to in vivo responses, 
particularly in the immune system with numerous cell and cell products expressed and 
regulated to elicit an appropriate response to perceived immunological threats, must be 
guarded. 
A common approach when investigating responses of immune cells to a xenobiotic is 
exposure of spleen or thymus cell (whole or molecularly selected populations) suspensions to 
the xenobiotic in the growth media with simultaneous mitogen stimulation. Warner et al. 
(1994) harvested spleens and PP from B6C3F1 female mice (8 - 10 weeks old) following 
facility acclimation for 7 days with AIN-76A diet. Tritiated thymidine incorporation, 
measure of proliferation, and [14C]leucine incorporation, measure of protein synthesis, were 
assessed in spleen cell suspensions, macrophage depleted, cultured with DON (0, 1, 10, 100, 
or 1000 ng/ ml media) for 72 hours. Proliferation (p < 0.01) and protein synthesis (p < 0.01) 
were significantly inhibited by 100 ng DON/ml in cultures stimulated with LPS but 1000 
ng/ml was required to reach significant reduction with Con-A mitogen. Supernatant 
cytokines were measured by ELISA from CD4+ (T helper cells) that had been exposed to 
DON (0, 25, 100, 200 ng/ml media) and Con-A (5 fig/ml media) for 48 hours then washed 
and fresh media added with continued incubation for 5 additional days. IL-6 (p < 0.01) and 
IL-5 (p < 0.05) were significantly elevated by exposure to 25 ng/ml and 100 ng/ml DON and 
suppressed, not significantly, by 200 ng/ml. IL-4 was significantly elevated by 200 ng/ ml (> 
10 fold, p < 0.01) while IL-10 was elevated but not significantly with exposure to 25 ng/ml. 
Concerned about washout of influence of DON in the 5 days following removal, the authors 
reported a similar pattern of cytokine production occurred in the same doses for continual 
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exposure cultures. Together this data indicated protein synthesis was inhibited in mixed cell 
cultures but cytokines expression was increased in a subset of splenic lymphocytes possibly 
indicating selective, regulatory, protein inhibition but the protein synthesis inhibition was not 
assessed in the T-cell subset, therefore this effect can only be hypothesized. Although the 
authors noted confirmation of macrophage depletion from the cell suspensions, the potential 
for sufficient macrophage presence to secrete activation factors for T-cell cytokine secretion 
could not be ruled out. Since stimulation of IL-6, IL-10 and IL-5 occurred at 25 ng DON/ ml 
media, it would be meaningful to conduct studies with lower doses comparable to 
characterize this effect in potential DON serum levels. 
Ouyang et al. (1995) repeated the cytokine portion of the previous study using the 
same protocol (same research group) except that culture supernatant samples were taken 2 
and 7 days after continuous culture of B6C3F1 murine CD4+ cells with DON (0 - 250 
ng/ml) and Con-A (5 ng/ml media). The objective of the study was trichothecene comparison 
therefore several other cytokine profiles were reported. IL-2 was inhibited by 250 ng DON/ 
ml at 2 days exposure compared to untreated cells, but after 7 days incubation IL-2 was 
significantly increased compared to lower doses (p < 0.05). Interestingly the apparent IL-2 
concentration, about 2.5 units/ml, at 250 ng DON/ml media did not change over the time 
periods but the controls and lower doses had initially higher levels of IL-2, about 5 U/ml, 
then declined to about a third, 0.5 U/ml. IL-5 and IL-4 were inhibited in a dose responsive 
manner by > 100 ng/ml (2 days) but was elevated by 100 ng/ml and almost not detected in the 
250 ng/ml (7 days). This pattern of inhibition at 2 days and stimulation at 7 days was also 
evident with equivalent concentrations for NIV but 2 - 3 X higher concentration was 
required for 15-ADON and 10 X or more for 3-ADON. Cytokine mRNA expression was 
measured at 2 days DON exposure with significant induction at 50-100 ng/ml for IL-2 and 50 
ng/ml for IL-4. IL-5 and IL-6 mRNA were not affected by the treatments. The results of this 
study indicated the importance of considering acute versus chronic DON exposure effects. 
Initial contact with the mycotoxin inhibited cytokine production at higher doses than were 
required for increased synthesis, or lack of degradation, at lower doses with sub-acute 
exposures, keeping in mind the results are for an isolated lymphocyte cell type. 
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Miller and Atkinson (1986) investigated low dose responses of peripheral blood 
lymphocytes from PVG rats, no sex stated, to DON in media. Lymphocytes, separated by 
Ficoll-Hypaque gradient, were incubated with PHA and DON (0 - 200 ng/ ml media, five 
replicate wells per concentration) for 42 hours then [3H]thymidine (1 jiCi/ well) was added 
until completion of incubation at 48 hours. Stimulated proliferation, about 130% controls, 
occurred for DON concentrations between 0.005 and 0.5 ng DON/ ml media (no statistics) 
and was inhibited by 50 or 100 ng/ml. Release of mitogenic substances from cell subsets was 
investigated by isolating peritoneal macrophages from male PVG rats and incubated, after 
removal of nonadherent cells, with DON (150 or 300 ng/ml media), Con-A (mitogenic) or 
cycloheximide, prototypic protein synthesis inhibitor. The media was removed after 24 hours 
and fresh media was added prior to additional 16-20 hour incubation. Media was removed 
and used as a conditioning media added to peripheral rat lymphocytes, described previously, 
for assessment of proliferation. Conditioning media, supernatant from macrophages exposed 
to 300 ng/ml DON, caused significantly increased lymphocyte proliferation (p < 0.001) 
compared to Con-A-conditioning media and this media was also found to stimulate 
significant proliferation in the thymocyte co-stimulator assay, C3H murine thymocytes 
stimulated with PHA, compared to Con-A treated macrophage conditioning media or control 
media, indicating considerable IL-1 activity. The author concluded that DON stimulated 
mitogenic cytokine release from macrophages contributing to lymphocyte proliferation but 
this was contradictory to the concentrations reported, as the stimulatory effect on incubating 
DON directly with lymphocytes was markedly lower than that used to stimulate cytokine 
release in macrophages. IL-1 was the cytokine reportedly responsible for this effect but IL-12 
had not yet been described in the literature and could contribute to this effect. This report was 
the only one known to investigate these extremely low DON concentrations on peripheral 
lymphocytes of any species. 
Peritoneal macrophages from female Swiss mice were exposed to DON (1 - 1000 ng/ 
ml media) for 4 hours then assessed for alteration of microbiocidal and phagocytic activity 
(Saccharomyces cerevisiae challenge), super oxide production, phagosome-lysosome fusion 
and viability (Ayral et al., 1992). While macrophage viability was not affected (LDH release) 
across all DON concentrations, microbiocidal and phagocytic activity was significantly 
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reduced by >1 ng/ml (p < 0.05) with reduced super oxide production compared to controls. 
Phagosome-lysosome fusion was inhibited by >100 ng DON/ml media. This experiment was 
replicated five times with duplication each time therefore the data appears valid. Clearance of 
the challenge organism required opsonization and apparently from this data, lethal oxidative 
mechanisms once engulfed. The low threshold sensitivity of murine peritoneal macrophages 
may explain previously described data for in vivo inhibition of M. avium clearance in mice as 
this organism requires intracellular growth. The authors do not speculate further the 
mechanism of action and there have not been any reports investigating ex vivo responses of 
peritoneal macrophages to in vivo DON exposure. 
Numerous studies have been published investigating in vitro exposure of human 
peripheral lymphocytes to DON in media. Meky et al. (2001) separated lymphocytes (healthy 
blood donors) from peripheral blood by Ficoll-Hypaque gradient centrifugation and exposed 
them to PHA and DON (50 - 500 ng/ml) for 5 days prior to cytotoxicity assessment with 
MTT assay. Cytokines were also assayed (ELIS A) in supematants (harvested daily) from 
lymphocytes exposed to DON (0, 100, 200, or 400 ng/ml media) ± PHA for 3 days or 8-9 
days. DON caused reduced lymphocyte proliferation in concentrations greater than 100 
ng/ml and an IC50 216 ng/ml was determined from the standard curve. The authors indicated 
reduced proliferation without reduced cell viability but did not report the basis for this 
statement. IL-2, but not IL-4 or IL-6, was stimulated in culture after 72 hours at 200 and 400 
ng/ml compared to cells exposed to PHA alone (p < 0.05). When cultures periods were 
extended (DON 400 ng/ml) IL-2 was significantly elevated at 24 hours and increased every 
24 hours with peak production at 113 hours (p < 0.05). IL-4 was significantly elevated at 72 
and 113 hours of incubation (p < 0.05) but then declined. IL-6 was depressed at 24 hours 
incubation (p < 0.05) then was below but not significantly different from controls. When two 
donors' lymphocytes were compared over 9 days of incubation with DON (200 ng/ml), IL-2 
peaked at 72 hours for both donors, returning to control levels for one donor at 120 hours and 
168 for the other. IFN-y was inhibited for 72 hours for both donors then reached peak 
production at 120 hours for one donor and 168 hours for the other with no decline in 
concentrations for the remainder of the culture period (216 hours). IL-6 was unchanged by 
DON in either donor. An omission in this study was historical information about the donors. 
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Confounding immunomodulatory influences such as smoking, prior mycotoxin intake, and 
nutritional status were not reported. These factors were commonly under-reported in studies 
of this type. A second concern was the length of incubation without mention of media 
supplementation or change. Potentially cells could become stressed due to nutrient utilization 
over 8-9 days in culture. Lower concentrations of DON (biologically relevant) in culture 
would provide data that could more accurately be compared to rodent studies. Although 
human serum levels of DON have not been reported, it does not seem feasible that the upper 
levels tested in this study would occur with common food levels. 
A more comprehensive approach to in vitro exposure of human peripheral blood 
lymphocyte to DON was reported by Berek et al. (2001). Lymphocyte proliferation was 
assessed, [3H] thymidine incorporation, in PHA and Con-A mitogen stimulated cultures 
exposed to 10 - 5000 ng DON/ml. Lymphocytes, void of adherent cells, were incubated with 
51Cr labeled Rh+ Type O RBCs, and anti-Rh(D) antisera, 1:20 vol/vol dilution in media, 
along with different concentrations of DON to assess antibody-dependent cellular 
cytotoxicity (ADCC). NK cell cytotoxicity was evaluated by incubating peripheral 
lymphocytes with 51Cr labeled K-562 cells and different concentrations of DON for 16 hours 
prior to supernatant collection to count radioactivity release. Three donors were tested and 
the authors indicated undetectable DON levels in sera by ELIS A. The complete data sets 
were not reported but lymphocyte proliferation was inhibited (p < 0.05) by 100 ng DON/ml 
media with both mitogens. Both cytotoxicity assays were significantly inhibited by 50 ng 
DON/ ml (p < 0.05) although it did not appear to be dose dependent for ADCC as 22 ± 5% 
inhibition was reported for 50, 100, and 1000 ng/ml. There were some serious problems with 
this report as graph and figure captions did not match the data represented making the results 
difficult to accurately identify. A common omission in these studies was not reporting results 
for all concentrations tested and since most study objectives were immunosuppression, any 
effects observed at lower doses were ignored. These authors also stated concentrations for 
this study were selected based on concentrations that can occur in 'normal' human peripheral 
blood but no reference or rationale was given for this statement. This study was included in 
this review because it was the only report of cytotoxicity assessment in human lymphocytes. 
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Sensitivity of these cells to DON was not indicated although these would be considered acute 
exposures as the cells were only exposed to the toxin for 16 to 18 hours. 
Immature cells in the bone marrow or thymus are exposed to tissue levels of DON 
when ingested at high enough concentrations in most monogastric animals as reviewed 
earlier. A series of experiments were conducted to investigate the relative sensitivities of 
progenitor cells of different cell types. Lautraite et al. (1997) investigated the sensitivity of 
rat bone marrow cells and human umbilical cord progenitor cells. Cells from both species 
were incubated with conditioning media specific for activation of granulocyte-monocyte 
progenitors and DON at different concentration on solid media for 14 days, each 
concentration in triplicate, each experiment repeated three times. These cells form colonies 
(more than 50 cells), macroclusters (20 to 50 cells), and microclusters (5 to 20 cells) in 
culture and these were scored microscopically at 7, 10 and 14 days of culture. Human cell 
growth, % of control total aggregates of cells, was inhibited to some degree by all 
concentrations tested (as low as 2.96 ng DON/ml) with IC50 values of 8.9 ng DON/ml at 7 
days, 8.6 ng/ml at 10 days, and 11.5 ng/ml at 14 days incubation. Human cells were 
destroyed by > 74 ng/ml. Rat bone marrow cells were significantly (p < 0.05) less sensitive. 
All rat cells were destroyed by 296 ng DON/ml and IC50 values for 7, 10 and 14 days of 
incubation were 77, 44.4, and 47.4 ng DON/ml respectively. Cell formation type was 
affected as concentrations that inhibited overall growth had higher frequency of 
microclusters compared to untreated controls whereas at lower concentration the distribution 
was even between colonies, macro- and microclusters. The authors emphasized that this 
assay was the observation of cells produced from several divisions from the original 
progenitor cells, thus if differentiation is disrupted growth may be arrested. This was 
suggested in the response of granulocyte-monocyte progenitors due to increased frequency of 
microclusters indicating arrest of mitosis earlier in differentiation than larger aggregates of 
cells. There was also differences in culture time for different cell progenitors to acquire 
cluster formation so that assessing growth patterns at different time points during exposure 
indicated sensitivity of late-aggregate-forming cells although the specific cell type was not 
proposed. The importance of this report was the low level sensitivity expressed by human 
granulocyte-monocyte progenitors. Since the umbilical cord samples were obtained randomly 
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and without contact with the donor, prior exposure to mycotoxins was not reported to be 
assessed by the investigators. 
Froquet et al. (2001) investigated the response of human megakaryocyte (platelet) 
progenitors. A similar system was used as the previous study except the umbilical cord cells 
were separated by gradient density (d = 1.077 g/ ml) centrifugation to acquire light density 
cells. DON in acetone was added to the cells in semisolid media along with human 
recombinant thrombopoetin (50 ng/ml), human recombinant IL-6 (10 ng/ml) and IL-3 (10 
ng/ml) as growth stimulation factors. Following 12 days of incubation, cells were fixed and 
immunocytochemically stained for CD 41, primary monoclonal antibody to a glycoprotein 
surface marker on megakaryocytes. Colony formation scoring was conducted as previously 
described. DON at 74 ng/ml media was not cytotoxic although total colony growth was 55 ± 
20% of untreated controls. Significant inhibition of colony formation (p < 0.001) and 
stimulation of microclusters (p < 0.05) also occurred at this dose. Lower doses, 22.2, 7.4 and 
2.9 ng DON/ ml, did not alter colony formation. These cells were not as sensitive to DON 
exposure under optimal growth condition as white blood cell progenitors tested previously 
but the sensitivity was within the suspected range of in vivo serum levels. 
Froquet et al. (2003) investigated the effects of DON on mature human peripheral 
RBC, WBC and platelets. Platelets were separated from blood donated by healthy human 
adults by centrifugation and added back to plasma prior to exposure to DON in the plasma. 
Coagulation (measured by prothrombin time, activated partial thromboplastin time, and 
thrombin time assays) and platelet aggregation (response to collagen or adenosine-di-
phosphate) was not affected by concentrations as high as 2.96 |ig DON/ml plasma. Red 
blood cells and WBC were separated from umbilical cord blood by gradient density 
centrifugation (d = 1.077 g/ml). RBC were washed twice in glucose medium to retard 
spontaneous hemolysis and normalized to 20% Hct. WBC were washed and mixed with 
plasma. Both cell type suspensions were incubated in solution for 24 hours at 37°C with 
different concentrations of DON prior to viability assessments. WBC were not affected by 
DON up to 2.96 pg/ ml plasma after 6 hours incubation but at this concentration after 24 
hours viability was decreased 50% (p < 0.05) of untreated controls based on hemocytometer 
counting, assuming Trypan blue dye exclusion but not stated. RBC hemolysis was not 
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affected by any concentration although D-glucose concentration (0.2 ± 0.8 vs. 0.6 ± 0.8 
^Mol/ml) and L(+)lactate concentration were decreased (4.5 ± 2.9 vs. 4.8 ± 2.4 pMol/ml) by 
2.96 ng DON/ ml at 24 hours compared to solvent control incubations. Glutathione (reduced 
form) was also reduced compared to solvent controls (4.6 ± 1.6 vs. 5.5 ± 3.0 pMol/ g Hb) 
following 24 hour exposure to 2.96 |ig DON/ ml. Although the majority of data reported here 
was negative, this indicated relative tolerance of mature circulating RBC, WBC and platelets 
to short term exposure of DON. Since the lifespan of RBC is 120 days, investigation of 
effects due to longer exposures are warranted although culture conditions may be difficult. 
Together with data from the previous two reports, effects observed in vivo were more likely 
due to progenitor cell sensitivity rather than effects on mature circulating cells. 
Immune function alterations following DON exposure in mice have included; reduced 
antibody titers to sRBC (Tryphonas et al., 1984), altered serum protein profiles (Tryphonas et 
al., 1984, 1986), thymic atrophy (Robbana-Barnat et al., 1988), reduced clearance (Pestka et 
al., 1987) and reduced time of death (Tryphonas et al., 1986) to L. monocytogenesis 
challenge, reduced clearance of S. enteritidis (Hara-Kudo et al., 1996), and lack of defense 
against mycobacterial mastitis (Atroshi et al., 1994). Acute and sub-chronic doses have 
stimulated cytokine mRNA expression with increased serum cytokines (Zhou et al., 1997, 
1998). In vivo immunologic studies have not been conducted in species other than mice but 
in vitro investigations have been conducted in several species including humans. Rodent 
spleen cells exhibit dose-response effects with stimulated proliferation at very low doses 
(Miller and Atkinson, 1986) and inhibition at higher biologically relevant exposures (Miller 
and Atkinson, 1986; Warner et al., 1994). Cytokine release from murine spleen cells 
(Ouyang et al., 1995) and human peripheral blood lymphocytes (Meky et al., 2001) exhibited 
time and dose dependent response with inhibition at 2 days culture but stimulation after 
longer periods. DON induced the release of lymphocyte growth factors from mouse 
peritoneal macrophages (Miller and Atkinson, 1986) and functionality of these cells was 
inhibited by extremely low doses in vitro without any effect on viability (Ayral et al., 1992). 
Human peripheral blood NK cytotoxicity and lymphocyte proliferation were inhibited (Berek 
et al., 2001). Progenitors of granulocytes (Lautraite et al., 1997) and megakaryocytes 
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(Froquet et al., 2001) exhibited cytotoxicity to low DON doses but mature RBC, WBC, and 
platelets were not affected by acute exposure (Froquet et al., 2003). 
Overall conclusions regarding immunomodulation by DON 
Immunomodulation in response to DON exposure does not appear to be species 
specific although sensitivity due to bioavailability in vivo may affect levels in contact with 
immune cells. While in vitro studies help define explicit responses, these can only reflect 
direct responses by the specific cells exposed, and do not include the influences of the whole 
animal. DON has been shown to influence cytokine mRNA expression and cytokine 
secretion in vivo and in vitro and most likely is an important mechanism of biological 
influence. Effects were dependent on dose and length of exposure with particular sensitivity 
observed in some cell types (macrophages and stem cells). Although functional assays have 
been conducted on human cells in vitro, little is gained from this work without epidemiologic 
data documenting extensive dietary and xenobiotic histories, actual plasma and urine 
mycotoxin levels, and conducting immunologic assays to determine basal function as well as 
host resistance. Anecdotal evidence exists for immunosuppression in humans (Bhat et al., 
1989) but experimental evidence is lacking. 
Acute Exercise Stress Effects on the Immune System 
Acute stress has been induced in mice by numerous techniques including electric 
shock, rotational stress, swimming, and restraint. The focus of this review will be on the 
main aspects of acute exercise stress and the effects induced in the immune system. We were 
interested in this model because segments of the population are exposed similarly, military 
personnel in particular, and this may serve as a model for other acute stressors perhaps 
psychological. Some relevant human studies on this subject will be introduced to correlate 
the appropriateness of the mouse model. Treadmill running to exhaustion was our model for 
acute exercise stress. Hoffman-Goetz et al. (1988) investigated the effects of acute exercise 
to fatigue and 8 week exercise training on splenic immune functions, only the information 
directly related to acute exercise stress will be reviewed. Male mice (C57BL/6J) were group 
housed and acclimated to the facility for at least a week prior to starting the training program 
or waiting until the end of the study to participate in one time exercise to fatigue on a 
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treadmill. Exhaustion was determined when the mice could no longer maintain speed with 
physical prodding (60 - 70 minutes). Mice were rested for 30 minutes before termination. 
Plasma corticosterone was determined by extraction and duplicate samples compared 
spectrophotometrically with a standard curve. Single cell spleen suspensions were prepared, 
cell viability determined by Trypan blue dye exclusion, enumeration by hemocytometer, and 
lymphocyte proliferation assays (IX 106 cells/ well in triplicate) measured by [3H]thymidine 
incorporation following media only, LPS (1.0 ng/ml), and pokeweed mitogen (PWM) (0.5 
ng/ml) cellular incubations. Plasma corticosterone levels were significantly higher in mice 
that had been exercised to exhaustion (p < 0.0001) compared to unexercised controls. There 
were no significant effects on total spleen cell numbers or response of the spleen cells to 
either mitogen. The authors concluded that corticosterone elevation was not responsible for 
splenic immunosuppression as hypothesized. This study performed a limited number of 
assays but with adequate sample size (n = 10) and statistical analysis to support their 
conclusions. 
Further assessment of the effects of acute exercise stress using the treadmill model 
was continued by Hoffman-Goetz et al. (1989). Male mice (C3He) were treated similarly to 
the prior study. Following 30 minutes rest after exhaustion, mice were terminated and spleen, 
thymus, and several lymph nodes collected. Cell populations within each tissue were 
determined by monoclonal antibody labeling of cells for expression markers Thy 1.2 (all T-
lymphocytes), L3T4 (T-helper cells), Lyt2 (T-suppressor/cytotoxic cells) and Ig expression 
(B-cells) with enumeration by direct immunofluorescent flow cytometry (20,000 cells 
counted per sample). Consistent with the previous study, there were no differences between 
treatment groups for total cell concentration in these three tissues. Thymus cell composition 
was altered by acute exercise stress resulting in suppression of Thy 1.2+ cells (p < 0.05) and 
Lyt2+ cells (p < 0.001) in response to this treatment. Splenic Ig+ cells were significantly 
reduced (p < 0.008) in acutely exercised mice compared to sedentary controls but other cell 
types were not affected. No differential effects were observed in the lymph nodes. Together 
with the previous study, assuming corticosterone elevation in these mice, splenic cellular 
population was not altered by this stress other than reduced Ig+ B-cells. Differences observed 
between lymphoid organs may suggest alteration of local environments within these organs 
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resulting in marker loss or trafficking these cells into the circulation. It is important to note 
that the exercise stress occurred over about an hour followed by a thirty minute rest period 
thus cellular responses observed occur rapidly. 
Further assessment of differential effects on lymphocyte subsets due to acute exercise 
stress was conducted by Randall Simpson et al. (1989). The same mouse strain and exercise 
protocol (n = 6) as above was used including labeling and flow cytometry of the cells. Prior 
to labeling cell subsets, spleen cell suspensions (106 cells per 500 pi per well in 
quadruplicate) were incubated with media alone, Con-A (1.0 pg/ml) or Con-A plus purified 
IL-1 (1 LAF unit) for 96 hours. In response to Con-A, a higher percentage of Thy 1.2+ (pan 
T-lymphocytes) (p = 0.0034) as a result of a significant increase of Lyt-2+ (T-
suppressor/cytotoxic) cells (p < 0.001) compared to sedentary controls. There was a trend of 
reduced Ig+ cells (p = 0.06) by acute exercise stress in response to mitogen activation. 
Addition of IL-1 to the culture was not different from Con-A for any of the cell subsets. 
Increasing the number of T-suppressor cells upon activation following a bout of acute 
exercise stress could be a mechanism to control mitogenesis but as the authors discuss, other 
suppressor cells are also activated during mitogenic stimulation in culture (macrophages), T-
suppressor cells can provide helper functions or other suppressive molecules produced in 
culture (cytokines?). These results confirm the results of the previous study indicating no 
differences in un-activated spleen T-cell populations but distinct responses upon activation 
occur. Ig+ B-cells were suppressed by the stress with or without mitogenic activation. 
Further investigation will be required to investigate the mechanisms of these effects and the 
in vivo consequences, if any. As previously stated, in vitro studies limit the extrapolation to 
in vivo effects due to influences from many tissues and systems particularly in the immune 
system with complicated and overlapping regulation. 
The effects of treadmill exercise to exhaustion on NK cytotoxicity was assessed 
(Randall Simpson and Hoffman-Goetz, 1990). The same mouse strain and exercise protocol 
was used as the previous three reports. The classic 51Cr release assay was conducted with 
spleen cell suspension (1.5 X 107 cell/ml) and YAC-1 cells (1 X 105 cell/ml) mixed in 
effector: target ratios 150:1, 75:1, 37.5:1, and 18.25:1 in triplicate and incubated 4 hours 
prior to assessment of radioactivity in supematants. NK enumeration in the spleen cell 
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suspensions was done by labeling cells with asialo GMi (ASGMi, NK marker) and detecting 
indirect immunofluorescence by flow cytometry. Splenic tissue was analyzed for 
catacholamines by extraction and HPLC. No treatment effects were detected for 
norepinephrine levels in the spleen but epinephrine levels were significantly higher in mice 
exercised to fatigue (33 ± 3.0 pg/mg protein, p < 0.05, n = 8) compared to sedentary controls 
(10.9 ±1.3 pg/mg protein, n = 9). NK cytotoxicity was significantly reduced by acute 
exercise stress (p < 0.05) compared to sedentary controls at 150:1 E:T ratio and the same 
pattern was observed across all ratios. NK cells expressing ASGMi was also reduced by 
exercise treatment (p < 0.05). The authors reported similar inhibition of NK cell cytotoxicity 
observed with other acute stressors, but only transiently. This series of experiments reported 
alterations in spleen and thymus lymphocyte populations and functionality with elevations in 
corticosterone and epinephrine due to acute exercise stress. Information on alterations of 
cytokine production or receptor expression for this model of acute stress has not been 
reported. 
Mechanisms of cellular immune effects from acute exercise stress were investigated 
by Azenabor and Hoffman-Goetz (1999). Female C57BL/6 mice exercised on a treadmill to 
exhaustion and killed immediately or rested for 24 hours were compared to sedentary 
controls (n = 10) for splenic and thymic cellular concentration of antioxidant enzymes 
superoxide dismutase (SOD) and catalase. Lipid peroxide was assayed from cell-fragment 
pellets and plasma uric acid and ascorbic acid was measured. The thymus had a significantly 
higher concentration of lipid peroxidase (p < 0.05) immediately after acute exercise and 
remained high 24 hours later compared to sedentary controls. The spleen also had higher 
lipid peroxidase (p < 0.05) due to acute exercise and it continued to climb 24 hours later 
although the thymic levels were 3-4 times higher across all treatment groups. Both 
antioxidant enzymes in both tissue types were significantly (p < 0.05) consumed immediately 
following acute exercise but returned to control levels 24 hours later. Plasma uric acid was 
reduced but not significantly by acute exercise stress at both times but plasma ascorbic acid 
was significantly reduced only after 24 hours post-exercise (p < 0.05). This pattern of 
responses reflected production of oxidative damage and built-in mechanisms of 
compensation as discussed by the authors. Under these controlled conditions with only one 
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stressor, this response seemed appropriate but the addition of other stressors such as 
nutritional deficiencies or infectious agents may overwhelm the compensatory capacity of the 
animal. 
The observation of elevated corticosteroids following stress has been commonly 
documented. The effect of this hormone response on the immune system has been studied for 
a long time particularly since this class of compounds is used as treatments for allergies, 
asthma, and immune cell cancers (lymphoma). Specific immune responses of mice to the 
acute stress following adrenalectomy provide evidence for influence of corticosterone 
(Esterling and Rabin, 1987). Male Swiss-Webster mice were either adrenalectomized under 
anesthesia or under went a sham operation then both groups were allowed to heal to 2 weeks. 
All mice were injected i.p. with sRBC (0.4 ml 5% in PBS) and half of each group were 
stressed by rotation (5 X 60 minute cycles, 10 minutes rotating 100 rpm followed by 50 min 
rest) immediately after the sRBC priming and for 3 additional days. The other half of the 
surgical groups rested for 24 hours after sRBC priming then was rotationally stressed for 3 
days. Immunized unstressed controls were maintained and killed in the same timeframe (n = 
7-13 mice per group). Antibody titers to sRBC (microhemagglutination) were measured in 
blood collected at time of death. Single cell spleen suspensions were prepared and the 
hemolytic plaque assay and immunofluorescence staining for enumeration of lymphocyte 
subsets was conducted. There was a significant effect of stress on the PFC (p < 0.001) as the 
animals stressed immediately after sRBC priming were not significantly different from 
primed but not stressed controls but the animals given 24 hours rest had significantly reduced 
PFC regardless of adrenal presence. The same pattern occurred for serum antibody titers (p < 
0.01). T-cell populations were adrenal dependent but did not respond to timing of stress. 
Both T-helper (Lyl+) and T-suppressor (Ly2+) cells were significantly higher in 
adrenalectomized mice (p < 0.05) if stress occurred immediately after sRBC priming but T-
suppressor cells were not different from non-stressed controls for either adrenal treatment. 
The authors were careful to express limitations of interpreting and extrapolating this data to 
general conclusions about the relationship between stress, adrenal hormones, and immune 
responses because timing, frequency, severity, and duration of stress must be considered to 
compare between studies. The finding of an adrenal independent effect on suppression of 
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PFC and antibody titers to sRBC in the animals stressed 24 hours after immunization may 
indicate a sensitivity of a particular phase of cell activation in the process of epitope 
recognition or protein processing. This study has limited relevance to our primary research 
but it did indicate that corticosteroids are not the only endocrine product of acute stress that 
can affect antibody production and that interactions occur between times of immunization 
and stress that can significantly affect the resulting immune response. 
The use of mouse models to study the effects of acute exercise stress on immune 
function has been utilized because responses have been comparable to humans and relatively 
large studies can be conducted in a controlled environment. Humans can be studied directly 
to some extent. Weinstock et al. (1997) investigated the release of cytokines into the urine 
and serum and from whole blood cell cultures of male athletes before and after exhaustive 
exercise stress (sprint triathlon, average completion time 68 minutes). Blood and urine was 
collected 24 hours prior to exercise, 1 and 20 hours after exercise. Cytokines were measured 
in serum and urine by ELIS A. Whole blood was cultured with LPS (1 ng/ml), PHA (5 
pg/ml), Con-A (10 pg/ml) or culture media only for 24 hours then supernatant was removed 
after centrifugation. Cell counts performed on whole blood revealed a significant increase (p 
< 0.01) 1 hour after exercise in total WBC, granulocytes (neutrophils) and monocytes while 
the lymphocytes were decreased (p < 0.01) compared to 24 hours before exercise. Cell counts 
had returned to pre-exercise levels 20 hours after exercise. Immediate exercise dependent 
elevations in IL-6 (p < 0.01) and TNF-a (p < 0.05) was observed in all subjects. Although 
several subjects expressed them, IL-2 and IFN-y did not exhibit exercise dependent changes. 
Only IL-6 had significantly higher frequency of detection in urine 1 hour after exercise 
(13/15 subjects, p < 0.01) compared to pre-exercise (4/15) or 20 hours post-exercise (2/15). 
Spontaneous release of cytokines from whole blood cultures indicated suppression of IL-6 
and TNF-a at both time points post-exercise, IL-ip was suppressed only at 20 hours post-
exercise while IFN-y was elevated by 1 hour post exercise and remained higher compared to 
pre-exercise levels. IL-2 was not detected in media only cultures. LPS (B-cell) mitogen 
stimulated cultures significantly depressed TNF-a, IL-lp, and IFN-y while stimulating IL-6 
at 1 hour post-exercise. Con-A depressed IFN-y 1 hour post-exercise and stimulated IL-2 
release 20 hours post-exercise. PHA depressed IL-2 at 1 hour post-exercise but slightly 
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stimulated its secretion 20 hours post-exercise compared to pre-exercise levels. Since whole 
blood was not corrected for elevations of cell counts 1 hour post-exercise, cytokine 
concentrations were normalized to concentration per 1000 lymphocytes or monocyte, 
depending on assumed expressing cell type, resulting in only IL-6 significantly depressed 
(concentration per 1000 monocytes) in LPS stimulated cultures 1 hour post-exercise. This 
study was significant in that it showed the transient nature of immune cell and cytokine 
production following acute exercise stress. It was a good study to investigate human in vivo 
effects because the lymphocytes were kept in the blood matrix so that cells could influence 
each other by the cytokines produced. Stress hormones present in the blood were minimally 
diluted thus potentially continuing to exert effects over the 24 hour incubation period. These 
men were trained so the results reported here could not be extrapolated to untrained 
individuals but the responses were pair-wise compared to themselves so appropriate 
statistical analysis was conducted. The training regimes of the subjects were quite varied and 
may also affect results although in the previous mouse studies, training (results not included) 
was independent of the acute response. Other than differential WBC count, there was no 
information to determine the lymphocyte cell types as had been done in the previous mouse 
studies. 
Acute exercise stress has a unique profile of responses in the immune system that can 
be modified depending on the intensity, duration, and type of exercise conducted. There were 
apparently complicated neuroendocrine effects directly on circulating and tissue based 
immune cells involving in particular corticosteroids and catacholamines. Numerous murine 
models of acute exercise stress to study the mechanisms have been developed but the 
treadmill model was chosen due to access to equipment and prior experience. Although 
murine cytokine data did not appear to be available for acute exercise stress in an appropriate 
model, some human data was available that appeared comparable to the murine model. Mice 
forced to exercise to fatigue on a treadmill and rested for 30 minutes exhibit: elevated plasma 
corticosterone levels without altering splenocyte proliferative responses to LPS or pokeweed 
mitogen (Hoffman-Goetz et al., 1988); decreased Ig+ spleen cells, decreased total T-
lymphocytes with specific reduction of T-suppressor cells in the thymus but no alterations in 
the lymph nodes (Hoffman-Goetz et al., 1989); all T-lymphocytes, T-suppressor/cytotoxic 
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and Ig+ spleen cells stimulated significantly by Con-A (but not additionally by IL-1) 
compared to un-stressed control mice (Randall Simpson et al., 1989); NK cytotoxicity and 
NK spleen cells significantly reduced while splenic epinephrine was elevated (Randall 
Simpson and Hoffman-Goetz, 1990). Thymus and spleen undergo oxidative stress following 
acute exercise (Azenabor and Hoffman-Goetz, 1999). Antigen specific PFC is suppressed if 
acute stress occurs 24 hours after immunization but not immediately and independent of 
corticosterone where as suppression of lymphocyte subsets did appear to be corticoid 
dependent (Esterling and Rabin, 1987). Men acutely exercise-stressed had elevated blood 
WBC, neutrophils, and monocytes with concurrent lymphocytosis (Weinstock et al., 1997). 
These men also secreted increased levels of IL-6 into blood and urine and whole blood 
cultures revealed suppression of IL-6 and TNF-a and stimulation of IFN-y spontaneously 
released, while mitogen activation in these cultures tended to suppress cytokine release from 
blood collected 1 hour post-exercise compared pre-exercise levels (Weinstock et al., 1997). 
The body of literature concerning exercise and immunity is immense. The murine model 
appears comparable to human responses although numerous authors caution comparing 
across exercise models. 
Interaction of DON and acute exercise stress? 
It seems reasonable that dietary DON exposure and acute exercise (or other ) stress 
could occur in the same person, or group. Dietary animal studies have indicated toxic 
endpoints in monogastric animals at levels of exposure frequently occurring in worldwide 
food sources. Both dietary DON and acute exercise stress have caused immunosuppression in 
mice. The mechanisms of immune function alteration following acute exercise have been 
relatively well characterized with oxidative stress playing a significant role. Although 
mechanism of toxicity for DON exposure was characterized early, evidence is building for 
mechanisms involving cellular signal transduction pathway activation or inhibition. 
Oxidative stress also affects these pathways which could be a mechanism for interaction 
between DON and acute stress. No published reports have investigated similar interactions. 
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CHAPTER 3. CAFFEINE AS INTERNAL STANDARD FOR HIGH PERFORMANCE 
LIQUID CHROMATOGRAPHY ANALYSIS OF DEOXYNIVALENOL IN WHEAT 
SAMPLES 
A paper to be submitted to Journal of AO AC INTERNATIONAL 
Cindy A. Landgren1, Patricia A. Murphy2, and Suzanne Hendrich3 
Abstract 
A method was developed to utilize caffeine as an internal standard for analytical 
detection of deoxynivalenol (DON) in wheat samples using high performance liquid 
chromatography (HPLC) with ultraviolet detection. Ground wheat samples were extracted 
with aqueous acetonitrile and spiked with 30 |xg caffeine (CAP). Sample aliquots were 
cleaned up through an alumina-charcoal column and analytes were separated with linear 
aqueous methanol gradient, UV detection at 220 nm. Retention times for DON and CAF 
were approximately 9.0 min and 16.0 minutes respectively. Fungal culture material (124 
(ig/g) was added to commercial wheat flour to achieve mean DON concentrations of 0.26, 
0.51, 1.99, and 5.96 pg/g. Three replicates of each concentration were analyzed daily and 
repeated four days. An internal standard curve was developed plotting sample concentration 
against area response ratios (DON/CAF). Correlation coefficient (r) was 0.983 and no 
significant difference between or among days of analysis occurred. Recovery of DON spiked 
samples at 1.00 pg/g was 100.5% in this system. This method will allow analysis of samples 
using an accessible, stable, and inexpensive compound not likely to be found in most samples 
of interest. 
Introduction 
Deoxynivalenol (DON) (Figure 3.1) is a secondary metabolite of Fusarium sp that 
occurs commonly worldwide in staple foods (Placinta et al., 1999). Methods for detection of 
DON include TLC, GC, ELISA, and HPLC (Krska et al., 2001). Most methods specify 
1 Graduate student, primary researcher, and author. 
2 Professor, Department of Food Science and Human Nutrition 
3 Professor and corresponding author, Department of Food Science and Human Nutrition 
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standard addition spiking as confirmation of DON presence. Due to the FDA advisory level 
of 1 (ig/g in food for human consumption, efforts have not been made to reduce the limit of 
detection below 0.5 fxg/g. Internal standard addition has not been published for HPLC/UV 
analysis. Caffeine (CAF) (Figure 3.1) was chosen as a candidate for an internal standard due 
to an optimum UV absorbance wavelength of 210 nm, low molecular weight of 194, 
compatible solvent solubility, and chemical stability in DON analytical methods (Merck, 
1996). It also qualified as an internal standard due to absence in samples of interest. The 
purpose of this study was to develop a "gold standard" method in our laboratory for 
comparison to future screening method research. 
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Figure 3.1. Molecular Structure of Deoxynivalenol (DON) and Caffeine (CAF). 
Materials and Methods 
Chemicals 
DON, CAF, yeast extract, potato dextrose agar (PDA), and carboxymethyl cellulose 
(C-0806) (CMC) were from Sigma (St. Louis, MO). HPLC grade acetonitrile and methanol 
were from Fisher Scientific (Pittsburgh PA). Water was filtered though Waters Milli-Q® 
system and buffered to pH 7.0 with 3.0 M NaOH (if needed) prior to use. Ground charcoal 
was from Acros Organics, NJ and was from a single lot. Fusarium cultures were purchased 
from Fusarium Research Center, Pennsylvania State University, University Park, PA. 
Samples 
Negative wheat flour samples were purchased from local commercial sources. DON 
contaminated culture material was produced (Witt et al., 1985) on autoclaved rice using 
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lyophilized Fusarium graminearum (R-5245, USA OH). Culture material was dried, ground 
to a meal, and stored at -20°C. Analysis by HPLC determined DON concentration by 
standard curve. The culture material used for internal standard curve development contained 
124.18 pg DON/g dry weight. 
Extraction and Cleanup 
Fungal culture material was added to 25 g wheat flour to achieve target DON 
concentrations of 0.25, 0.50, 2.0, and 6.0 pg/g. Acetonitrile and water (84:16) was added 
(100 ml) to each sample along with 30 p,g of caffeine dissolved in extraction solvent. The 
sample was blended at high speed in Vi pint blender jars for 3 minutes, filtered through paper 
coffee filters into flasks and covered with Parafilm. Solid phase extraction columns were 
constructed of 1 gram alumina (80-200 mesh) 40:1 with ground charcoal in a 5 ml syringe 
barrel with a fitted Whatman #4 filter paper frit at the top and bottom of the packing. Five ml 
sample extract was applied to the column and allowed to flow by gravity into a 15 ml glass 
test tube. Two ml of the eluate was quantitatively transferred to a 12 X 75 mm glass cuvette 
and dried under a gentle stream of nitrogen in 50° C water bath. The residue was dissolved in 
400 pi of 15% methanol: buffered water and filtered through 0.45 |xm 4mm PVDF syringe 
filter into HPLC autosampler vial. 
HPLC Analysis 
The HPLC system was a Hewlett Packard 1050 with UV diode array detector, 
autosampler, and degasser, with an YMC-Pack ODS-A C18 RP, S5jx 4.6 X 100 mm, with 4.6 
mm guard column from Waters (Franklin, MA). Data acquisition and analysis was performed 
by ChemStation software. Injection volume was 50 jxl with 0.7 ml/min flow rate by linear 
gradient of 15-20% methanol over 25 minutes with a step-up to 80% methanol for 5 minutes 
for wash out and re-equilibration at 15% methanol for 15 minutes. Total run time was 50 
min/sample. DON standard curve was determined over 0.2 to 6.0 jag/g sample and standards 
were run each day of sample analysis. For internal standard curve validation, three replicates 
of each concentration were prepared daily and repeated on four separate days. Statistical 
analysis was performed with SAS (Cary, NC) using weighted least squares linear regression. 
Safety 
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Culture material was handled in a certified BL2 laminar hood. Biohazard safety and 
hazardous waste generation requirements of Iowa State University Environmental Health and 
Safety were followed. A USDA permit was obtained for the transport and use of Fusarium 
cultures. 
Results and Discussion 
Extraction and Cleanup 
Several processes in this method required alteration from a peer-reviewed method 
(Trucksess et al., 1998). The pH of laboratory filtered Milli-Q® water tended to be acidic 
causing a source of variability in CAF recovery. pH was monitored for all water used in 
sample processes and adjusted to 7.0 ± 0.2 if necessary. The commonly used commercial 
SPE column for trichothecene mycotoxins (Mycosep™, Romer Labs, Inc., Washington MO) 
resulted in excessive loss of caffeine. Our 40:1 alumina-charcoal column produced a cleaner 
chromatograph and greater DON recovery as compared to the commercial SPE column. 
Numerous ratios of alumina, charcoal and Celite were tried, as well as cation exchange resin 
and Sep-Pac C-18 columns. Alumina and charcoal SPE columns could be made ahead of 
time and stored at room temperature covered with foil. No vacuum apparatus was required 
for extract flow through the column at 1 ml/minute and the eluate was clear and colorless. 
LC Analysis 
DON standard curve was prepared from analysis of control solutions in 
concentrations of 0.2, 0.4, 1.0, 2.0, and 6.0 jag/g. Linearity was verified daily across 
concentration range with an average correlation coefficient (r) of 0.999. Limit of detection 
was 5.8 ng/injection based on signal to noise (3:1) calculation (Cunico et al., 1998). Limit of 
quantification was 0.4 |ig/g based on multiple injections yielding relative standard deviation 
of 5.26%. Relative standard deviation (RSD) at each concentration level was calculated as 
standard deviation of response ratio DON peak area relative to CAF peak area /mean DON: 
CAF response ratio X 100. This was lower than previously reported (Trucksess et al., 1996 & 
1998) due to inclusion of lower concentration standards. 
DON recovery was determined from spiking blank wheat flour samples at 1.00 pg/g. 
Mean recovery for triplicate samples was 100.5% with range of 95.4 to 104.4%. Several 
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commercial flour samples were analyzed to acquire a blank sample that was used for sample 
development. 
Figure 3.2. Representative HPLC chromatogram of wheat flour spiked with fungal culture 
material for DON concentration 0.25 |ug/g and 30 qg CAF internal standard spike. 
Culture material proved a consistent, inexpensive spiking source for internal standard 
curve development. Interfering components were adequately removed to detect low levels of 
DON and consistent CAF peak areas (Figure 3.2). Four sample runs were conducted with 
each concentration level in triplicate. The runs were conducted over two months and at least 
three days between runs. Statistical analysis revealed unequal variance across concentration 
levels increasing with greater DON concentrations in the samples. In order to account for this 
weighted least squares linear regression analysis was conducted. A weight was applied to the 
concentration (independent variable) that represented the inverse of squared standard 
deviation of the residual concentration. The internal standard curve could be described by the 
equation y = 0.07854 + 0.68204x (r = 0.983). There was no significant difference between 
days so that the reduced model included only the concentration variable. Confidence limits 
(95%) were calculated from predicted values (Figure 3.3). Further method precision 
evaluation was conducted by utilizing the Horwitz ratio (Burgess, 2000) because runs had 
been performed over a wide time frame (Table 3.1). Our analysis followed published 
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findings that RSDs are greater in samples of lesser concentration (Whitaker et al., 2000). 
HORRAT values less than two are generally accepted as adequately precise (Burgess, 2000). 
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Figure 3.3. Response ratio (DON/CAF) predicted values and 95% confidence limits from 
weighted least square linear regression procedure. Calculations based on 12 samples per 
concentration level. 
Table 3.1. Horwitz ratio (HORRAT) evaluation of method precision. 
Sample 
Concentration 
Mg/g 
Response Ratio 
DON /CAF area 
Relative 
Standard 
Deviation 
Observed 
Relative 
Standard 
Deviation 
Calculated 
HORRAT 
0.26 ±0.01 0.28 ± 0.07 25.7% 19.7% 1.31 
0.51 ±0.02 0.38 ± 0.07 18.7% 17.7% 1.06 
1.99 ±0.01 1.54 ±0.18 11.5% 14.4% 0.80 
5.96 + 0.01 4.13 ±0.53 12.7% 12.2% 1.04 
Footnote: Mean and standard deviations of sample concentrations and response ratios of 12 
samples per level. Relative standard deviation observed was calculated from standard 
deviation/ mean response ratio X 100. Relative standard deviation calculated was from RSD 
_ 2 (1-0.5 log C)> w|:lcre Q was relative concentration so that 100% has value of 1 or 10°. 
HORRAT was the ratio RSD observed/RSD calculated. A HORRAT value of less than 2 was 
considered adequately precise. 
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This method was used to analyze commercial wheat flour and bread mixes acquired 
locally (Table 3.2). 
Table 3.2. Commercial wheat-based sample analysis by HPLC following 30 ug CAF internal 
standard addition. 
Sample Type Sample Code Response Ratio 
Area DON/Area 
CAFa 
DON 
Concentration 
Mg/gb 
Wheat flour GM 0.37 0.43 
Wheat flour WM nd nd 
Bread mix 52B 2.11 2.98 
Bread mix 52M 2.59 3.68 
Bread mix 55M 0.24 ± 0.20 nd 
Bread mix 36M 0.23 ±0.10 0.28 to nd 
Bread mix 99M 0.15 ±0.21 0.26 to nd 
Wheat MW 3.80 ±0.97 4.87 ± 0.93 
Wheat0 PW 2.59 ± 0.70 14.45 ± 4.60 
Footnotes: DON concentration calculated from linear regression of internal standard curve 
using fungal culture spiked wheat flour at 0.25, 0.50, 2.0 and 6.0 pg/g, 12 samples per 
concentration. 
a Mean ± sd (where multiple sample analyses), nd indicated no DON peak detected to 
calculate response ratio. 
b Mean ± sd (where multiple sample analyses), nd indicated concentration below limit of 
detection. 
c Concentration calculation included adjustment for 5X sample dilution prior to analysis. 
Due to an interest in low DON concentrations for subsequent research, a robust 
internal standard HPLC/UV method was developed reducing the limit of quantification. 
Caffeine proved suitable for an internal standard due to its absence from most food samples 
of interest and compatibility with current HPLC methods for DON sample preparation and 
analysis. This method reduced waste solvent and sample handling due to one analysis per 
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sample rather than two required with external standard addition. Wheat was the only matrix 
of interest currently therefore additional method validation would be required for other 
matrixes. This method utilized common laboratory reagents and proved robust over a range 
of DON contamination commonly observed in commercial wheat products. 
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CHAPTER 4. SENSITIVE SCREENING BIOASSAY FOR DEOXYNIVALENOL 
DETECTION IN FOOD SAMPLES 
A paper to be submitted to Food and Chemical Toxicology 
Cindy A. Landgren1 and Suzanne Hendrich2 
Abstract 
A bioassay was used to screen for deoxynivalenol (DON) in commonly contaminated 
food samples. Six corn and six wheat samples acquired from local sources were tested. 
Samples were prepared by extraction of foods with aqueous acetonitrile and alumina: 
charcoal solid phase extraction. Human K-562 erythroleukemia cells, modeling immune stem 
cells, were incubated with sample extract and cell proliferation was assessed by MTS 
(dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner 
salt) dye reduction assay. An aliquot of each sample was analyzed by HPLC for DON, 3-
ADON (3-acetyldeoxynivalenol) and 15-ADON ( 15-acetyldeoxynivalenol), the latter two 
compounds not detected in any sample. DON was detected in one corn and two wheat 
samples by both methods with correlation of 0.97, p < 0.0001. Samples containing DON 
ranged in concentrations from 204 to 3792 ng DON/g food. Concentration resulting in 50% 
inhibition of proliferation (IC50) for DON was 534 ng/ml media. Samples negative for DON 
by HPLC had bioassay responses as percent of controls >88%, with limit of detection of 140 
ng/ ml (based on ±3 sd). This sensitive bioassay, as a model for immune cell progenitors, 
detected DON in a variety of food matrixes within the range of contamination present in the 
human food supply. 
Introduction 
Deoxynivalenol is a fungal secondary metabolite produced predominantly by 
Fusarium graminearum in a wide variety of cereal grains (Rotter et al., 1996). Other 
1 Graduate student, primary researcher, and author. 
2 Professor and corresponding author, Department of Food Science and Human Nutrition 
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trichothecene mycotoxins such as 3-ADON and 15-ADON may be produced by the same 
fungal species and all are resistant to food processing (Hazel and Patel, 2004; Wolf-Hall et 
al., 1999). DON was the most common mycotoxin contaminant of food worldwide with 
estimated daily consumption of 0.78 to 2.4 fig/ kg bw per day from five GEMS/Food 
regional diets (Canady et al., 2001); the FDA has set an advisory level at 1 mg/kg in human 
food (Rotter et al., 1996). Many cell lines have been tested for cytotoxicity in response to 
purified trichothecenes (as reviewed by Gutleb et al., 2002; Jestoi et al. 2004). Human K-562 
erythroleukemia cells were one of the most sensitive lines and have shown comparable 
sensitivity with human peripheral lymphocytes exposed to DON in vitro, median cytotoxic 
dose (CD50) of 300 ng DON/ml media and median inhibition of phytohemagglutinin-induced 
blastogenesis of 430 ng DON/ml media (Visconti et al., 1991). The K-562 cell line originated 
from pleural effusion of a person with chronic myelogenous leukemia. K-562 cells are 
multipotent and can spontaneously differentiate into erythrocyte, granulocyte or monocyte 
progenitors although they have not been shown to express T or B lymphocyte markers 
(Lozzio et al., 1981). Minervini et al. (2004) proposed that the toxic mechanism of purified 
DON in K-562 cells was decreased cellular metabolism due to median proliferation 
inhibition dose (ID50) of 651.2 ± 8.9 ng/ ml media by MTT [5-(3-carboxymethoxyphenyl)-2-
(4,5-dimethylthiazol-2-yl)-3-(4-sulfophenyl) tetrazolium bioassay] and/or decreased cell 
proliferation with ID50 of 473.6 ± 148.0 ng/ml media by BrdU (5-bromo-2'-deoxyuridine) 
uptake assay rather than cell necrosis or plasma membrane damage, cytotoxic concentration 
> 24. 8 (jg DON /ml media by Trypan Blue dye exclusion. 
The objective of this study was to determine the sensitivity of human K-562 cells to 
extracts of commonly DON contaminated food samples for high throughput, economical, 
biologically relevant screening and correlate this bioassay with standard HPLC analysis. 
Materials 
DON (51481-10-8), 3-ADON (50722-38-8), 15-ADON (88337-96-6), HEPES buffer 
were purchased from Sigma Chemical (St. Louis MO); K-562 cells originally from ATCC; 
CellTiter 96® [3-(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium, inner salt; MTS] (Promega, Madison WI). Dimethylsulfoxide (DMSO), 
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ethanol, acetonitrile (ACN), and methanol (MeOH) HPLC grade were from Fischer 
Scientific (Pittsburgh PA); Roswell Park Memorial Institute (RPMI) 1640, L-glutamine, 
gentamicin, heat inactivated fetal bovine serum (FBS) were from Gibco (Invitrogen Corp., 
Carlsbad CA). 
Methods 
Cell Culture 
K-562 human erythroleukemia cells were cultured and maintained according to 
Visconti et al. (1991). Briefly cells were grown in RPMI 1640 supplemented with 10% FBS, 
1% L-glutamine, HEPES buffer (10 raM) and gentamicin (50 |a,g/ml final conc.) (CRPMI). 
Cells were maintained at 5 X 1Q5 cells/ml renewed with fresh media three times weekly in 75 
cm2 culture flasks, and incubated at 37°C with 5% CO? in air. Cells were prepared for assay 
by centrifuging for 7 min at 920g, counted with a hemocytometer with viability assessment 
by Trypan Blue dye exclusion (> 95% viability) prior to cell dilution in CRPMI to 2.5 X 105 
cells/ml. 
Sample Preparation 
Standard solutions were made by diluting purified DON in CRPMI supplemented 
with 1.7% (v/v) ethanol and 0.3% (v/v) DMSO (Widestrand et al., 2003). This vehicle, 
without DON added, was the negative control media. Serial dilutions were made for final 
well concentrations of DON of 662.1 ng/ml to 82.8 ng/ml as confirmed by HPLC. Solutions 
were filtered through 0.22-micron cellulose acetate filters (Costar, Cambridge MA) prior to 
addition to microtiter plate wells. 
Six corn (blue corn chips, flour and meals) and five wheat products (whole wheat 
noodles, baking mix, and flours) were purchased from local commercial sources. One 
additional whole berry wheat sample was a known naturally contaminated sample. All 
reusable glassware in contact with samples was oven baked for >3 hours at 180°C to destroy 
endotoxins. Food samples were ground if needed to pass a #20 screen and 25 g was extracted 
with 100 ml ACN: Milli-Q® water (84:16) blended at high speed for 3 minutes in Vi pint 
blender jars. The crude extract was filtered through a paper coffee filter and a six ml aliquot 
was applied to a 1.5 g alumina and ground charcoal (40:1) solid phase extraction column. 
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The eluate was collected and exactly 4.00 ml dried under a stream of N2 in a 50°C water 
bath. The residue was dissolved in 800 JJ.1 DMSO/EtOH/CRPMI equating to 625 mg food 
sample per ml media. 
HPLC Analysis 
A second aliquot of sample crude extract was prepared as above except that the 
residue was dissolved in 800 pi 20% aqueous MeOH and filtered through 0.45-micron 
syringe filter (Alltech, Deerfield IL) into an autosampler vial. The HPLC system was a 
Hewlett Packard 1050 with UV photodiode array detector, autosampler, and degasser. Data 
acquisition and analysis was performed by ChemStation software. Analytes were separated 
using a YMC-Pack ODS-A C18 RP, S5p 4.6 X 100 mm, with 4.6 mm guard column from 
Waters (Franklin MA). Samples, 50 pi injection, were analyzed by linear gradient 15 to 20% 
MeOH: DI water over 25 minutes with step up to 80% MeOH for 5 minutes then re-
equilibration at 15% for 15 minutes, with flow rate of 0.7 ml/minute and total run time 50 
min per sample. DON standard curve was determined in range 0.2 to 6.0 pg/g and ran each 
day of sample analysis. Analysis for 3-ADON and 15-ADON was performed similarly but 
mobile phase was 15% ACN: 85% DI water. 
MTS Cell Proliferation Assay 
Standard or sample media solutions (100 pi) were plated to 96 well flat bottom 
microliter plates with serial 1:1 dilutions in sample media in triplicate, four dilutions per 
sample, followed by 100 pi of K-562 cell suspension (2.5 x 104 cells/ well). The plates were 
incubated for 46 hours at 37°C in 5% C02. Then 15 pi freshly thawed MTS reagent 
(CellTiter 96®) was added to each well. The plate was incubated for two hours and well 
absorbance read by a microplate reader (ELx808, Bio-tek Instruments, Inc.) at 490 nm. 
Calculations and Statistical Analysis 
The mean absorbance for each standard dilution or sample were blanked with the 
media control and converted to a percentage of the negative control [% of control response = 
(test mean response - mean blank)/ (negative control mean response - mean blank) X 100%]. 
The percentage of control response of DON standards was plotted against the DON 
concentration per ml of media to develop a standard curve. Food sample DON concentration 
was calculated from a linear regression equation of the standard curve. Analysis of variance 
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and student t-test were used to compare sample mean DON concentrations and negative 
controls. P values < 0.05 were considered significant. Three replicate experiments were 
conducted. 
Results 
The DON standard curve for the bioassay produced a median inhibition of cell 
proliferation (IC50) at 534 ng DON/ml media, compared to control samples. One com and 
two wheat samples were positive for DON in both the bioassay and HPLC analysis (Table 
4.1). Positive samples in the bioassay had percent control response significantly different 
from the negative control (p < 0.05) at the highest concentration of food extract per ml 
media. Positive samples had peak area responses by HPLC analysis of greater than the limit 
of detection (LOD) of 93 ng/g food. The correlation between results of the two methods was 
0.97, p < 0.0001 (Figure 4.1). 
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Table 4.1. Comparison of K-562 Bioassay and HPLC Detection of DON Concentration in 
Corn and Wheat Foods 
Food Sample 
Sample 
Origin 
Bioassay3 
% control 
Bioassay5 
ng DON/g food 
HPLC0 
ng DON/g food 
Cornmeal IA 88.3 ±3.9 nd nde 
Cornmeal MN 55.4 ±7.2 629.58 ± 349.0 386.67 ± 84.3 
Cornmeal IL 87.6 ± 1.0 nd nd 
Cornmeal MO 88.1 ±9.2 nd nd 
Blue corn chips NB 95.4 ± 4.5 nd nd 
Corn flour OR 93.8 ±6.3 nd nd 
Wheat flour, 
white 
IL 99.9 ± 3.9 nd nd 
Wheat flour, 
white 
IA 104.9 ± 3.2 nd nd 
Wheat baking 
mix 
CANADA 98.8 ±6.7 nd nd 
Wheat flour, 
white 
MN 80.9 ± 4.3 203.59 ±33.0 288.96 ±17.8 
Wheat, whole 
berries 
MI 38.2 ± 1.0 3791.93 ±282.4* 4364.68 ± 66.8 
Wheat, whole 
grain noodles 
MI 88.3 ±7.1 nd nd 
a Mean percent of control K-562 cells (± SE), triplicate wells per experiment, three 
independent experiments, food extract equivalent to 625 mg/ml media. 
b Calculated DON concentration (ng/g ± SE) in food based on purified DON standard curve 
(82.7 - 662.1 ng/ml), triplicate wells per plate. 
C DON concentration (ng/g ± SE) by HPLC/UV on aliquot extract from each experiment 
(n=3). 
d Not detected, within three standard deviations of control (LOD = 140 ng/ml). 
Below limit of detection of 93 ng/g based on 3:1 signal to noise ratio 
Calculation based on dilution 1:1 of extract for bioassay (n=2). 
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Figure 4.1. Correlation of K-562 bioassay and HPLC analysis for DON in food samples. 
Mean DON concentration of each positive sample, bioassay samples were mean percent of 
control for each plate (n =3) and HPLC analysis was one sample per experiment. The whole 
wheat berry sample had duplicate bioassay values because dilution was required to more 
accurately estimate DON concentration. 
The wheat berry sample was highly contaminated and plated in the first experiment 
without dilution. Serial 1:1 dilution in the plate did not reduce the inhibition of K-562 cell 
proliferation by this sample thus the extract was diluted 1:1 prior to plate dilutions in the 
subsequent experiments to titrate toxin concentration. Com not contaminated with DON was 
more inhibitory of cell proliferation than were uncontaminated wheat samples but there was 
no significant difference between the matrixes or from negative controls. At the highest 
extract concentration of 625 mg food sample equivalent/ml media, mean negative wheat 
samples showed effects on K-562 cell proliferation of 98.4 ± 2.4% of untreated controls and 
negative com samples had mean cell proliferative response of 91.2 ± 2.0% of untreated 
controls (Figure 4.2). Other matrices tested in our lab had significant matrix effects on K-562 
I l l  
cell proliferation. Soy flour promoted cell proliferation causing 113.9 ± 6.3% of the cell 
proliferation found in the negative plate control whereas cell proliferation was inhibited by a 
rye and oat flour samples, 82.6 ±4.1% and 36 ± 1.0% of negative plate controls respectively. 
Mean Neg Com Foods (n=5) 
Mean Neg Wheat Foods (n=4) 
Pos Cornmeal (MN) 
Pos Wheat Flour (BL) 
Pos Wheat Berries (MI) 
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Figure 4.2. Inhibition of K-562 cell proliferation following 48-hr exposure to extracts of com 
and wheat foods. Percent control response (± SE) was mean absorbance of triplicate wells 
per plate compared to untreated controls using the MTS dye reduction assay, three replicate 
experiments. Food sample amount was the dry weight of food per ml media represented in 
well dilutions. 
* Significantly different (p= 0.02) from mean negative wheat samples by Student t-test. 
** Significantly different (p < 0.01) from mean negative com samples by Student t-test. 
*** Significantly different (p < 0.01) from mean negative wheat samples by Student t-test. 
Discussion 
Numerous cell lines have been assessed for cytotoxicity due to DON exposure. The 
variability in sensitivity was dependent on cell line, detection assay, and matrix effects of 
sample screened. Recently work has focused on the 3T3 fibroblast cell line with bioassay 
development for screening cereal extracts comparing DNA synthesis with BrdU (Widestrand 
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et al., 2003). The BrdU was the most sensitive bioassay, IC50 4.6 and 13 ng toxin/ml media, 
for these cells when compared to the MTT, IC50 12 and 68 ng toxin/ml media, and LDH 
release, IC5018 and 42 ng toxin/ml media, assays based on response of 3T3 cells to purified 
T-2 and HT-2 toxin, respectively. 3T3 cells showed sensitivity to DON by the BrdU assay, 
IC50 263 ± 18 ng toxin/ml media, but IC50 could not be determined for MTT or LDH release 
assays due to lack of sensitivity up to 2500 ng toxin/ml media (Widestrand et al., 1999). 
Although 3T3 cells are sensitive to some bioassay measurements, in vivo DON toxicity has 
not been identified in related tissue types such as cartilage or other connective tissue. 
Visconti et al. (1991) compared DON cytotoxicity in K-562, MIN-GL1 Epstein - Barr 
virus transformed human B-cell line, and human peripheral lymphocytes using the MTT 
colorimetric bioassay. K-562 cells showed a CD50, mean cytotoxic dose, of 300 ng purified 
DON/ml and ID50, mean proliferation inhibitory dose, of 430 ng DON/ml in mitogen-
stimulated human peripheral blood lymphocytes. Toxicity for 15-ADON was similar 
compared with DON in these cells although 3-ADON showed fivefold less toxicity than did 
DON. Immunotoxicity has been reported repeatedly for in vitro DON exposure to human 
peripheral blood cells (reviewed by Pestka and Smolinski, 2005) with particular sensitivity of 
human umbilical cord granulocyte progenitors, IC50 8.9 ng DON/ml (Lautraite et al., 1997), 
therefore using a cell line of human immune system origin seemed relevant. Minervini et al. 
(2004) investigated cell viability by Trypan Blue dye exclusion, cell metabolism by 
mitochondrial MTT conversion, and cell proliferation by BrdU DNA incorporation in K-562 
cells exposed to purified DON. Cell viability (>80% viability) was not affected by DON 
concentrations up to 84 [iM (24.9 pg/ml media) whereas ID50 was 2.2 and 1.6 pM for the 
MTT and BrdU assays, respectfully. The mechanism of toxicity was proposed as inhibition 
of cell proliferation but not cell death. This mechanism seemed to hold for the K-562 cells in 
our bioassay since the highly contaminated wheat sample (3.7 pg/g) exhibited a maximum 
inhibition of cell proliferation of 35% of controls although microscopically cells appeared 
intact. As a practical bioassay, the K-562 cells had a range of sensitivity around the FDA 
advisory level of 1.0 pg DON/g food. 
The MTT colorimetric bioassay has been used extensively to measure the 
mitochondrial dehydrogenase enzymatic reduction of tetrazolium salts into formazan that can 
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be detected spectophotometrically (Rotter et al., 1993). The absorbance value obtained is 
directly proportional to the cell population and mitochondrial metabolic activity. The MTS 
bioassay relies on similar enzymatic activity but the resulting formazan is water soluble, 
eliminating the requirement of the organic solvent crystal dissolution step in the MTT assay. 
When the MTT and MTS bioassays were compared for BHK-21 (baby hamster kidney) cell 
response to DON exposure, the cells were equally sensitive to both assays (Rotter et al., 
1993). A further advantage of the MTS assay was continual color development in culture 
while MTT color development kills the cells, due to aspiration of media and addition of 
isopropanol, so underdevelopment cannot be resolved without repeating the bioassay. This 
comparison of bioassays was not conducted for our study but the one-step addition of MTS 
to test cell cultures would facilitate use of this bioassay for screening food samples in areas 
with limited access to technology, e.g., low-income countries. The bioassay also utilizes a 
lower level of resources than HPLC, only requiring refrigeration for media storage, 
incubation facilities, and standard sample preparation equipment. 
Limited studies have screened food extracts for mycotoxins using bioassays and of 
these, fewer have investigated processed foods. Widestrand et al. (2003) applied cereal 
extracts from ground wheat, wheat bran, barley and oats to 3T3 cells and assessed 
cytotoxicity by BrdU DNA incorporation. They found some matrix effects in all extracts at 
maximum concentration of 400 mg grain equivalent/ml media but oats were cytotoxic in 
some samples at 100 mg grain equivalent/ml media. Other fungal metabolites may have been 
present but further work was needed to investigate the matrix effect of oats. Porcher et al. 
(1987) investigated matrix effects of corn extracts on murine splenocytes and LF hepatoma 
cells measuring [3H] thymidine incorporation. These cells showed similar sensitivity to 
purified DON, IC50 115 and 200 ng DON/ml media splenocytes and LF cells, respectively, 
but some naturally contaminated corn samples had inhibitory effects on both cell types that 
could not be explained by DON or other mycotoxins (T-2 toxin, HT-2, zearalenone, and 
diacetoxyscirpenol) analyzed by gas chromatography. We did not find significant inhibitory 
matrix effects in this series of experiments, using sample extracts equivalent to 625 mg 
grain/ml media, but in preliminary trials we observed cytotoxicity with other corn, oats, and 
rye food samples. Test samples were negative for 3-ADON and 15-ADON by HPLC/UV but 
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were not analyzed for other mycotoxins in our studies. Numerous other mycotoxins, 
including type A and B trichothecenes, zearalenone and related compounds, and/or 
fumonisin could have been present in these food samples. Extraction and clean-up of the 
food samples used in this study was specific for DON and its derivatives but similar sample 
preparation was conducted by Widestrand et al. (2003) where analysis for T-2 toxin, HT-2 
toxin, nivalenol, and DON was conducted by gas chromatography with electron capture 
detection and 3T3 fibroblast MTT bioassay. They used the MycoSep™ #225 clean-up 
column which resulted in >80% recovery of tested mycotoxins. K-562 cells were sensitive to 
T-2 and HT-2 toxin with CD50 of 1.0 and 20 ng purified toxin/ml media respectively 
(Visconti et al., 1991). K-562 cells were also tested for nivalenol sensitivity by this group and 
had similar CD50 of 300 ng/ml compared with DON and 15-ADON. Our study found strong 
correlation between bioassay detection and HPLC analysis with the same extract, therefore 
presence of immune-reactive amounts of other mycotoxins was not likely. Further analysis 
by GC or HPLC methods would verify absence of other mycotoxins. 
Jestoi et al. (2004) investigated the cytotoxicity of organic and conventionally grown 
processed food extracts applied to feline fetal lung cells. DON, 3-ADON, and 14 others were 
analyzed in the samples by gas chromatography-mass spectroscopy and cytotoxicity was 
assessed by visual determination of cell death or inhibited growth. They found no correlation 
between the analytical mycotoxin concentration and cytotoxicity to the cells even though 
samples collected were not highly contaminated, maximum DON concentration 107 ng/g 
grain samples. They included foods that were highly processed such as ready-to-eat baby 
cereal and instant drink mix but no baked or extruded products. DON can be partially 
remediated by some food processing practices such as tortilla making or extensive milling 
(as reviewed by Hazel and Patel, 2004) but levels were stable or may be increased by other 
processes such as yeast bread production and brewing. Wolf-Hall et al. (1999) found DON to 
be stable in foods exposed to autoclave temperatures with significant enzymatic release of 
DON from the starch matrix by the addition of a-amylase to the sample before extraction, 
resulting in 3 to 30% greater DON recovery from corn grits and canned dog food, 
respectively. In some foods tested, DON may be underestimated if there has been extensive 
binding to the starch matrix of the contaminated cereals. The samples included in this trial 
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were not treated with a-amylase and only one sample had been heat treated, blue corn chips. 
Because the bioassay and HPLC DON concentrations were strongly correlated, binding of 
DON to carbohydrate molecules was not suspected. This aspect of DON binding in heat-
treated foods should be considered in further development of this bioassay for other food 
samples. 
The use of animals or other biological systems to evaluate the effects of a compound 
is the foundation of toxicology. Bioassays utilizing cell culture systems can evaluate 
biological effects in a controlled environment without the use of animals and mycotoxin 
screening fits well into this type of analysis (Buckle and Sanders, 1990). Screening for toxin 
contamination in a large number of samples with minimal analytical costs would be 
beneficial in regions epidemically contaminated with mycotoxins. This was illustrated by a 
report of broiler illness due to mycotoxin feed contamination correlated with cytotoxicity in a 
human epithelial cell line, HEp II, exposed to extracts of broiler feeds causing illness (Robb 
et al., 1982) with confirmation by TLC and GC. Strong correlation of bioassays with 
analytical methods further supports their utility. Bioassays could also provide evidence for 
loss of toxicity, such as testing decontamination strategies, prior to resource intensive animal 
studies. This bioassay utilizes an easy to maintain, nonadherent human cell line that exhibited 
proliferation inhibition upon exposure to purified DON and DON-contaminated extracts from 
commercially available foods. The range of detection was well below the FDA advisory level 
for human food and although there was an upper limit of detection (approximately 2.0 pg/g), 
DON concentrations in food samples could be titrated through dilution. This method had 
significant correlation with HPLC/UV, an established analytical method and could be 
performed in a similar timeframe for multiple samples. This bioassay could be performed as 
an inexpensive sensitive screening method where expensive analytical instrumentation was 
not available or correlation with in vivo activity was desired. 
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CHAPTER 5. LOW-LEVEL DIETARY DEOXYNIVALENOL AND ACUTE EXERCISE STRESS 
RESULT IN IMMUNOTOXOTY IN BALB/C MICE. 
A paper to be submitted to the Journal of Immunotoxicology 
Cindy A. Landgren1, Marion L. Kohut2, and Suzanne Hendrich3 
Abstract 
We hypothesized that acute exercise stress would exacerbate immunosuppressive 
effects of sub-acute exposure to dietary deoxynivalenol (DON). Male BALB/c mice were fed 
0 or 2 mg DON/kg diet for 14 days, n=12 per dose, then exercised to fatigue on a treadmill. 
Mice were euthanized by decapitation, trunk blood and spleens were collected. Single cell 
suspensions of splenocytes were used to quantify immune function by plaque hemolysis and 
conconavalin-A (Con-A) stimulated lymphocyte proliferation assays. Serum corticosterone 
level was determined by enzyme immunoassay. Only the non-exercised DON-fed mice 
showed significant splenocyte proliferation suppression, 32.9 ± 17.9% of non-exercised 
controls (p = 0.021). Exercised controls and DON-fed exercised animals showed splenocyte 
proliferation of 68-75% of non-exercised controls. Antibody response to a T-dependent 
antigen, sheep red blood cells, was significantly less for exercised DON-fed mice than in 
controls (p = 0.031). Serum corticosterone levels were significantly higher for both exercised 
groups compared to the unexercised groups (p < 0.001). IL-4 secretion from mitogen-
stimulated splenocytes was elevated by DON alone (p < 0.05) while IL-2 was elevated by 
DON with exercise stress (p< 0.05). 
Our hypothesis was confirmed with respect to T-cell dependent antibody production, 
but not for splenocyte proliferation under Con-A stimulation. Exercise stress abrogated 
DON-mediated suppression of splenocyte proliferation, perhaps mediated by induction of 
elevated stress hormones counteracting cytokine expression alterations of DON. 
Introduction 
1 Graduate student, primary researcher, and author. 
2 Associate Professor, Department of Human Health and Performance 
3 Professor and corresponding author, Department of Food Science and Human Nutrition 
117 
Deoxynivalenol (DON) is the most common mycotoxin occurring in the food supply 
worldwide with most regional diets having less than 1 mg/kg (Pestka and Smolinski, 2005). 
High contamination can occur depending on environmental conditions permitting synthesis 
of the mycotoxin from Fusarium spp. commonly infecting wheat, corn, barley, oats, rye, and 
triticale (Rotter et al., 1996). Human intoxications were correlated with the high incidence of 
moldy crops (Bhat et al., 1989, Li et al., 2002) and DON was found in high concentrations in 
grains collected from these regions. Human illness (nausea, emesis, abdominal pain, bloody 
stools and increased incidence of secondary infections in children) has been suspected to be 
caused by DON due to its high incidence in foods in the affected area, low DON 
concentrations although high prevalence in areas where people were not affected, and low 
incidence and concentrations of other mycotoxins such as nivalenol, 3 -acetylnivalenol and T-
2 toxin. Epidemiologic studies have not been conducted but detection of DON in human 
urine as a biomarker of exposure (Meky et al., 2003) may prove useful to determine if human 
DON exposure is a disease risk factor. 
Toxic effects of dietary DON have been studied in many species with swine being the 
most sensitive, emesis LOAEL 0.1 mg/kg bw, and others in the following order: mice = cats 
= dogs > rats > poultry > ruminants (Pestka and Smolinski, 2005). Toxic effects include 
emesis, reduced feed intake, reduced weight gain and immunotoxicity (Rotter et al., 1996). 
The immune system was sensitive to DON exposure since the replication required upon 
immune cell activation may be limited by the primary mechanism of action of DON, protein 
translational inhibition (Rotter et al., 1996). Mice are used extensively for evaluating 
xenobiotic effects on the immune system due to comparability with the human immune 
system and availability of reagents. Low-level dietary DON has had mixed effects on murine 
immune function depending on strain, dose and length of exposure. Tryphonas et al. (1986) 
found no significant effect on plaque-forming cell numbers (PFCs) or Con-A, 
lipopolysaccharide (LPS), or phytohemagglutinin P (PHA-P)-stimulated lymphocyte 
proliferation at 1, 2 or 4 mg DON/kg diet in Swiss-Webster mice fed for 5 weeks. Robbana-
Bamat et al. (1988) reported significant reduction in serum levels of antibody to sheep red 
blood cells (sRBC) when weanling male BALB/c mice were fed 10 mg DON/kg diet for one 
or two weeks without significantly inhibited proliferation of splenocytes stimulated with 
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PHA or LPS. Forsell et al. (1986) found significant reduction of body weight after 24 days 
feeding of 2 mg DON/kg diet to B6C3F1 weanling female mice while white blood cell count 
was significantly reduced in mice fed 10 mg DON/ kg diet or greater. Greene et al. (1994) 
found reduced final body weight, rough hair coats and poor grooming in female and male 
B6C3F1 mice fed 2 mg DON/kg diet for 12 weeks. Transient significant reduction in 
erythropoetic activity in bone marrow and spleens occurred in Swiss-Webster mice fed 6.25 
mg DON/kg naturally contaminated wheat-based diet for four weeks but parameters were not 
different from controls when mice were fed up to 18 weeks (Arnold et al., 1986). Mice were 
sensitive to DON for various parameters but 2 mg/kg in the diet appears to be the overall 
LOAEL for sub-chronic studies. 
Limited work has investigated interactions of DON with other xenobiotics or stresses 
on the immune system. Islam et al. (2002) found significant potentiation of glucocorticoid 
release and trichothecene-induced lymphocyte apoptosis in mice due to a single LPS (0.1 
mg/kg bw i.p.) and simultaneous DON exposure (12.5 mg/kg bw oral). 
Running to exhaustion on a treadmill by mice was an established model to study 
acute exercise stress. Hoffman-Goetz et al. (1988) determined that this model of stress 
produced significant elevation of serum corticosterone in C57BL/6J mice but no significant 
change in lymphocyte proliferation with LPS or pokeweed mitogen stimulation compared to 
sedentary controls. Acute exercise stress in C3He mice caused a significant reduction in the 
percent splenic Ig+ B-cells but not in T-helper, T-suppressor or total T-cells (Hoffman-Goetz 
et al., 1989) however when splenocytes were incubated with Con-A, T-suppressor cells 
increased significantly and the B cell effect was not observed (Randall Simpson et al., 1989). 
Pedersen et al. (1997) proposed more significant immunosuppressive contribution from 
elevated catecholamine and growth hormone in immediate response to exhaustive exercise 
and a lag of immunomodulatory effects of glucocorticoids. To our knowledge there are no 
reported investigations of acute exercise fatigue interaction with any xenobiotic 
immunotoxicant. 
The purpose of this study was to investigate interactive effects of two commonly 
encountered modulators of the immune system using a murine model. We investigated a 
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dietary concentration of DON which could occur in the human food supply and measured 
endpoints of immunotoxicity and an indicator of acute exercise fatigue. 
Materials 
DON was from Sigma (St. Louis MO). Diet components were from Harlan Teklad 
(Madison WI) and ICN Biomedical Inc. (Irvine CA). HBSS (Hank's balanced salt solution) 
and AIM-V® (Adoptive Immunotherapy Media) media was from GIB CO (Invitrogen Corp., 
Carlsbad CA). Guinea Pig Complement Low-Tox® was from Accurate Chemical Scientific 
Corp. (Westbury NY). OCTEIA® Corticosterone (enzymeimmunoassay) was from ALPCO 
Diagnostics (Windham NH). Sheep red blood cells were from National Veterinary Service 
Laboratory (Ames LA). 
Methods 
Animals 
The animal protocol was reviewed and approved by Iowa State University Committee 
on Animal Care. Twenty-four male 8-week-old BALB/c mice were purchased from Harlan 
(Indianapolis IN). They were housed individually in shoebox cages with hardwood shavings 
and acclimated for 7 days on AIN-93G diet (Reeves et al., 1993). They were fed ad libitum, 
water changed three times a week and exposed to reversed 12 hour light/dark cycle at 72°F 
and 20% humidity. All animals were trained twice on the treadmill during the acclimation 
period for 15 min at 10 m/min. Following acclimation all animals were weighed and blocked 
into three groups by weight then randomly assigned within each block to the treatment 
groups, 2 mice per treatment within each block. The treatment groups were: No DON/ No 
exercise, 2 ppm DON/ No exercise, No DON/ Exercise, and 2 ppm DON/ Exercise. DON 
was added to the diet at 2 mg/kg from standard solution (500 jag/ml in water). DON 
concentration in the diet was confirmed by HPLC analysis in our laboratory. The diet was 
formed into biscuits by mixing the dry diet with adequate water to form dough, which was 
rolled out, scored and allowed to dry on screen racks at room temperature until firm, about 
two days. Food was stored in sealed plastic bags at 4°C until use. Food consumption was 
measured daily for all animals. DON standards and contaminated equipment was handled 
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with use of personal protective equipment. Decontamination of glassware and diet mixing 
equipment was by soaking in 10% hypochlorite prior to cleaning. 
Exercise Stress 
The animals were exercised by block, one block per day on three consecutive days 
and order was determined randomly. The non-exercised mice in the block were exposed to 
the noise of the treadmill by placing them in close proximity. The exercise started in the 
morning toward the end of the set dark cycle to occur during their active nocturnal period. 
Animals were placed in individual lanes and the treadmill speed was started at 10 m/min with 
speed increased by 2-3 m increments every 20 min, maximum speed attained was 20 m/min. 
Mice were removed from the treadmill when they could no longer maintain pace with 
physical prodding and returned to their cages for 30 min with access to food and water. Time 
to fatigue was 2.5 to 4.25 hours. 
Tissue Collection 
Individual cages were transported to the necropsy room where animals were 
decapitated within 2 min of picking up the cage. Trunk blood was collected, spleens removed 
aseptically and immediately placed in stomacher bags containing 10 ml HBSS and processed 
until tissue dissolution by stomacher laboratory blender (Tekmar, Cincinnati OH). Single cell 
suspension was achieved by filtering through sterilized nylon mesh and washing cells once in 
HBSS before suspending in AIM-V® media. Cell viability was determined by Trypan Blue 
dye exclusion (>95% for all animals) and concurrent cell counting by hemocytometer. Blood 
was allowed to clot at room temperature, centrifuged at 2500 rpm for 10 min, and serum 
separated and frozen at -20°C as soon as possible. 
Lymphocyte Proliferation 
Spleen cell concentration was adjusted to 5 X 106 cells/ml with AIM-V® media and 
100 (il was pipetted into six replicate wells per animal in 96 well round bottom plate, Con-A 
added to three wells (1 [Xg/well, 10 JJ.1) and three wells remained as controls. The plate was 
incubated at 37°C, 5% CO% for 72 hours. CellTiter 96® (Promega, Madison WI) 10 (ll was 
added to all wells and incubated for 60 minutes at 37°C, when well absorbance was read at 
450 nm in microplate reader (Benchmark™, Biorad Corp., Hercules CA). Mean absorbance 
of Con-A treated wells and control wells for each subject was calculated, difference 
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determined and compared to the control treatment group to assess percent inhibition of 
lymphocyte proliferation. 
Hemolytic Plaque Assay 
This assay quantifies the number of B-cells activated to produce IgM in response to a 
T-cell dependent antigen, sRBC. All mice were primed four days prior to sacrifice with 0.20 
ml intraperitoneal injection of 20% sRBC, vol/vol in PBS, which had been washed three 
times with PBS. Spleen cells were diluted with AIM-V® media to 3 X 106 cells/ml. Sheep 
RBC (4%) suspension in AIM-V® media was prepared the day of assay by washing sRBC 
three times with PBS prior to dilution to final concentration. Guinea pig complement was 
absorbed to sRBC by rehydrating the lyophilized pellet with 1 ml sterile water then mixing 
with 250 fil washed packed sRBC in a microcentrifuge tube, incubating on ice for 10 min, 
centrifuging at 1500 rpm for 10 min and decanting the complement, repeating 3 times. 
Aliquots of the absorbed complement were stored at -20°C until day of use when it was 
thawed and diluted 3:1 with AIM-V® media within 20 min of use. The plaque assay was 
conducted as per Cunningham and Szenberg (1968). Double-sided microscope slide 
chambers were constructed the day before the assay. The following components were mixed 
in 1.5 ml microcentrifuge tubes: 50 pi spleen cell suspension, 50 pi 4% sRBC, and 50 pi 
absorbed diluted guinea pig complement. Duplicates of each subject were performed and one 
sample using AIM-V® media instead of complement was the negative control. From each 
replicate 50 pi was pipetted into each side of one slide assembly, three slide assemblies per 
subject, 4 test chambers and 2 controls. Slide edges were sealed with melted paraffin and 
incubated in humidified boxes for 60 min at 37°C. Lysing of sRBCs in response to the 
interaction of complement and IgM produced plaques, with a single plaque-forming cell 
(PFC) in the center, that were counted in each chamber under 4X magnification. Mean PFCs 
were calculated from 4 chambers per subject. Mean plaques times 20 equaled PFCs per 106 
spleen cells. 
Serum Corticosterone 
This assay was conducted according to the manufacturer's instructions for the 
OCTEIA kit. Briefly 30 pi of thawed mouse serum was diluted with PBS containing horse 
serum 1:10. Included calibrators, controls and diluted mouse samples were pipetted (100 pi) 
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in duplicate into provided antibody coated microplate. Enzyme conjugate, corticosterone 
labeled with horseradish peroxidase, was added to each well (100 pi) and the plate was 
incubated for 18 hours at 4°C. The plate was washed three times manually with PBS 
supplemented with 0.05% Tween and tapped dry. Tetramethylbenzidine (TMB) was added to 
each well (200 pi) by multichannel pipettor. The plate was incubated for 30 min at room 
temperature then 100 pi of hydrochloric acid stop solution was added to all wells. Well 
absorbance was measured at 450 nm by a Biorad microplate reader. A standard curve was 
constructed with calibrators and serum concentration of corticosterone was read from the 
curve and corrected for 10X dilution factor. 
Cytokine Analysis 
Spleen cells, 5 X 106 cells/ml in AIM-V media, were pipetted into 24-well flat bottom 
plates, 1 ml per well. Three wells per subject were stimulated with Con-A (1 pg/ml) and two 
were unstimulated control wells. Supernatants were collected from wells at 24 and 48 hours 
for IL-2, IL-4, and IFN-y determination. Supernatant aliquots were frozen at -20°C until 
batch ELISA was conducted. Cytokine concentration was determined using mouse 
monoclonal antibodies in kits (PharMingen, San Diego CA) and following manufacturer's 
instructions. Briefly, 96-well ELISA plates (Costar, Coming NY) were coated with capture 
antibody for IL-2, IL-4 or IFN-y overnight at 4°C. Plates were blocked with PBS-10% heat-
inactivated fetal bovine serum for one hour at room temperature before the addition of 
standards and thawed supernatants (100 pi) and incubation at room temperature for two 
hours. Plates were washed in plate washer between each step with PBS-0.05% Tween. 
Bio tiny lated anti-mouse cytokine monoclonal antibody with avidin-horseradish peroxidase 
conjugate was added to each well (100 (il) and plates were incubated for one hour at room 
temperature. Plates were washed prior to addition of TMB and hydrogen peroxide substrate, 
incubation in the dark for 30 min, and read at 655 nm on a Biorad microplate reader. 
Cytokine concentrations were determined from best fit linear regression of blanked mean 
absorbance of standards against standard dilutions. 
Statistics 
One-way analysis of variance was conducted with SAS with student T-test for pair-
wise contrasts. Cytokine comparisons were evaluated by repeated measures analysis with 
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Tukey-Kramer adjustment for post-hoc pair-wise comparison in SAS (SAS 9.1, Cary NC). P 
value <0.05 was considered significant. 
Results 
There were no significant differences between treatment groups for initial (22.9 ±1.1 
g) or final body weight (24.5 ±1.0 g), average daily feed intake (3.25 ± 0.22 g), body weight 
gain (1.6 ± 0.8 g), or total spleen cells (2.21 ± 0.70 X 108). 
A significant difference was found between the treatment groups for Con-A 
stimulated lymphocyte proliferation (Figure 5.1). A possible error occurred in Con-A dilution 
for one block of animals resulting in cell death and plate exclusion, therefore n=4 for each 
treatment group. Mice fed 2 mg DON/kg and not exercised had significant inhibition of 
proliferation when compared to the control group. 
No DON/ No Stress 2 ppm DON/ No Stress No DON/ Stress 2 ppm DON/ Stress 
Figure 5.1. Inhibition of Con-A stimulated splenocvte proliferation in response to sub-acute 
dietary DON. Spleen cells (5 x 106/ml), from BALB/c mice after completion of acute 
exercise fatigue +/- 2 mg/kg dietary DON for 14 days, were incubated with Con-A for 72 
hours. Proliferation was assessed by MTS dye reduction assay. Values are mean ± SEM. 
Different letters significantly different from each other, p = 0.021, n = 4 per treatment. 
There was significant reduction of B-cells expressing antibodies specific for sRBC in 
mice fed 2 mg DON/ kg diet and exercised compared to the control group and a trend toward 
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a significant main effect of exercise stress (p = 0.06) (Figure 5.2). Manual enumeration of 
spleen cells was not consistent across all blocks because the counts were done by two 
different technicians, thus one block was excluded from these results. 
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Figure 5.2. Interaction of 2 mg/kg dietary DON and acute exercise stress inhibits plaque-
forming cells in spleen to sRBC. Spleen cells (3 X 106 cell/ml) from BALB/c mice after 
completion of acute exercise fatigue +/- 2 mg/kg dietary DON for 14 days were assessed for 
number of PFCs by Jerne-Salzberg plaque assay. Mean PFCs ± SEM based on four chambers 
per mouse. Different letters significantly different from each other, p = 0.031, n = 4 per 
treatment. 
There was a significant main effect of stress on serum corticosterone levels (Figure 
5.3). ELISA analysis of supernatant from Con-A stimulated splenocytes revealed a 
significant increase in IL-4 secretion after 48 hours of culture in cells harvested from DON 
fed non-exercised mice compared to all other treatments (Figure 5.4). IL-2 was significantly 
elevated from DON-fed stressed mice compared to either non-stressed groups after 48 hours 
culture (Figure 5.4). No treatment differences in IL-2 or IL-4 expression were observed after 
24 hours culture or for IFN-y at either time point. 
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Figure 5.3. Serum corticosterone significantly elevated by acute exercise stress in B ALB/c 
mice. Serum corticosterone determined by enzyme immunoassay from blood collected 30 
minutes after completion of acute exercise fatigue of B ALB/c mice +/- 2 mg/kg dietary DON 
for 14 days. Values are means ± SEM, n = 6. ^Significant main effect of acute exercise stress 
(p < 0.001). 
Discussion 
B ALB/c mice were chosen for our study because they had shown sensitivity to DON 
at low dietary doses and are used commonly in immunotoxicity studies. B ALB/c male mice 
have been used in two DON feeding studies (Robbana-Barnat et al. 1987 & 1988) where the 
earlier trial found significantly reduced food intake with 2.5 mg/kg dietary DON (p < 0.05, n 
= 12) for one week with the second study finding a trend toward reduced weight gain and 
reduced anti-sRBC serum antibodies but no effect on feed intake in the 5 mg DON/kg diet 
group (n = 8) for one or two week feedings. There were no apparent differences between 
these two studies by the same laboratory indicating sensitivity of this mouse strain but 
potential variability within the strain. The dietary dose chosen for our study seemed likely to 
produce an observable effect without overt clinical illness. 
No DON/ No Stress 2 ppm DON/ No No DON/ Stress 2 ppm DON/ Stress 
Stress 
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Figure 5.4. Dietary DON inhibits IL-4 and stimulates IL-2, with acute exercise stress, in Con-
A stimulated spleen cells. Con-A stimulated spleen cell supernatants, from BALB/c mice 
after completion of acute exercise fatigue +/- 2 mg/kg dietary DON for 14 days. IL-4 and IL-
2 determined by murine monoclonal antibody ELISA. Values are mean ± SEM for 2 
replicates per subject, n = 4 mice per treatment. Different letters significantly different from 
each other at 48 hours incubation (p < 0.05). No significant different between treatment 
groups at 24 hours incubation. 
Significant inhibition of proliferation of spleen cells stimulated by Con-A, a 
polyclonal T-cell mitogen, in mice fed DON and not exercised might be due to the effect of 
elevated IL-4 since this cytokine promotes differentiation of B-cells and inhibits Thl cells 
(Elenkov and Chrousos, 2002). IL-4 has been shown to be expressed in vitro from Con-A 
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stimulated CD4+ T-cells from female B6C3F1 mice after 7 days incubation with 100 ng 
DON/ml media (Ouyang, et al., 1995). Rat peripheral blood lymphocyte proliferation 
following PHA mitogen-stimulation was inhibited by 50 and 100 ng DON/ ml media (Miller 
and Atkinson, 1986). Protein synthesis, assessed by [14C]leucine incorporation assay, and 
proliferation, measured by [3H]thymidine incorporation, of LPS-stimulated splenocytes from 
female B6C3F1 mice was inhibited by 100 ng DON/ml media (Warner et al., 1994) with 
elevated IL-4 in macrophage depleted lymphocytes with 25 to 100 ng DON/ml. This study 
indicated that protein synthesis inhibition occurred concurrent with increased secretion of IL-
4 in response to DON exposure in vitro, although the in vivo situation was much more 
complicated, this finding may help to explain the results observed in our study. 
Acute exercise ameliorated the effect of DON on splenocyte proliferation, perhaps 
because exercise was known to affect T cell subpopulations. Mice exhaustively exercised 
had significantly increased percentage of T-suppressor splenocytes when stimulated in 
culture with Con-A (Randall Simpson et al., 1989). IL-2 was significantly elevated in our 
study by dietary DON + exercise stress compared to non-exercised mice. This seemed 
reasonable since lymphocyte proliferation was not different from control and IL-2 is a potent 
T-cell and NK cell growth factor (Handa, et al., 1983). Increased percentage T-suppressor 
cells in response to catecholamine induced lymphocyte trafficking (Pedersen and Hoffman-
Goetz, 2000) could be responsible for this IL-2 release. DON has stimulated IL-2 release and 
increased expression of IL-2 mRNA after 10 ppm dietary DON for 4 weeks in male B6C3F1 
mice (Zhou et al., 1998), lower doses were not tested. Increased IL-2 may be an additive 
effect of DON and acute exercise stress. 
Our results indicated significant inhibition of PFCs by 2 mg DON/kg diet with acute 
exercise stress, which has not been reported at this dose in mice or any other species. Plaque 
forming cells are differentiated B-cells producing mostly IgM since primary immunization of 
antigen was 4 days prior. Sheep RBCs are T-cell dependent antigens thus for antibody 
expression the antigen must be processed by antigen presenting cells, MHC II recognition 
and activation of T helper cells, and antigen presentation for B-cell activation (Abbas et al., 
1996). Numerous cytokines must also be produced by these cells to promote activation, 
differentiation, and clonal expansion of the different cell populations. IL-2 has an inhibitory 
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feedback on Th2 cells which may have been additively stimulated by DON and acute 
exercise stress. DON and other trichothecene mycotoxins inhibit protein synthesis (Rotter et 
al., 1996) which may further inhibit the ability of cells to produce antibody although cytokine 
production may stimulated. The same acute stress model in male C3He mice resulted in a 
trend toward decreased Ig+ cells in splenic cultures with Con-A (Randall Simpson et al., 
1989). Conversely stress hormones such as glucocorticoids and catecholamines can inhibit 
release of cytokines (IL-12, IL-1) from antigen presenting cells inhibiting cellular and 
promoting humoral immune functions (Elenkov and Chrousos, 2002) as well as inhibit end 
stage differentiation of B-cells (Madden et al., 1995). Elevated plasma corticosterone 
confirmed significant stress in the acutely exercised mice in our study. New cytokines have 
been discovered recently (IL-23, IL-27) that have overlapping functions with IL-12 (Agnello, 
et al., 2003), but their response to stress hormones has not yet been revealed. 
The interactive effect observed in our study could be a combined effect of acute 
exercise-induced reduction of B-cell numbers and/or inhibited end-stage differentiation in the 
spleen, altered cytokine expression and/or secretion, inhibitory or stimulatory. Phenotypic 
evaluation of spleen cell populations with a cytokine assessment battery would define this 
interaction more clearly. To date, inhibition of synthesis of specific proteins by DON has not 
been determined. Genomic or proteomic global investigation to identify possible high affinity 
protein targets is warranted. 
Conclusions 
To our knowledge, this is the first report of an immunotoxic interaction between a 
low-level dietary exposure to DON, or any other xenobiotic, and acute exercise stress. Acute 
exercise stress may protect the mouse from DON immunotoxicity due to differential effects 
on lymphocyte subsets and cytokine cell signaling proteins. Acute exercise stress interacted 
with dietary DON to cause a significant reduction in PFCs, which may be a result of stress 
hormone activity and DON effects on one or more cells involved in the T-dependent 
response to sRBCs. Effects seen in this study were observed at a lower level of DON than 
has been previously reported and may reflect special sensitivity in B ALB/c male mice. 
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Further investigation on immune function is warranted with this model of two commonly 
occurring human stressors, acute exercise and low level dietary DON. 
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CHAPTER 6. IMMUNOMODULATORY EFFECTS OF LOW-DOSE DIETARY 
DEOXYNIVALENOL AND ACUTE EXERCISE STRESS IN BALB/C MICE 
A paper to be submitted to Toxicological Sciences 
Cindy A. Landgren1, Marion L. Kohut2, Joan E. Cunnick3, and Suzanne Hendrich4 
Abstract 
Dietary deoxynivalenol (DON) dose response and interaction with acute exercise 
stress was investigated in male B ALB/c mice with emphasis on alteration of functional 
immune parameters. Mice were fed 0, 1 or 2 mg DON/ kg diet for 28 days then half of each 
dose group were exercised to fatigue on a treadmill. DON at 2 mg/kg diet inhibited weight 
gain (p < 0.0002), red blood cell counts, and hematocrit but increased feed intake (p = 
0.0003). Blood lymphocyte count was suppressed by DON feeding (24.9 ± 4.8%) but more 
potently reduced by acute stress (57.5 ± 2.1%, p < 0.05). DON at 1 mg/ kg diet significantly 
stimulated splenocyte NK cytotoxicity (156%, p < 0.01), PFCs (121% control, 155% of 2 
ppm, p < 0.05), and spontaneous interferon-y secretion (p < 0.05). Splenocyte IL-4 was 
stimulated in mice stressed alone compared to control or 1 mg DON/kg diet alone. 
Significant inhibitory effects of acute exercise were observed for spleen to body weight ratio 
(p < 0.0001), hematocrit (p = 0.017), hemoglobin (p < 0.0001) and NK cell cytotoxicity (p < 
0.05). Exercise stress increased blood neutrophils (173.6%, p < 0.0003) and neutrophil to 
lymphocyte ratio (348%, p < 0.0001). This is the first report of in vivo immunostimulatory 
effects of sub-chronic low dose DON feeding promoting both cellular and humoral responses 
through differential cytokine production, which may be abrogated by acute exercise stress. 
Apparent immunological hormesis of feeding 1 mg DON/kg diet deserves further 
investigation. 
Introduction 
1 Graduate student, primary researcher, and author. 
2 Associate Professor, Department of Human Health and Performance 
3 Associate Professor, Department of Animal Science 
4 Professor and corresponding author, Department of Food Science and Human Nutrition 
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Deoxynivalenol (DON) contamination of food crops (wheat, corn, barley, oats, rye) 
occurs worldwide and humans can be commonly exposed to levels < 1 mg/kg in foods but 
can encounter contamination as high as 5 to 20 mg/kg (Pestka and Smolinski, 2005). Human 
intoxications have been reported that were correlated with the high incidence of moldy crops 
(Bhat et al., 1989; Li et al., 2002). Occurrence of human illness, exhibited as gastrointestinal 
distress in adults and increased upper respiratory tract infections in children, was suspected to 
be caused by the prevalence of DON contamination of foods in the affected area with 
concomitant low incidence and concentrations of other mycotoxins such as nivalenol and T-2 
toxin. Epidemiologic studies have not been conducted but presence of DON in human urine 
was proposed as a biomarker for DON exposure (Meky et al., 2003) and may prove useful to 
determine if DON exposure is a risk factor for human clinical illness. 
Toxic effects of dietary DON have been studied in many species with swine being the 
most sensitive, emesis LOAEL 0.1 mg/kg bw, reduced weight gain LOAEL 0.07 mg/kg bw, 
but dogs, emesis LOAEL 0.3 mg/kg bw, and mice, reduced weight gain LOAEL 0.3 mg/kg 
bw, inhibition lymphocyte proliferation LOAEL 0.5 mg/kg bw, appear similarly sensitive 
with others in the following order: rats > poultry > ruminants (Pestka and Smolinski, 2005). 
DON is a protein translation inhibitor and the immune systems' high mitotic requirement 
may contribute to sensitivity to this toxin (Rotter et al., 1996). 
The murine model was used extensively for evaluating xenobiotics' effect on the 
immune system due to similarity of immune responses with the humans and availability of 
reagents. Dietary exposures of less than 10 mg DON/kg diet have had mixed effects on 
murine immune function depending on strain, dose, length of exposure and method of 
assessment. Tryphonas et al. (1986) found no significant effect on antigen specific plaque 
forming cells (PFCs) or Concanavalin-A (Con-A), lipopolysaccharide (LPS), or 
phytohemagglutinin P (PHA-P) mitogen-stimulated splenocyte proliferation in Swiss-
Webster male mice fed 1, 2 or 4 mg DON/ kg diet for 5 weeks. The same strain fed 6.25 mg 
DON/ kg diet for 4 weeks had reduced bone marrow and splenic red blood cell production 
(Arnold et al., 1986). Weanling male B ALB/c mice fed 10 mg DON/ kg diet for one or two 
weeks had significantly reduced serum antibody titers to sheep red blood cells (sRBC) and 
inhibited PHA and LPS stimulated splenocyte proliferation, no effect was observed in mice 
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fed 5 mg DON/ kg diet (Robbana-Barnat et al., 1988). Dietary DON at 2 mg/ kg diet for 24 
days resulted in significant body weight reduction in B6C3F1 weanling female mice while 10 
mg/ kg resulted in significantly decreased white blood cell counts (WBC) (Forsell et al., 
1986). Female and male B6C3F1 mice fed 2 mg DON/ kg diet for 12 weeks had reduced 
final body weight, rough hair coats and poor grooming (Greene et al., 1994). B ALB/c male 
mice exposed to 2 mg DON/ L in drinking water for 2 weeks exhibited reduced splenic 
clearance of Salmonella enteritidis 7 days after oral exposure (Hara-Kudo et al., 1996) 
indicating impaired host resistance at low level DON exposure. 
Limited work investigated interactions of DON with other xenobiotics or stressors on 
the immune system. Islam et al. (2002) found significant synergistic glucocorticoid-
dependent lymphocyte apoptosis following acute concurrent LPS (0.1 mg/kg bw ip) and 
DON (12.5 mg/kg bw) exposure in male B6C3F1 mice. 
Exhaustion of mice by treadmill running was an established animal model to study 
the effects of acute exercise stress. Hoffman-Goetz et al. (1988) measured significant 
elevations of serum corticosterone without significant change in lymphocyte proliferation 
with LPS or pokeweed mitogen stimulation compared to sedentary controls in C57BL/6J 
mice using this model. Acute exercise stress in C3He mice caused a significant reduction in 
the percent of Ig+ B-cells but no effect on T lymphocyte subsets in the spleen (Hoffman-
Goetz et al., 1989) but when splenocytes were incubated with Con-A, T-suppressor cells 
increased significantly and the B cell effect was not observed (Randall Simpson et al., 1989). 
Azenabor and Hoffman-Goetz (1999) reported imbalance of oxyradical production and 
antioxidant enzyme defenses in the thymus and spleen after a bout of exhaustive exercise in 
C57BL/6 female mice. Pedersen et al. (1997) proposed more significant immunosuppressive 
contribution from elevated catecholamine and growth hormone in immediate response to 
exhaustive exercise and a lag of immunomodulatory effects of glucocorticoids. We found 
inhibition of PFC response to 2 mg DON/ kg diet and acute exercise stress in B ALB/c mice 
[Landgren et al., (2005) Low-level Dietary Deoxynivalenol and Acute Exercise Stress Result 
in Immunotoxicity in BALB/c Mice, manuscript in progress]. To our knowledge there are no 
other reports of acute exercise fatigue interaction with a xenobiotic immunotoxicant. 
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The purpose of this study was to investigate interactive effects of two commonly 
encountered immunomodulators conducting a battery of Tier I immune function tests as 
proposed by Luster et al. (1988). We hypothesized an interactive dose-responsive 
immunosuppression between low-dose dietary DON and acute exercise stress that would be 
characterized as impaired humoral immune function and cytokine alterations. 
Methods 
Materials 
Pretrial rodent chow, cornstarch, casein, dextran cornstarch, sucrose, soybean oil, 
fiber, AIN-93G mineral and vitamin mixes were from Harlan Teklad (Madison WI). Choline 
bitartate and L-cysteine were from ICN Biomedical Inc. (Irvine CA). Recombinant human 
IL-2 (rhIL-2), HEPES [4-(2-hydroxyethyl)piperazine-1 -ethanesulfonic acid], and EDTA 
(ethylenediaminetetraacetic acid) were from Sigma, St. Louis MO. Hank's balanced salt 
solution (HBSS), Roswell Park Memorial Institute (RPMI 1640) and Adoptive 
Immunotherapy Media (AIM-V®) media were from GIB CO (Invitrogen Corp., Carlsbad 
CA). Guinea Pig Complement Low-Tox® was from Accurate Chemical Scientific Corp. 
(Westbury NY). Sheep RBCs were from Remel Microbiology Products, Lenexa KS. MTS 
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium] CellTiter 96® was from Promega Corporation, Madison WI. 
Animals 
The animal protocol was reviewed and approved by Iowa State University Committee 
on Animal Care. Fifty-four 6-8 week old male B ALB/c mice were purchased from Harlan 
(Indianapolis IN). They were housed individually in shoebox cages with hardwood shavings, 
fed rodent diet ad libitum, water changed three times a week and exposed to 12-hour reversed 
light/dark cycle at 72° F and 20% humidity. Mice were fed semi-purified AIN-93G diet 
beginning at 11-13 weeks of age. An acclimation period of 7 days on control diet occurred 
prior to 28 d DON feeding. Animals were weighed weekly and observed daily for any signs 
of illness. All animals were trained twice on the treadmill during the acclimation period for 
15 min at 10 m/min. Animals were divided into three blocks by weight and randomly 
assigned within each block to the treatment groups, 3 mice per treatment within each block. 
Animals were fed 0, 1 or 2 mg DON/ kg diet, n= 18/ dose; half the animals at each dose were 
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exercised to exhaustion. DON was added to the diet from autoclaved culture material which 
was prepared by solid culture of Fusarium graminearum [R-5245 (USA, OH), Fusarium 
Research Center, PSU, University Park PA 16802] per Witt et al. (1985). Briefly 350 g 
commercial converted rice was autoclaved with 150 ml deionized water then inoculated with 
106 macroconidia, from CMC media starter liquid culture, and incubated for 20 days at 28°C. 
Culture was autoclaved, air dried and ground to a meal for storage at -20°C. Diets were 
analyzed by HPLC for confirmation of DON levels. Culture material was analyzed (NDSU, 
Fargo ND) and found to contain 123 mg/kg DON, 112 mg/kg 3 -acetyldeoxynivalenol (3-
ADON) but no other mycotoxins. AIN-93G semi-purified diet (Reeves et al., 1993) with and 
without DON was formulated into biscuits by mixing the dry diet with adequate water to 
form dough, which was rolled out, scored and allowed to air dry at room temperature until 
hard (less than 2 days). Feed was stored in sealed plastic bags at 4°C until needed. Food 
consumption was determined daily for all animals. DON culture material and DON 
contaminated diets were handled using personal protective equipment. All reusable 
laboratory and feed mixing equipment were decontaminated by soaking in 10% hypochlorite 
before cleaning. 
Exercise Stress 
Animals were exercised by block and the order was determined randomly. The non-
stressed controls were exposed to the noise of the treadmill by placing them in close 
proximity. Exercise occurred in the morning during the active nocturnal period. Animals 
were placed in individual lanes and exercised to fatigue by increasing the treadmill speed 
from 10 to a maximum of 28.5 m/min in 2-3 m increments every 20 min. Mice were removed 
from the treadmill when they could no longer maintain pace with physical prodding and 
returned to their cages and allowed access to food and water. Time to fatigue ranged from 
2.25 to 3.5 hours. 
Tissue Collection 
After 30 minutes cage rest, exercised animals and a paired non-exercised control were 
euthanized by decapitation and trunk blood collected into microcentrifuge tubes containing 
15 |il 10% EDTA, spleens were removed aseptically and immediately placed in centrifuge 
tubes containing RPMI1640 supplemented with 50 (xg/ml gentamicin, 2 mM L-glutamine, 
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10 mM HEPES buffer, and 10% heat-inactivated fetal bovine serum (complete media-
CRPMI). Spleen weight was determined by difference of centrifuge tube weight before and 
after spleen collection. Splenocyte single cell suspensions were made by gently grinding 
spleens in fresh CRPMI between two frosted microscope slides; tissue fragments were settled 
out prior decanting. Spleen and trunk blood cell counts, Hb, and Hct were determined by 
automated cell counter (Hemavet®, CDC Technologies, Inc., Oxford CT) within two hours 
of collection. Remaining blood was centrifuged at 2500 rpm for 10 min, plasma separated 
and frozen at -20°C. 
NK Cytotoxicity Assay 
The spleen cell suspension was adjusted to 5 X 106 cells/ml with CRPMI and added 
to 96-well microtiter plates in triplicate for effector to target (E:T) ratios 25:1, 50:1, and 
100:1. Preliminary studies on NK cytotoxicity response of B ALB/c splenocytes to rhIL-2 
(500 ng/ml) determined optimum activation concentration of 5 ng/well. rhIL-2 was added to 
each well (10 |A1) except one set of 50:1 for unstimulated controls. CRPMI was added to 
equalized all wells at 220 p.1. Plates were incubated for 20 hours at 37°C in 5% CO?. The 
following day, 7.5 X 106 YAC-1 (ATCC), in log growth phase, were incubated with 200 p,Ci 
of 51Cr (PerkinElmer, Boston MA) for 70 minutes. The target cells were washed three times 
in CRPMI, counted, diluted and 1 x 104 cells added per well. Six replicates of YAC-1 cells 
only with and without rhIL-2 were included each day. The plates were incubated for 4.5 
hours at 37°C in 5% CO2. YAC-1 cells in total release wells were lysed with the addition of 
170 gl 10% trichloroacetic acid and plates were centrifuged at 500 rpm for 5 min. 
Supernatant (110 jj.1) was removed from each well by multichannel pipettor and transferred to 
microtubes. The tubes were loaded onto the gamma counter (Gamma Trac 1191) and each 
sample counted for one min. Mean 51Cr release from YAC-1 controls, total release and 
splenocyte/YAC-1 combinations from each animal was calculated. Background control 51Cr 
release and total release was used to calculate specific 51Cr release at each E.T ratio for each 
animal's splenocyte sample. % Specific 51Cr release = (Mean 51Cr release per splenocyte 
sample- mean YAC-151Cr release)/ (Mean total 51Cr release - Mean YAC-151Cr release) X 
100. Percent YAC-1 5lCr release was calculated to verify target cell viability from equation: 
(Mean YAC-151Cr release - Mean media only blank)/ (Mean total 51Cr release - Mean media 
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only blank) X 100. Background YAC-1 51Cr release from target cells was 4.43 ± 0.29% 
across the three days of sample collection. 
Lymphocyte Proliferation 
Spleen cell suspension (5 X 106 cell/ml) was pipetted (100 |ll) into nine wells per 
animal in 96-well round bottom microliter plates. Three replicate wells per animal were 
treated with: LPS 0.5 pg/well (10 |ll), Con-A 1 (ig/well (10 (4,1), and unstimulated controls 
with 10 |il media. Plates were incubated at 37°C, 5% CO2 for 72 hours. MTS was added to 
all wells (10 |ll) and incubated for 165 min at 37°C. Plates were read at 490 nm on a 
microplate reader (Benchmark™, Biorad Corp., Hercules CA). The difference between the 
mean mitogen stimulated wells and mean control wells for each subject was calculated and 
compared to the control treatment group to determine percent control response lymphocyte 
proliferation for each mitogen. 
Hemolytic Plaque Assay 
All mice were primed four days prior to sacrifice with 0.20 ml intraperitoneal 
injection of 20% sRBC (vol/vol) in PBS that had been washed three times with HBSS. The 
same batch of sRBCs was used throughout this study. Spleen cells were diluted with AIM-
V® to 3 X 106 cells/ml. A 4% sRBC suspension in AIM-V® media was prepared the day of 
assay by washing sRBC three times with HBSS prior to dilution to final concentration. 
Guinea pig complement was absorbed to sRBC by rehydrating the lyophilized complement 
(Low-Tox®) with 1 ml Nanopure® (Bamstead Corp., Dubuque LA) water then mixing with 
250 |ll washed packed sRBC, incubating on ice for 10 min, centrifuging at 1500 rpm for 10 
min and decanting the complement. This was repeated three times to remove alternate 
pathway components from the complement. Aliquots of the absorbed complement were 
stored at -20°C until day of use when it was thawed and diluted 1:3 with AIM-V® media 
within 20 min of use. The plaque assay was conducted using double-sided slide chambers 
(two microscope slides stuck together with double sided tape), according to the Cunningham 
and Szenberg (1968) protocol, constructed the day before the assay and verified to hold 50 pi 
per chamber. Equal volumes (50 pi) of the following components were mixed in 1.5 ml 
microcentrifuge tubes: mouse splenocyte suspension, 4% sRBC, and absorbed diluted guinea 
pig complement. Duplicates of each animal's splenocyte sample and negative control 
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samples using AIM-V® media instead of complement were prepared. Reaction mixtures (50 
jxl) were quickly pipetted into each side of one slide assembly resulting in three slide 
assemblies per animal, 4 test chambers and two no-complement control chambers. Slide 
edges were sealed with melted paraffin and incubated for 60 min at 37°C in humidified 
boxes. Plaques were counted by 4X magnification and multiplied by 20 to determine PFCs 
per 106 spleen cells. No plaques were observed in any of the negative control samples. 
Cytokine Assay 
Spleen suspension (5 X 106 cell/ml) was added to 24-well plates (1 ml/well) with 
stimulatory mitogens: Con-A (10 pg/ml media) for IL-2, IL-4, IL-10, and IFN-y; LPS (5 
|ig/ml media) for IL-6; or media only. The plates were incubated at 37°C in 5% CO2. 
Supernatant was removed from one well of each treatment at 24-hour intervals and 
transferred to cryotubes for storage at -20°C until assayed: IL-6 at 24 hours only; IL-2 at 24 
and 48 hours; IL-4, IL-10 and IFN-y at 48 and 72 hours of incubation. 
Cytokine concentrations were determined using mouse monoclonal antibodies in kits 
(PharMingen, San Diego CA) and following manufacturer's instructions. Briefly, 96-well 
ELISA plates (Coming, Corning NY) were coated with cytokine specific capture monoclonal 
antibody overnight at 4°C. Plates were blocked with PBS-10% heat-inactivated fetal bovine 
serum for one hour at room temperature before the addition of standards and thawed 
supernatants (100 pi) and incubation at room temperature for two hours. Plates were washed 
between each step with PB S-0.05% Tween. Biotinylated anti-mouse cytokine monoclonal 
antibody with avidin-horseradish peroxidase conjugate was added to plates and incubated for 
one hour at room temperature. Plates were washed prior to addition of tetramethylbenzidine 
(TMB) and hydrogen peroxide substrate then incubated in the dark for 30 min and read at 
655 nm on Biorad (Benchmark) microplate reader. Cytokine concentrations were determined 
from best fit linear regression of blanked mean absorbance of standards against standard 
concentrations. 
Statistics 
Two-way analysis of variance was conducted with SAS (SAS 9.1, Cary NC) using 
Tukey adjustment for multiple comparisons. Cytokine concentrations were compared by 
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repeated measures mixed analysis of variance procedure and Tukey-Kramer adjustment for 
multiple comparisons. P value of less than 0.05 was considered significant. 
Results 
All mice tolerated the diets well. The mice fed 2 mg DON/ kg diet gained 
significantly less weight over the 28 day feeding period compared with the other two diets 
while consuming significantly more feed daily (Figure 6.1). 
H3 Ave. Daily Food Intake 
Total Weight Gain 
No DON 1 ppm DON 2 ppm DON 
Figure 6.1. Reduced weight gain and increased feed intake in B ALB/c mice fed 2 mg DON/ 
kg diet for 28 days. *Main effect of 2 mg/ kg dietary DON on weight gain over 28 day 
feeding period. Values are group mean ± SE, p < 0.001. n = 18 per dose. #Main effect of 
dietary DON, 2 mg/kg significantly different from 0 or 1 mg DON/ kg diet. Values are group 
mean ± SE, p < 0.001, n = 18 per dose. 
Both DON and acute exercise stress had effects on white and red blood cells. Blood 
neutrophils were significantly increased by acute exercise stress (Figure 6.2). The neutrophil 
to lymphocyte ratio was also significantly increased by acute exercise (Figure 6.2). A 
significant interaction between DON and acute exercise (p = 0.007) occurred for circulating 
lymphocytes independent of DON dose (Figure 6.3). The effect of acute exercise on 
lymphocytes was greater, 42.5 ± 2.1% of control, than the effect of DON intake, 75.1± 4.8% 
of control. 
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Figure 6.2. Blood neutrophils and neutrophil to lymphocyte ratio significantly increased by 
acute exercise stress. Trunk blood WBC differential counts from B ALB/c mice fed 0, 1, or 2 
mg/kg dietary DON for 28 days then exercised to fatigue on a treadmill. Total WBC was not 
different between exercised and non-exercised groups. ^Significant main effect of acute 
exercise on neutrophil count, p < 0.0003, and neutrophil to lymphocyte ratio, p <0.0001. 
Values are group mean ± SE, n = 27. 
4.00 
3.50 
§ 3.00 
« 
1 2.50 
0 
 ^ 2.00 
1 
g 1.50 
|
E 1.00 
0.50 
0.00 
Figure 6.3. Acute exercise stress and dietary DON suppress blood lymphocytes. Trunk blood 
lymphocyte counts after 28 day feeding of 0, 1, or 2 mg DON/ kg diet and acute exercise to 
No DON/ No DON/ 1 ppm 1 ppm 
No Exercise Exercise DON/ No DON/ 
Exercise Exercise 
2 ppm 2 ppm 
DON/ No DON/ 
Exercise Exercise 
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fatigue on a treadmill. Different letters significantly different, p < 0.05. Values are group 
mean ± SE, n = 9. 
Red blood cell parameters were affected by DON (Table 6.1) and exercise (Table 6.2) 
independently. Differences in sample sizes were due to loss of sample from blood clotting. 
Measured spleen related parameters also revealed significant effects due to treatment 
variables. Spleen cell count per weight of spleen was not affected by treatment. 
Table 6.1. Red blood cell parameters suppressed by 2 mg/ kg dietary DON in B ALB/c mice 
No DON DON 1 mg/ kg diet DON 2 mg/ kg diet 
RBC count 9.4 ± 0.4 9.3 ±0.3 8.0 ±0.3* 
109 cells/ ml blood (n = 16) (n = 17) (n = 17) 
Hematocrit % 46.1 ± 1.5 45.3 ± 1.3 39.6 ± 1.3* 
(n = 16) (n — 16) (n = 17) 
Footnote. Blood collected at termination with EDTA anticoagulant and parameters analyzed 
by automated blood analyzer. Values mean ± sd of dietary groups with indicated animal 
numbers. ^Significantly different from other two dietary groups, p < 0.05. 
Table 6.2. Red blood cell and spleen weight affected by acute exercise stress in B ALB/c 
mice. 
No Acute Exercise Acute Exercise Stress 
Hematocrit % 45.7 ± 1.1 41.7 ± 1.2* 
(n = 24) (n = 26) 
Hemoglobin 15.3 ± 0.2 14.2 ± 0.2* 
(g/dl) (n = 27) (n = 27) 
Spleen Weight (mg) 143 ±7 118 ± 3* 
(n = 27) (n = 27) 
Spleen to Body 5.5 ±0.1 4.9 ±0.1* 
Weight Ratio (n = 27) (n = 27) 
Footnote. Blood collected at termination with EDTA anticoagulant and parameters analyzed 
by automated blood analyzer. Values mean ± sd of groups with indicated animal numbers. 
* Significantly different from non-stressed group, p < 0.05. 
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Functional immune assays were stimulated or unresponsive to treatments. Spleen cell 
suspensions were incubated with polyclonal T-cell mitogen Con-A and B-cell mitogen LPS. 
No significant treatment effects were observed for proliferation in response to either of these 
mitogenic agents. Splenocyte NK cytotoxicity was generally low but a main inhibitory effect 
of acute exercise stress occurred across all E:T ratios (p < 0.05) and a main effect of DON 
was observed with 1 mg/ kg being stimulatory compared to no DON or 2 mg/kg fed groups 
at the 100:1 E:T ratio (Figure 6.4). B-cells producing antibodies against sRBC were also 
stimulated by incorporation of 1 mg DON/ kg diet of B ALB/c mice compared to 2 mg/ kg 
but was not significantly greater than non-DON fed groups (Figure 6.5). 
25:1 IL-2 50:1 IL-2 
Effector to Target Ratio 
100:1 IL-2 
—A— 1 ppm/ No Stress 
- A- 1 ppm DON/ Stress 
No DON/No Stress 
2 ppm/ No Stress 
- €> 2 ppm/ Stress 
- E> No DON/ Stress 
Figure 6.4. Natural killer cell function enhanced by 1 mg/ kg dietary DON and inhibited by 
acute exercise stress. Percent specific release measured by5 Cr release assay. #Main effect of 
DON 1 mg/kg at 100:1 E: T ratio, p < 0.01. *Main effect of acute exercise stress in all rhIL-2 
activated E: T ratios, p < 0.05. Values are group mean, SE not included for clarity, n = 9 per 
group. 
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Figure 6.5. Plaque-forming cells specific for sRBC increased by 1 mg/kg dietary DON in 
B ALB/c mice. Specific antibody production in spleen cells immunized with sRBC. All 
animals primed 4 days prior to termination, measured with hemolytic plaque assay. Main 
effect of 1 ppm dietary DON, different letters significantly different, p = 0.0167. Values are 
group mean ± SE, n = 9. 
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Figure 6.6. Increased spontaneous interferon-y release from spleen cells of 1 mg/ kg dietary 
DON in BALB/c mice. ELISA measurement of cytokine release from spleen cell 
supernatants without mitogen stimulation at 48 and 72 hours of incubation. *Main effect of 1 
mg DON/ kg diet at 72 hours incubation, p = 0.02. Values group mean ± SE, n = 9. 
Of the five cytokines assessed from Con-A or LPS mitogen-stimulated splenocyte 
cultures, significant treatment effects were found only for IFN-y and IL-4. No significant 
treatment effects were observed for IL-2, IL-6, or IL-10. Without mitogen activation, 
secretion of IFN-y was significantly greater in the 1 mg DON/ kg diet groups after 72 h 
incubation (Figure 6.6) but was potently stimulated by Con-A across all treatment groups 
(1146.8 ±71.0 pg/ml). There was strong significant correlation (r = 0.79, p < 0.001) between 
NK cytotoxicity and IFN-y secretion. Con-A stimulated IL-4 secretion was significantly 
elevated in exercised mice not fed DON compared with unexercised controls and mice fed 1 
mg/kg DON and not exercised. All other treatments did not differ statistically from either 
extreme in effect on IL-4 (Figure 6.7). Despite no significant treatment effects on 
spontaneous IL-2 release from spleen cell incubations, IL-2 supernatant concentrations were 
positively correlated to NK cytotoxicity (r = 0.62, F = 39.29, p < 0.0001) and PFCs (r = 0.65, 
F = 37.61, p< 0.0001). 
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Figure 6.7. Stimulatory effect of acute exercise stress on IL-4 expression in Con-A 
stimulated murine spleen cells. ELIS A measurement of cytokine release from spleen cells 
with Con-A (10 pg/ml) stimulation for 48 or 72 hour incubations. Different letters 
significantly different from each other, p < 0.05. Values group mean ± SE, n = 9. 
Discussion 
This study was designed to follow a standardized immunomodulation 
evaluation as proposed by Luster et al. (1988) and recommended by the National Toxicology 
Program (NTP, 2005). B ALB/c mice fed 2 mg DON/ kg diet had reduced body weight gain 
similar to previous feeding study reports (Forsell et al., 1986, Greene et al., 1994). Sensitivity 
to DON feeding appeared comparable between B6C3F1 mice used in these studies and 
B ALB/c mice. Increased feed intake has been reported in only one study feeding 20 mg 
DON/ kg diet to Sprague-Dawley male rats (Morrissey et al., 1985). 3-ADON was found in 
these samples but absence of other mycotoxins was confirmed by an outside laboratory 
(NDSU). Since culture material was used as the DON source, unknown appetite stimulatory 
compounds may have been present although this seems unlikely since only 40.4 g of culture 
material was added to each kg diet to achieve 2 mg/kg. 3-ADON did not significantly alter 
feed intake of weanling male mice fed 2.5 mg/ kg diet for 3 weeks (Kasali et al., 1985). Diet 
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form was a hard biscuit allowing easy daily monitoring whereas most diet studies use 
powdered diets which could be difficult to monitor subtle changes of intake. 
Several changes in blood cells were observed due to exercise stress. Reduced 
circulating erythrocytes due to exercise stress may be related to oxidative damage to red 
blood cells. Oxidative stress occurred in acutely exercised mice (Azenabor and Hoffman-
Goetz, 1999) and RBCs from B ALB/c mice were more susceptible to H2O2 induced 
hemolysis than those from C57BL/6 mice indicating strain sensitivity (Kruckeberg, 1991). 
Even though total WBC counts were not different across treatments, significant neutrophilia 
was induced by acute exercise stress, also producing increased neutrophil: lymphocyte ratio. 
Men participating in a sprint triathalon had similar neutrophil and lymphocyte responses 
(Weinstock et al., 1997). Blood neutrophils from rats were increased in circulation due to 
shedding of endothelial L- selectin adhesion molecules within 30 minutes of stressful event, 
although causative agents were unidentified (Strausbaugh et al., 1999). Alterations of 
leukocyte numbers in circulation are due to differential cell trafficking. 
Splenocyte activities were also affected by exercise stress. NK cell cytotoxicity 
inhibition following acute exercise stress was documented in humans (Pedersen et al. 1991) 
and mice (Randall Simpson and Hoffman-Goetz, 1990). The effect was transient, dependent 
on intensity and duration of exercise stress, and independent of training. Stress hormones 
were thought to mediate the effect by altering functional adhesiveness with the target cells 
and repressing the expression of granzyme A, granular killing protein, since NK cell numbers 
were not reduced (Zhou et al., 1997a). Other studies indicated reduced NK cell numbers 
following intense acute exercise due to the high number of ^-adrenoceptors on NK cells 
resulting in redistribution in response to catecholamines (Pedersen and Hoffman-Goetz, 
2000). Glucocorticoids were increased by acute exercise (Hoffman-Goetz et al., 1988; 
Landgren et al., 2005 manuscript in progress) although catecholamines were not measured. 
Reduced NK cell cytotoxicity may have been due to either of these mechanisms. 
A significant reduction in Hct and RBC count was observed due to 2 mg/ kg dietary 
DON which may inhibit erythropoesis over the 28 day feeding period since RBC lifespan is 
120 days. Arnold et al. (1986) found significantly reduced Hct in mice fed 6.25 mg/ kg DON 
for 5 weeks. No adverse effects on hemolysis or coagulation in mature human RBCs of 
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umbilical cord origin incubated with DON concentrations up to 2.96 pg/ml in medium 
(Froquet et al., 2003) suggesting the reduction in Hct and RBC count in our study was not 
due to direct effects of DON on mature RBCs. 
Absolute blood lymphocyte count revealed an interaction between exercise stress and 
DON, with a dose independent suppression but a greater suppression across exercised 
groups. Reduction in circulating lymphocytes could occur due to DON induced apoptosis 
directly or in response to lack of survival signals or inhibited blastogenesis in the bone 
marrow. Since blood lymphocyte depression was not dose dependent, DON exposure at low 
doses may exhibit a threshold effect for lymphocyte precursors. Stress hormones were 
probably the main effectors of circulating lymphocytes after exercise stress (Weinstock et al., 
1997) causing redistribution of lymphocytes from the circulation into lymph nodes, bone 
marrow and skin (Dhabhar, 2002). DON most likely acted by different mechanisms to affect 
lymphocytes, as we previously observed no corticosterone elevation from 2 mg/ kg dietary 
DON. Bone marrow and blood cell phenotyping may help to characterize lymphocyte 
responses to concurrent DON exposure and acute exercise stress. 
NK cytotoxicity and PFC assays functionally assess innate and humoral immunity, 
respectively. This is the first report of significant in vivo immunostimulatory effects of DON 
on these two assays. 3-ADON fed to male CD-I mice did not exhibit any inhibitory effects of 
mitogen stimulated lymphocyte proliferation or PFC response to sRBC at 2.5 pg/ g diet, the 
lowest dose tested (Tomar et al., 1987), therefore both of these effects may be explained by 
the effects of DON on cytokines. NK cells secrete IFN-y when activated in response to IL-2. 
IL-2, produced by T-cells in response to IL-1 and IL-12 from macrophages, stimulates B-cell 
differentiation and autocrine activation of T-cells (Abbas et al., 1996). Despite no significant 
treatment effects on spontaneous IL-2 release, IL-2 concentration had strong positive 
correlation with NK cytotoxicity. In vitro DON exposure caused increased IL-2 and 
sustained production for 120 hours (50 and 100 ng DON/ml in media) in murine EL-4 
thymoma cells but was inhibited 500 ng DON/ ml (Li et al., 1997). Miller and Atkinson 
(1986) reported that DON (0.005 to 0.5 ng/ml) stimulated rat blood lymphocyte proliferation 
and stimulatory factor(s) were secreted into supernatant from DON-exposed macrophages. 
IL-12 was a potent regulatory cytokine produced by macrophages and dendritic cells which 
147 
stimulated NK cells to produce IFN-y (Elenkov and Chrousos, 2002). Induced expression of 
IL-12 mRNA has occurred with acute dosing of DON to mice (Zhou et al., 1997b). We 
propose a low-dose stimulatory effect of DON on macrophages that led to IL-12 release, T-
cell IL-2 release that activated NK cells and promoted differentiation of antigen-specific B-
cells. This dose response may fit the description of hormesis, low dose stimulation and high 
dose inhibitory effects. 
In an extensive literature review of immunologic hormetic-like responses, Calabrese 
(2005) listed a large number of endogenous substances, pharmacologic agents, and toxicants 
that stimulated one or more immune endpoints at low doses and exhibited immunotoxic 
effects at higher doses. B ALB/c mice were reported to be the second most common animal 
model with hormetic-like biphasic dose responses. Whether the immunostimulation was 
beneficial or harmful may depend on the antigenic challenge(s), confounding or interactive 
immunomodulators. Mechanisms for the immunostimulatory effects observed in our study 
most likely were due to complicated and not fully defined DON effects on cellular signal 
transduction pathways. Shifrin and Anderson (1999) determined that trichothecene protein 
synthesis inhibitors bound to the ribosome and triggered stress signal pathways termed the 
"ribotoxic stress response" not necessarily requiring translational arrest. In vitro DON 
exposure activated or inhibited mitogen-activated protein kinase (MARK) pathways 
depending on cell type, dose, and length of exposure and immune system effects could occur 
as MAPK pathway activation can stimulate expression of cytokines or activate apoptosis 
(reviewed by Pestka et al., 2004). In vivo DON induces MAPKs but studies have been 
limited to high acute doses. Other molecules upstream or downstream of MAPK may be 
identified to have inhibitory or stimulatory effects on cellular function. 
Oxidative stress mechanisms may also play a role in DON toxicity. Redox 
homeostasis is maintained in the cell mainly by glutathione but the buffering system can be 
overwhelmed if key enzymes in the synthesis of reactive oxygen species (ROS) scavenging 
molecules are inhibited (reviewed by Morel and Barouki, 1999). Ueno and Matsumoto 
(1975) determined that fusarenon-X, a chemically related trichothecene with an acetyl 
substitution for the hydroxyl of DON at C3, significantly inactivated three different thiol-
enzymes when incubated prior to addition of the specific enzyme substrate, one mycotoxin 
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molecule bound in each critical -SH. High affinity protein synthesis inhibition by DON is 
conceivable, particularly for proteins that are constitutively synthesized. No other work on 
this effect of trichothecenes has been reported nor discussed as a toxic effect. Numerous 
molecules in signal transduction pathways rely on active thiol motifs, particularly in reactive 
oxygen species homeostasis. DON at low doses may promote chronic oxidative stress by 
binding to constitutive ROS scavenger enzymes resulting in immune function dysregulation. 
Immunostimulatory and inhibitory functions of the immune system of B ALB/c mice 
were identified following 28 day feeding of two doses of DON with an acute exercise stress 
co-variable. This is the first report, to our knowledge, of functional in vivo 
immunostimulatory responses of 1 mg/ kg dietary DON and hormetic-like dose responses. 
Mechanistic studies to identify effects of DON on immune-related gene expression and 
especially DON-sensitive proteins, such as cytokines and free radical scavengers, in global 
assays, would further characterize the complicated signal transduction effects observed to be 
affected by DON. Investigations of DON toxicity using human lymphocyte proliferation 
assays should control for possible prior low-dose DON or other immunotoxicant exposure 
due to the possibility of confounding suppression of circulating lymphocytes. In the 
controlled conditions of animal feeding trials, complicated in vivo effects are not easily 
explained. Dietary relevance of these doses to human exposures should be a key 
consideration. Further studies are warranted to investigate length of exposure effects, 
differential effects on immune cell subsets, and ultimately host resistance effects. 
149 
CHAPTER 7. GENERAL CONCLUSIONS 
General Discussion 
This body of work covered a wide range of disciplines while investigating one mycotoxin, 
deoxynivalenol. Interest in this mycotoxin seemed warranted as it was ubiquitous in human 
food supplies, stable to all but alkaline food production processes, substantial but ineffective 
efforts to prevent cereal plant infection with DON-producing Fusarium fungi, and 
toxicological effects in monogastric species at DON doses similar to frequently occurring 
food supply levels. 
In order to conduct any analytical or screening method development, a reference 
method either in house or in a referral laboratory is required. HPLC was available in our 
laboratory but no internal standard addition methods had been published therefore 
established HPLC methods required a DON spiked sample along with the unknown to 
quantify the analyte. Caffeine proved to be a suitable internal standard due to its stability in 
the solvent systems, compatible UV absorbance, and absence from analytical samples of 
interest. Once a standard method was established, screening methods could be developed for 
comparison. As our knowledge of DON toxicity grew it became apparent that the immune 
system was particularly sensitive to DON exposure and development of a bioassay based on 
immune cell models would serve two purposes. K-562 cells were chosen as a model because 
they were one of the most sensitive cells to cytotoxicity from DON exposure which was 
comparable to human peripheral lymphocytes. Thus the K-562 assay could be used as a 
model for a known biological effect while being sensitive enough to screen cereal samples 
and accurately predict DON concentrations compared to HPLC analysis. 
The body of evidence investigating low dietary exposures (less than 10 ppm) to DON 
has revealed variable immunologic effects, unresponsive to immunosuppressive in numerous 
mouse strains. Impaired host resistance in mice and anecdotally in humans indicate the 
potential of effects. We hypothesized that immunotoxic effects of DON may be potentiated 
by an additional insult on the immune system, acute exercise stress. Two animal trials 
investigating this effect found supporting evidence for interaction between these two 
immunomodulating variables. The first study found suppressed PFCs to sRBC after two 
weeks of 2 ppm and a possible antagonistic but beneficial effect on lymphocyte proliferation 
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suppression. The second study did not support these finding for 2 ppm dietary DON after 28 
d feeding but interestingly found immunostimulation of NK cytotoxicity and PFCs due to 1 
ppm dietary DON which was slightly modulated by acute exercise stress. Both of these 
immune function assays measure ex vivo responses and together have shown high ability to 
predict true in vivo immunologic effects. The two animal studies differed in enough variables 
(age of animals tested, length of time of DON exposure, and source of dietary DON) that the 
studies were considered independent. The most likely reason for the apparent differences 
between the studies is the length of feeding as animals have shown adaptation to DON 
exposure over similar time periods. We hypothesized that 1 ppm dietary DON would be 
below the threshold for immunological effects of DON and were surprised by the stimulatory 
effects observed. Based on the cytokines measured, antagonistic effects between dietary 
DON and acute exercise stress seemed to act through independent mechanisms on 
lymphocyte subsets and cytokine production altering the balance between Thl/Th2 immune 
responses. 
Recommendations for Future Research 
This line of research could develop following numerous pathways. Initially the 
biological significance of immunostimulation should be investigated. Functionality of both 
the cellular and humoral arms of the immune system should be challenged as stimulation was 
observed in both i.e. Herpes simplex virus or tumor challenge and Listeria or Salmonella 
challenges. Investigations should attempt to define the length of exposure effect as it seems 
two different responses may be observed with this variable alone. Additional dose response 
studies are also warranted investigating lower dietary doses to define the dose-response 
curve. Additional insight into the mechanism of effect may be defined by broadening the 
battery of cytokines measured to include IL-12, IL-1, and any new cytokines for which 
reagents are available with possible involvement in the cellular effects observed. Concurrent 
with the challenge studies, immune cell populations and subsets should be investigated with 
specific marker phenotyping. This could be directly correlated with cytokine expression 
observed and has the advantages of being relatively easy to perform and directly reflects in 
vivo effects. Potentially more specific mechanistic information could be obtained from global 
investigation techniques becoming more popular. DON is an established protein synthesis 
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inhibitor although little is known about specificity or sensitivity to constitutively expressed 
proteins. The challenge to this approach will be development of the profile of proteins to be 
investigated. An ongoing line of research has focused on mRNA expression in response to 
DON exposure but known effects of DON are on transcription and cell signaling pathways 
questioning the utility of genomic investigations. Proteomic and/or metabolomic 
investigations may reveal high affinity protein alterations that may further characterize the 
molecular mechanisms of DON's in vivo immunomodulatory effects. 
Ultimately the worth of any of this research will only be validated if epidemiologic 
studies are conducted relating DON exposure in humans with risk of disease. Human illness 
has occurred concomitant with epidemics of moldy grain but definitive evidence of 
correlation has not been made. The ultimate question that deserves an answer: Does human 
exposure to dietary DON increase risk of disease with or without confounding 
immunomodulatory factors i.e. environmental stressors, nutritional deficiencies? 
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APPENDIX - HPLC ANALYSIS OF MURINE URINE AND FECAL SAMPLES 
Metabolic Cage Set-up for Urine and Feces Collection 
After the animals had been on treatment diets for at least 2 weeks, animals were 
placed in metabolic cages by random selection of the block order. This block order was 
maintained through the remainder of the experiment. Rat Nalgene® metabolic cages were 
modified to accommodate the comfort of the mice and most accurately collect urine and 
feces. A small gauge wire screen (3/8 inch chicken wire) was inserted over the floor of the 
cage. The rat food chute was not used. Alternatively the food biscuits were attached to a 
screen square placed outside of and over the food chute opening and close approximation 
was maintained with long rubber bands around the upper portion of the cage, therefore the 
mice ate their food through the squares of the grid and diet contamination of excretion was 
minimized. To increase recovery of urine and feces, the surface of the collection cone inside 
the cage was lightly coated with food-grade non-stick spray, urine was collected directly into 
a plastic 15 ml centrifuge tube and the animals were held in the metabolic cages for 48 hours. 
The inside of the collection funnel was rinsed with about 5 ml of 20% aqueous methanol to 
increase the recovery of urine. Fecal pellets were collected into a separate test tube with 
screw-top. Any large pieces of food that may have fallen into the collection tube were 
removed prior to storage of all samples at -20°C until analysis. Animals were rested in their 
shoebox cages for at least three days prior to any other procedure. 
Urine Analysis for Deoxynivalenol 
One the day of analysis, urine samples were thawed and divided in half into two 25 or 
50 ml flasks. An equal volume of acetate buffer (250 ml Milli-Q water, 5.78g sodium acetate, 
and 0.45 ml glacial acetic acid) was added to each sample. In one replicate, 5000 U 0-
glucuronidase was added and all flasks were sealed with Parafilm. Flasks were incubated 
overnight at 37°C on shaker water bath. 
Flasks were removed and allowed to cool and a stir bar was added. A volume of 
acetonitrile was added in the ratio 5.25 ml per ml of urine-buffer solution. The ACN was 
added slowly while the mixture was stirred and continued for 10 minutes. Solid phase 
extraction was accomplished by putting entire sample through a 5 g 20:1 alumina - charcoal 
column. Eluate was collected in a 125 ml round bottom flask. Do not allow the SPE packing 
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to go dry between extract additions. When last addition reaches the top of the packing, rinse 
the incubation flask with 5 ml of 84:16 aqueous ACN and add to column then allow to drain 
completely. Evaporate contents of round bottom flask on Rota-vap, with 50°C water bath, 
until about 1 ml residue left. Transfer to 12 X 75 cuvette with Pasteur pipette. Rinse flask 
twice with 1 ml DI water and add to cuvette. 
Precondition Sep-Pak C18 columns with 5 ml 100% methanol then 5 ml Milli-Q 
water. Load sample onto preconditioned column. Rinse Sep-Pak with 2 ml water, blow out 
residue water. Elute DON with 1 ml 40% aqueous methanol into a 12 X 75 cuvette. 
Evaporate sample completely under gently stream of nitrogen in 50°C water bath. Dissolve 
residue with 200 pi 20% aqueous methanol, briefly vortex, and filter through 0.45 pm 
syringe filter into plasma insert in HPLC autosampler vial. 
Samples (50 pi injection) were analyzed by HPLC/UV with flow rate of 0.7 ml/min. 
The following gradient was used: mobile phase 10% methanol, 90% buffered (pH -7.0) 
water, linear gradient to 30 minutes 10 to 15% methanol, 5 minutes 15 to 80% methanol, 3 
min at 80% methanol, 2 min to return to 10% methanol, then 15 min at 10% methanol for 
equilibration, total run time 55 minutes. 
Fecal analysis for Deoxynivalenol 
Fecal samples were dried at least 24 hours in exhaust hood prior to weighing and 
division of sample in half into two glass screw-top test tubes. Tubes were sealed with 
aluminum foil and samples were autoclaved for 5 min at 121°C, allow cooling in hood. 
Remove foil and add 2 ml of acetate buffer, sit on bench for 3-4 hours to soften fecal pellets. 
Samples were vortexed periodically to facilitate homogenization. Add 50 pi (^-glucuronidase 
(5000 U) to one sample replicate. Incubate all samples overnight in 37°C water bath. 
Transfer sample to 25 or 50 ml flask with magnetic stir bar, rinse tube with 1 ml 
acetate buffer, and stir sample for 10 min to break up any remaining fecal pellets. Add 15.75 
ml ACN slowly to sample while stirring and continue to mix for 30 min to extract DON. Run 
all of sample through SPE column of 2.5 g 40:1 alumina - charcoal packing in 12 ml syringe 
with #4 Whatman filter frit at bottom of syringe and ball of glass wool at top of packing. 
Collect eluate into large (20 ml) test tube. Rinse flask twice with 2 ml 84:16 aqueous ACN 
and add to SPE column. Drain completely then dry until about 1 ml residual extract under 
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gently stream of nitrogen in 50°C water bath. Add 1 ml water to sample tubes and vortex. 
Transfer sample by Pasteur pipette to open barrel of 3 cc syringe attached to preconditioned 
(as for urine) Sep-Pak C18 column. Rinse sample tube with 1 ml water and add to syringe 
before inserting the plunger and loading the sample on the Sep-Pak. Wash column with 2 ml 
water then elute DON with 2 ml 40% aqueous methanol into a 12 X 75 cuvette. Dry samples 
completely under gentle stream nitrogen in warm water bath. Dissolve residue with 150 |_il 
20% aqueous methanol and filter into plasma inserts in HPLC autosampler vials. 
Samples were analyzed by HPLC/UV with 50 pi injection with 1 ml/ min flow rate. 
Linear gradient with 6% methanol 94% buffered Milli-Q water as mobile phase, gradient to 
15% methanol in 40 min, step-up to 80% methanol in 5 min, hold at 80% for 3 min, 
equilibrate back to 6% methanol for 15 min with total run time per sample of 65 min. 
Results 
Numerous samples were utilized to optimize the analysis. Urine and feces from 
animals not fed DON were used for spiking samples and recovery. The following table gives 
data on DON intake and excretion from animals in the second mouse study, as available. 
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DON Intake and Excretion in B ALB/c Mice fed Dietary DON Subacutely 
Urine 
Mouse# DON 24h 24h 24h 3- Free Total % DON % DON % total % 
level feed DON ADON DON DON (ng) intake as intake as DON + excreted 
intake intake intake (ng) free DON total DON 3- as 
(g) (ng) (ng) ADON conjugate 
intake 
5 2 ppm 3.28 6510 5930 5161 7549 79.3 115.9 60.7 31.6 
13 2ppm 3.34 6630 6040 2348 2042 35.4 30.8 16.1 0 
17 2 ppm 2.82 5600 5100 3761 2867 67.2 51.2 26.8 0 
22 2 ppm 3.54 7030 6400 2803 3079 39.9 43.8 22.9 8.9 
29 2 ppm 2.9 5760 5240 7459 8963 129.5 155.6 81.5 16.8 
Mean 70.3 79.5 41.6 11.5 
sd 37.9 53.8 28.2 13.3 
33 1 ppm 3.37 3340 3040 1356 2895 40.6 86.7 45.4 53.1 
50 1 ppm 3.3 3270 2980 1042 5488 31.9 167.8 87.8 81 
55 1 ppm 2.81 2790 2540 374 811 13.4 29.1 15.2 53.8 
Mean 28.6 94.5 49.5 62.6 
sd 13.9 69.7 36.5 15.9 
Fecal 
2 2 ppm 3.06 6080 5530 225 282 3.7 4.6 2.4 20.3 
7 2 ppm 3.55 7050 6420 275 236 3.9 3.3 1.7 0 
8 2 ppm 2.77 5500 5010 614 697 11.2 12.7 6.6 12 
9 2 ppm 3.39 6730 6130 245 234 3.6 3.5 1.9 0 
20 2 ppm 3.21 6370 5800 415 265 6.5 4.2 2.2 0 
34 2 ppm 2.89 5740 5230 205 324 3.6 5.7 3 36.8 
38 2 ppm 2.95 5860 5330 238 313 4.1 5.3 2.8 23.9 
41 2 ppm 2.94 5840 5320 569 584 9.7 10 5.2 2.6 
44 2 ppm 2.94 5840 5320 364 320 6.2 5.5 2.9 0 
Mean 5.8 6.1 3.2 10.6 
sd 2.9 3.2 1.6 13.6 
1 1 ppm 2.93 2910 2650 355 283 12.2 9.7 5 0 
4 1 ppm 3.52 3490 3180 244 151 7 4.3 2.2 0 
6 1 ppm 2.76 2740 2490 219 667 8 24.3 12.7 67.2 
30 1 ppm 2.71 2690 2450 294 232 10.9 8.6 4.5 0 
43 1 ppm 3.23 3200 2920 63 352 2 11 5.8 82.3 
56 1 ppm 2.68 2660 2420 74 221 2.8 8.3 4.4 66.5 
Mean 7.2 11 5.8 36 
sd 4.1 6.9 3.6 39.8 
From this preliminary analysis of DON excreted in urine and feces from mice fed two 
dietary levels, the majority of DON was excreted in the urine while less than 10% was 
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excreted in the feces. No animals had data for both urine and feces therefore the total 
excretion could not be evaluated. Glucuronide conjugation did occur in these animals with 
interindividual variability. The inclusion of 3-ADON in the diet appeared to contribute to 
free and total DON excretion in some animals but not in others. From this data it was 
apparent mice excreted the majority of ingested DON through the urine and glucuronide 
conjugation occurred by variable extents across individuals. These animals were on test diets 
for at least 14 days prior to excrement collection so steady state intake and excretion should 
have been reached. Purified or confirmed DON only feeding would further define the 
metabolic pathway of DON. 
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